A;Fordøjelsesorganer og stofskifte;;Ingen fælles mængdeenhed;0;
A01;Midler mod sygdomme i mundhulen;;Ingen fælles mængdeenhed;0;
A01A;Stomatologica;;Ingen fælles mængdeenhed;0;
A01AA;Midler mod caries;;Pakninger;0;
A01AA01;Natriumfluorid;;Pakninger;0;
A01AB;Antiinfectiva til lokal brug i mundhulen;4;DDD;0;
A01AB02;Hydrogenperoxid;;ml eller g (præparat);0;
A01AB03;Chlorhexidin;;DDD;0;
A01AB04;Amphotericin;;DDD;0;
A01AB09;Miconazol;;DDD;0;
A01AB13;Tetracyclin;;Stk;0;
A01AB17;Metronidazol;;ml eller g (præparat);0;
A01AB22;Doxycyclin;;ml eller g (præparat);0;
A01AC;Corticosteroider til lokal brug i mundhulen;;ml eller g (præparat);0;
A01AC01;Triamcinolon;;ml eller g (præparat);0;
A01AD;Andre midler til lokal behandling i mundhulen;4;DDD;0;
A01AD01;Adrenalin;;Stk;0;
A01AD02;Benzydamin;;DDD;0;
A01AD11;Diverse;;ml eller g (præparat);0;
A02;Midler mod syrerelaterede forstyrrelser;3;DDD;0;
A02A;Antacida;3;DDD;0;
A02AA;Magnesiumforbindelser;;DDD;0;
A02AA04;Magnesiumhydroxid;;DDD;0;
A02AB;Aluminiumforbindelser;3;DDD;0;
A02AB01;Aluminiumoxid;3;DDD;0;
A02AB04;Dihydroxyaluminiumnatriumcarbonat;;DDD;0;
A02AB05;Aluminiumacetoacetat;3;DDD;0;
A02AC;Calciumforbindelser;;DDD;0;
A02AC02;Calciumsilicat;;DDD;0;
A02AD;Kombinationer og complexer af aluminium-, calcium-, og magnesium-forbindelser;;DDD;0;
A02AD01;Kombinationer af almindelige salte;;DDD;0;
A02AF;Antacida og midler mod flatulens;3;DDD;0;
A02AF**;(Ufuldstændig ATC-kode);3;DDD;0;
A02AH;Antacida og natriumhydrogencarbonat;3;DDD;0;
A02AH**;(Ufuldstændig ATC-kode);3;DDD;0;
A02B;Midler mod mavesår og gastro-oesophageal reflux (gord);3;DDD;0;
A02BA;H2-receptor antagonister;;DDD;0;
A02BA01;Cimetidin;;DDD;0;
A02BA02;Ranitidin;;DDD;0;
A02BA03;Famotidin;;DDD;0;
A02BA04;Nizatidin;;DDD;0;
A02BA07;Ranitidinbismuthcitrat;;DDD;0;
A02BB;Prostaglandiner;;DDD;0;
A02BB01;Misoprostol;;DDD;0;
A02BC;Protonpumpe-hæmmere;;DDD;0;
A02BC01;Omeprazol;;DDD;0;
A02BC02;Pantoprazol;;DDD;0;
A02BC03;Lansoprazol;;DDD;0;
A02BC04;Rabeprazol;;DDD;0;
A02BC05;Esomeprazol;;DDD;0;
A02BX;Andre midler mod mavesår og gastro-oesophageal reflux (gord);3;DDD;0;
A02BX02;Sucralfat;;DDD;0;
A02BX05;Bismuthsubcitrat;;DDD;0;
A02BX13;Alginsyre;3;DDD;0;
A03;Midler mod funktionelle gastrointestinale forstyrrelser;;DDD;0;
A03A;Midler mod funktionelle gastrointestinale forstyrrelser;;DDD;0;
A03AA;Synt. anticholin.estere med tertiære aminogrupper;;DDD;0;
A03AA04;Mebeverin;;DDD;0;
A03AB;Synt. anticholinergica, kvarternære ammoniumforb.;;DDD;0;
A03AB02;Glycopyrron;;DDD;0;
A03AB05;Propanthelin;;DDD;0;
A03AD;Papaverin og derivater;;DDD;0;
A03AD01;Papaverin;;DDD;0;
A03AX;Andre midler mod funktionelle gastrointestinale forstyrrelser;;DDD;0;
A03AX13;Silikoner;;DDD;0;
A03B;Belladonna og derivater, usammensatte præparater;;DDD;0;
A03BA;Belladonna-alkaloider, tertiære aminer;;DDD;0;
A03BA01;Atropin;;DDD;0;
A03BA03;Hyoscyamin;;DDD;0;
A03BB;Belladonna-alkal.semisynt.kvartern. ammoniumforb.;;DDD;0;
A03BB01;Butylscopolamin;;DDD;0;
A03F;Propulsives;;DDD;0;
A03FA;Propulsives;;DDD;0;
A03FA01;Metoclopramid;;DDD;0;
A03FA02;Cisaprid;;DDD;0;
A03FA03;Domperidon;;DDD;0;
A04;Antiemetica og midler mod kvalme;;Ingen fælles mængdeenhed;0;
A04A;Antiemetica og midler mod kvalme;;Ingen fælles mængdeenhed;0;
A04AA;Serotonin (5ht3) antagonister;2;DDD;0;
A04AA01;Ondansetron;;DDD;0;
A04AA02;Granisetron;;DDD;0;
A04AA03;Tropisetron;;DDD;0;
A04AA05;Palonosetron;;DDD;0;
A04AA55;Palonosetron, kombinationer;2;DDD;0;
A04AD;Andre antiemetica;;Ingen fælles mængdeenhed;0;
A04AD01;Scopolamin;3;DDD;0;
A04AD05;Metopimazin;;DDD;0;
A04AD10;Dronabinol;;mg (aktivt stof);0;
A04AD11;Nabilon;;DDD;0;
A04AD12;Aprepitant;;DDD;0;
A04AD54;Chlorbutanol, kombinationspræparater;3;DDD;0;
A05;Galde- og leverterapi;3;DDD;0;
A05A;Galdeterapi;3;DDD;0;
A05AA;Galdesyrer og derivater;3;DDD;0;
A05AA02;Ursodeoxycholsyre;;DDD;0;
A05AA03;Cholinsyre;3;DDD;0;
A05AA04;Obeticholsyre;;DDD;0;
A06;Midler mod obstipatio;1,2,3;DDD;0;
A06A;Midler mod obstipatio;1,2,3;DDD;0;
A06A***;(Ufuldstændig ATC-kode);3;DDD;0;
A06AB;Kontaktlaksantia;2,3;DDD;0;
A06AB02;Bisacodyl;;DDD;0;
A06AB06;Sennes-glycosider;3;DDD;0;
A06AB08;Natriumpicosulfat;;DDD;0;
A06AB20;Kontaktlaksantia i kombination;3;DDD;0;
A06AB58;Natriumpicosulfat, kombinationspræparater;2;DDD;0;
A06AC;Volumendannende laksantia;3;DDD;0;
A06AC01;Ispaghula (loppefrø);;DDD;0;
A06AC51;Ispaghula, kombinationspræparater;3;DDD;0;
A06AD;Osmotisk virkende laksantia;2,3;DDD;0;
A06AD**;(Ufuldstændig ATC-kode);3;DDD;0;
A06AD02;Magnesiumoxid;;DDD;0;
A06AD11;Lactulose;;DDD;0;
A06AD12;Lactitol;;DDD;0;
A06AD65;Macrogol, kombinationer;2,3;DDD;0;
A06AG;Klystermidler;1,3;DDD;0;
A06AG01;Natriumphosphat;3;DDD;0;
A06AG02;Bisacodyl;3;DDD;0;
A06AG06;Olie;3;DDD;0;
A06AG10;Natriumdocusat, incl. kombinationspræparater;1,3;DDD;0;
A06AG11;Natriumlaurilsulfoacetat, inkl. kombinationspræparater;3;DDD;0;
A06AH;Perifere opioidreceptor antagonister;;DDD;0;
A06AH01;Methylnaltrexonbromid;;DDD;0;
A06AH03;Naloxegol;;DDD;0;
A06AX;Andre midler mod obstipatio;3;DDD;0;
A06AX01;Glycerol;3;DDD;0;
A06AX04;Linaclotid;;DDD;0;
A06AX05;Prucaloprid;;DDD;0;
A07;Midler mod diare og tarminflammation/-infektion;2,3;DDD;0;
A07A;Intestinale antiinfectiva;;DDD;0;
A07AA;Antibiotica;;DDD;0;
A07AA02;Nystatin;;DDD;0;
A07AA09;Vancomycin;;DDD;0;
A07AA11;Rifaximin;;DDD;0;
A07AA12;Fidaxomicin;;DDD;0;
A07AC;Imidazol-derivater;;DDD;0;
A07AC01;Miconazol;;DDD;0;
A07B;Intestinale adsorptionsmidler;3;DDD;0;
A07BA;Kul-præparater;;DDD;0;
A07BA01;Aktivt kul;;DDD;0;
A07BB;Bismuth-præparater;3;DDD;0;
A07BB**;(Ufuldstændig ATC-kode);3;DDD;0;
A07C;Elektrolytter med kulhydrater;3;DDD;0;
A07CA;Orale rehydreringssalt-formuleringer;3;DDD;0;
A07CA**;(Ufuldstændig ATC-kode);3;DDD;0;
A07D;Antipropulsiva;2;DDD;0;
A07DA;Antipropulsiva;2;DDD;0;
A07DA01;Diphenoxylat;;DDD;0;
A07DA02;Opium;;DDD;0;
A07DA03;Loperamid;;DDD;0;
A07DA06;Eluxadolin;;DDD;0;
A07DA53;Loperamid, kombinationer;2;DDD;0;
A07E;Intestinale antiinflammatorica;3;DDD;0;
A07EA;Corticosteroider med lokal virkning;3;DDD;0;
A07EA01;Prednisolon;3;DDD;0;
A07EA02;Hydrocortison;3;DDD;0;
A07EA06;Budesonid;3;DDD;0;
A07EB;Antiallergica, excl. corticosteroider;;DDD;0;
A07EB01;Cromoglicinsyre;;DDD;0;
A07EC;Aminosalicylsyre og analoger;;DDD;0;
A07EC01;Sulfasalazin;;DDD;0;
A07EC02;Mesalazin;;DDD;0;
A07EC03;Olsalazin;;DDD;0;
A07EC04;Balsalazid;;DDD;0;
A07F;Mikroorganismer med virkning mod diare;3;DDD;0;
A07FA;Mikroorganismer med virkning mod diare;3;DDD;0;
A07FA01;Mælkesyreproducerende organismer;3;DDD;0;
A07FA02;Saccharomyces boulardii;;DDD;0;
A07X;Andre midler mod diare;3;DDD;0;
A07XA;Andre midler mod diare;3;DDD;0;
A07XA04;Racecadotril;3;DDD;0;
A08;Midler mod fedme, excl. diætmidler;2,3;DDD;0;
A08A;Midler mod fedme, excl. diætmidler;2,3;DDD;0;
A08AA;Centralt virkende anorexica;2,3;DDD;0;
A08AA02;Fenfluramin;;DDD;0;
A08AA03;Amfepramon;;DDD;0;
A08AA04;Dexfenfluramin;;DDD;0;
A08AA10;Sibutramin;;DDD;0;
A08AA56;Ephedrin, kombinationer;3;DDD;0;
A08AA62;Bupropion og naltrexon;2;DDD;0;
A08AB;Midler mod fedme med perifer virkning;;DDD;0;
A08AB01;Orlistat;;DDD;0;
A08AX;Andre midler mod fedme;;DDD;0;
A08AX01;Rimonabant;;DDD;0;
A09;Digestiva, incl. enzymer;2,3;DDD;0;
A09A;Digestiva, incl. enzymer;2,3;DDD;0;
A09AA;Enzympræparater;2,3;DDD;0;
A09AA02;Multienzymer (lipase, protease etc.);2,3;DDD;0;
A10;Antidiabetica;2;DDD;0;
A10A;Insuliner og analoger;;DDD;0;
A10AB;Insuliner og analoger til injektion, hurtigtvirkende;;DDD;0;
A10AB01;Insulin (human);;DDD;0;
A10AB04;Insulin lispro;;DDD;0;
A10AB05;Insulin aspart;;DDD;0;
A10AB06;Insulin glulisin;;DDD;0;
A10AC;Insuliner og analoger til injektion, middellang virkningstid;;DDD;0;
A10AC01;Insulin (human);;DDD;0;
A10AD;Insuliner og analoger t.inj., middel-/langtidsvirk. komb.m. hurtigtvirk;;DDD;0;
A10AD01;Insulin (human);;DDD;0;
A10AD04;Insulin lispro;;DDD;0;
A10AD05;Insulin aspart;;DDD;0;
A10AD06;Insulin degludec og insulin aspart;;DDD;0;
A10AE;Insuliner og analoger til injektion, langtidsvirkende;;DDD;0;
A10AE01;Insulin (human);;DDD;0;
A10AE04;Insulin glargin;;DDD;0;
A10AE05;Insulin detemir;;DDD;0;
A10AE06;Insulin degludec;;DDD;0;
A10AE54;Insulin glargin og lixisenatid;;DDD;0;
A10AE56;Insulin degludec og liraglutid;;DDD;0;
A10B;Blod-glucose sænkende midler, exkl. insuliner;2;DDD;0;
A10BA;Biguanider;;DDD;0;
A10BA02;Metformin;;DDD;0;
A10BB;Sulfonylcarbamid;;DDD;0;
A10BB01;Glibenclamid;;DDD;0;
A10BB03;Tolbutamid;;DDD;0;
A10BB07;Glipizid;;DDD;0;
A10BB09;Gliclazid;;DDD;0;
A10BB12;Glimepirid;;DDD;0;
A10BD;Komb. af orale blod-glucose sænkende midler;2;DDD;0;
A10BD03;Metformin og rosiglitazon;2;DDD;0;
A10BD04;Glimepirid og rosiglitazon;2;DDD;0;
A10BD07;Metformin og sitagliptin;2;DDD;0;
A10BD08;Metformin og vildagliptin;2;DDD;0;
A10BD09;Pioglitazon og alogliptin;2;DDD;0;
A10BD10;Metformin og saxagliptin;2;DDD;0;
A10BD11;Metformin og linagliptin;2;DDD;0;
A10BD13;Metformin og alogliptin;2;DDD;0;
A10BD15;Metformin og dapagliflozin;2;DDD;0;
A10BD16;Metformin og canagliflozin;2;DDD;0;
A10BD19;Linagliptin og empagliflozin;2;DDD;0;
A10BD20;Metformin og empagliflozin;2;DDD;0;
A10BD21;Saxagliptin og dapagliflozin;2;DDD;0;
A10BD23;Metformin og ertugliflozin;2;DDD;0;
A10BD24;Sitagliptin og ertugliflozin;2;DDD;0;
A10BF;Alfa-glucosidase hæmmere;;DDD;0;
A10BF01;Acarbose;;DDD;0;
A10BG;Thiazolindioner;;DDD;0;
A10BG02;Rosiglitazon;;DDD;0;
A10BG03;Pioglitazon;;DDD;0;
A10BH;Dipeptidylpeptidase 4 (dpp-4) hæmmere;;DDD;0;
A10BH01;Sitagliptin;;DDD;0;
A10BH02;Vildagliptin;;DDD;0;
A10BH03;Saxagliptin;;DDD;0;
A10BH04;Alogliptin;;DDD;0;
A10BH05;Linagliptin;;DDD;0;
A10BJ;Glucagon-lignende peptid-1 receptor (glp-1) analog;;DDD;0;
A10BJ01;Exenatid;;DDD;0;
A10BJ02;Liraglutid;;DDD;0;
A10BJ03;Lixisenatid;;DDD;0;
A10BJ05;Dulaglutid;;DDD;0;
A10BJ06;Semaglutid;;DDD;0;
A10BK;Natrium-glucose co-transporter 2 (sglt2) inhibitorer;;DDD;0;
A10BK01;Dapagliflozin;;DDD;0;
A10BK02;Canagliflozin;;DDD;0;
A10BK03;Empagliflozin;;DDD;0;
A10BK04;Ertugliflozin;;DDD;0;
A10BX;Andre  blod-glucose sænkende midler, ekskl. insuliner;;DDD;0;
A10BX02;Repaglinid;;DDD;0;
A10BX03;Nateglinid;;DDD;0;
A11;Vitaminer;1,3;DDD;0;
A11A;Multivitaminer, kombinationer;;DDD;0;
A11AA;Multivitaminer med mineraler;;DDD;0;
A11AA03;Multivitaminer og andre mineraler, incl. komb.;;DDD;0;
A11B;Multivitaminer, usammensatte;3;DDD;0;
A11BA;Multivitaminer, usammensatte;3;DDD;0;
A11BA**;(Ufuldstændig ATC-kode);3;DDD;0;
A11C;Vitamin a og d, incl. kombinationer af disse;1,3;DDD;0;
A11CA;Vitamin a, usammensatte præparater;;DDD;0;
A11CA01;Retinol (vitamin a);;DDD;0;
A11CB;Vitamin a og d i kombination;3;DDD;0;
A11CB**;(Ufuldstændig ATC-kode);3;DDD;0;
A11CC;Vitamin d og analoger;1,3;DDD;0;
A11CC01;Ergocalciferol;1,3;DDD;0;
A11CC02;Dihydrotachysterol;;DDD;0;
A11CC03;Alfacalcidol;;DDD;0;
A11CC04;Calcitriol;;DDD;0;
A11CC05;Colecalciferol;3;DDD;0;
A11D;Vitamin b1, også i komb. med vitamin b6 and b12;;DDD;0;
A11DA;Thiamin (vitamin b1), usammensatte præparater;;DDD;0;
A11DA01;Thiamin (vitamin b1);;DDD;0;
A11E;Vitamin b-complex, incl. kombinationer;3;DDD;0;
A11E***;(Ufuldstændig ATC-kode);3;DDD;0;
A11EA;Vitamin b-complex, uden andre stoffer;3;DDD;0;
A11EA**;(Ufuldstændig ATC-kode);3;DDD;0;
A11G;Ascorbinsyre (vitamin c), incl. kombinationer;;DDD;0;
A11GA;Ascorbinsyre (vitamin c), usammensatte præp.;;DDD;0;
A11GA01;Ascorbinsyre (vitamin c);;DDD;0;
A11H;Andre usammensatte vitaminpræparater;3;DDD;0;
A11HA;Andre usammensatte vitaminpræparater;3;DDD;0;
A11HA02;Pyridoxin (vitamin b6);;DDD;0;
A11HA03;Tocopherol (vitamin e);;DDD;0;
A11HA04;Riboflavin (vitamin b2);3;DDD;0;
A11HA05;Biotin;3;DDD;0;
A11HA08;Tocofersolan;;DDD;0;
A12;Mineralpræparater;1,2,3;DDD;0;
A12A;Calcium;1,2,3;DDD;0;
A12AA;Calcium;1;DDD;0;
A12AA**;(Ufuldstændig ATC-kode);;Ingen fælles mængdeenhed;0;
A12AA01;Calciumphosphat;;DDD;0;
A12AA02;Calciumglubionat;;DDD;0;
A12AA04;Calciumcarbonat;;DDD;0;
A12AA06;Calciumlactogluconat;;DDD;0;
A12AA07;Calciumchlorid;;DDD;0;
A12AX;Calcium, kombinationer med d-vitamin og/eller andre stoffer;2,3;DDD;0;
A12AX**;(Ufuldstændig ATC-kode);2,3;DDD;0;
A12B;Kalium;;DDD;0;
A12BA;Kalium;;DDD;0;
A12BA01;Kaliumchlorid;;DDD;0;
A12BA02;Kaliumcitrat;;DDD;0;
A12C;Andre mineralpræparater;3;DDD;0;
A12CA;Natrium;;DDD;0;
A12CA01;Natriumchlorid;;DDD;0;
A12CB;Zink;;DDD;0;
A12CB01;Zinksulfat;;DDD;0;
A12CC;Magnesium;3;DDD;0;
A12CC04;Magnesiumcitrat;;DDD;0;
A12CC30;Magnesium (forskellige salte i kombination);3;DDD;0;
A12CE;Selen;;DDD;0;
A12CE02;Natriumselenit;;DDD;0;
A14;Anaboliske midler til systemisk brug;;DDD;0;
A14A;Anaboliske steroider;;DDD;0;
A14AB;Estren-derivater;;DDD;0;
A14AB01;Nandrolon;;DDD;0;
A16;Andre midler til fordøjelsesorganer og stofskifte;3;DDD;0;
A16A;Andre midler til fordøjelsesorganer og stofskifte;3;DDD;0;
A16AA;Aminosyrer og derivater;;DDD;0;
A16AA04;Mercaptamin;;DDD;0;
A16AA05;Cargluminsyre;;DDD;0;
A16AA06;Betain;;DDD;0;
A16AB;Enzymer;3;DDD;0;
A16AB02;Imiglucerase;;DDD;0;
A16AB03;Agalsidase alfa;;DDD;0;
A16AB04;Agalsidase beta;;DDD;0;
A16AB05;Laronidase;;DDD;0;
A16AB07;Alglucosidase alfa;;DDD;0;
A16AB08;Galsulfase;3;DDD;0;
A16AB09;Idursulfase;3;DDD;0;
A16AB10;Velaglucerase alfa;;DDD;0;
A16AB12;Elosulfase alfa;;DDD;0;
A16AB13;Asfotase alfa;3;DDD;0;
A16AB15;Velmanase alfa;;DDD;0;
A16AX;Div. midler til fordøjelsesorganer og stofskifte;3;DDD;0;
A16AX03;Natriumphenylbutyrat;;DDD;0;
A16AX04;Nitisinon;;DDD;0;
A16AX05;Zinkacetat;;DDD;0;
A16AX06;Miglustat;;DDD;0;
A16AX07;Sapropterin;3;DDD;0;
A16AX08;Teduglutid;;DDD;0;
A16AX09;Glycerolphenylbutyrat;;DDD;0;
A16AX10;Eliglustat;;DDD;0;
A16AX12;Trientin;;DDD;0;
A16AX14;Migalastat;;DDD;0;
A16AX15;Telotristat;;DDD;0;
B;Blod og bloddannende organer;;Ingen fælles mængdeenhed;0;
B01;Antithrombosemidler;1,2,3;DDD;0;
B01A;Antithrombosemidler;1,2,3;DDD;0;
B01AA;Vitamin k antagonister;;DDD;0;
B01AA03;Warfarin;;DDD;0;
B01AA04;Phenprocoumon;;DDD;0;
B01AB;Heparin-gruppen;1;DDD;0;
B01AB01;Heparin;1;DDD;0;
B01AB02;Antithrombin;;DDD;0;
B01AB04;Dalteparin;;DDD;0;
B01AB05;Enoxaparin;;DDD;0;
B01AB06;Nadroparin;;DDD;0;
B01AB08;Reviparin;;DDD;0;
B01AB10;Tinzaparin;;DDD;0;
B01AC;Blodplade-aggregationshæmmere excl. heparin;2,3;DDD;0;
B01AC04;Clopidogrel;;DDD;0;
B01AC06;Acetylsalicylsyre;;DDD;0;
B01AC07;Dipyridamol;;DDD;0;
B01AC09;Epoprostenol;3;DDD;0;
B01AC11;Iloprost;;DDD;0;
B01AC13;Abciximab;;DDD;0;
B01AC16;Eptifibatid;;DDD;0;
B01AC17;Tirofiban;;DDD;0;
B01AC21;Treprostinil;;DDD;0;
B01AC22;Prasugrel;;DDD;0;
B01AC24;Ticagrelor;;DDD;0;
B01AC25;Cangrelor;;DDD;0;
B01AC27;Selexipag;;DDD;0;
B01AC30;Kombinationer;2;DDD;0;
B01AD;Enzymer;1,3;DDD;0;
B01AD01;Streptokinase;;DDD;0;
B01AD02;Alteplase;1;DDD;0;
B01AD04;Urokinase;;DDD;0;
B01AD07;Reteplase;;DDD;0;
B01AD10;Drotrecogin alfa (aktiveret);;DDD;0;
B01AD11;Tenecteplase;;DDD;0;
B01AD12;Protein c;3;DDD;0;
B01AE;Direkte virkende thrombin-inhibitorer;;DDD;0;
B01AE02;Lepirudin;;DDD;0;
B01AE03;Argatroban;;DDD;0;
B01AE04;Melagatran;;DDD;0;
B01AE05;Ximelagatran;;DDD;0;
B01AE06;Bivalirudin;;DDD;0;
B01AE07;Dabigatranetexilat;;DDD;0;
B01AF;Direkte faktor xa-hæmmere;;DDD;0;
B01AF01;Rivaroxaban;;DDD;0;
B01AF02;Apixaban;;DDD;0;
B01AF03;Edoxaban;;DDD;0;
B01AX;Andre antithrombosemidler;;DDD;0;
B01AX01;Defibrotid;;DDD;0;
B01AX05;Fondaparinux;;DDD;0;
B01AX07;Caplacizumab;;DDD;0;
B02;Haemostatica;;Ingen fælles mængdeenhed;0;
B02A;Antifibrinolytica;;DDD;0;
B02AA;Aminosyrer;;DDD;0;
B02AA02;Tranexamsyre;;DDD;0;
B02AB;Proteinase hæmmere;;DDD;0;
B02AB01;Aprotinin;;DDD;0;
B02AB02;Alfa1 antitrypsin;;DDD;0;
B02B;Vitamin k og andre haemostatica;;Ingen fælles mængdeenhed;0;
B02BA;Vitamin k;;DDD;0;
B02BA01;Phytomenadion;;DDD;0;
B02BB;Fibrinogen;;DDD;0;
B02BB01;Human fibrinogen;;DDD;0;
B02BC;Haemostatica til lokal brug;;Stk;0;
B02BC**;(Ufuldstændig ATC-kode);;Stk;0;
B02BC01;Absorberbar gelatinesvamp;;Stk;0;
B02BC02;Oxideret cellulose;;Stk;0;
B02BC05;Adrenalon;;Stk;0;
B02BC30;Kombinationer;;Stk;0;
B02BD;Blodkoagulationsfaktorer;;Ingen fælles mængdeenhed;0;
B02BD01;Koagulationsfaktor ix, ii, vii og x i kombination;;Tusind enheder;0;
B02BD02;Koagulationsfaktor viii;4;Tusind enheder;0;
B02BD03;Faktor viii-hæmmer passerende koagulationsfaktor;;Tusind enheder;0;
B02BD04;Koagulationsfaktor ix;;Tusind enheder;0;
B02BD06;Von willebrand faktor og koag.faktor viii i komb.;;Tusind enheder;0;
B02BD07;Koagulationsfaktor xiii;;Tusind enheder;0;
B02BD08;Koagulationsfaktor viia;;Tusind enheder;0;
B02BD10;Von willebrand faktor;;Tusind enheder;0;
B02BD11;Catridecacog;;Tusind enheder;0;
B02BX;Andre systemiske haemostatica;;DDD;0;
B02BX04;Romiplostim;;DDD;0;
B02BX05;Eltrombopag;;DDD;0;
B02BX06;Emicizumab;;DDD;0;
B02BX08;Avatrombopag;;DDD;0;
B03;Midler mod anæmi;3;DDD;0;
B03A;Jernpræparater;3;DDD;0;
B03AA;Jern(ii), orale midler;;DDD;0;
B03AA01;Ferroglycinsulfat;;DDD;0;
B03AA03;Ferrogluconat;;DDD;0;
B03AA06;Ferrosuccinat;;DDD;0;
B03AA07;Ferrosulfat;;DDD;0;
B03AA08;Ferrotartrat;;DDD;0;
B03AB;Jern(iii), orale midler;;DDD;0;
B03AB05;Ferrioxid-polymaltosekomplekser;;DDD;0;
B03AB10;Ferrimaltol;;DDD;0;
B03AC;Jern, parenterale midler;;DDD;0;
B03AC**;(Ufuldstændig ATC-kode);;DDD;0;
B03AE;Jern i andre kombinationer;3;DDD;0;
B03AE02;Jern, multivitaminer og folsyre;3;DDD;0;
B03B;Vitamin b12 og folsyre;3;DDD;0;
B03BA;Vitamin b12 (cyanocobalamin og derivater);;DDD;0;
B03BA01;Cyanocobalamin;;DDD;0;
B03BA02;Cyanocobalamin-tannin-komplex;;DDD;0;
B03BA03;Hydroxocobalamin;;DDD;0;
B03BB;Folsyre og derivater;3;DDD;0;
B03BB01;Folsyre;3;DDD;0;
B03X;Andre midler mod anæmi;;DDD;0;
B03XA;Andre midler mod anæmi;;DDD;0;
B03XA01;Erythropoietin;;DDD;0;
B03XA02;Darbepoetin alfa;;DDD;0;
B03XA03;Methoxypolyethylenglycol-epoetin beta;;DDD;0;
B03XA06;Luspatercept;;DDD;0;
B05;Blodsubstitutter og perfusionsvæsker;1;L;0;
B05A;Blod og beslægtede produkter;;L;0;
B05AA;Blodsubstitutter og plasmaprotein-fraktioner;;L;0;
B05AA**;(Ufuldstændig ATC-kode);;L;0;
B05AA01;Albumin;;L;0;
B05AA05;Dextran;;L;0;
B05AA06;Gelatineforbindelser;;L;0;
B05AA07;Hydroxyethylstivelse;;L;0;
B05B;Infusionsvæsker;1;L;0;
B05BA;Opløsninger til parenteral ernæring;1;L;0;
B05BA**;(Ufuldstændig ATC-kode);;Ingen fælles mængdeenhed;0;
B05BA01;Aminosyrer;;L;0;
B05BA02;Fedtemulsioner;;L;0;
B05BA03;Kulhydrater;;L;0;
B05BA10;Kombinationer;;L;0;
B05BB;Opløsninger med virkning på elektrolytbalancen;1;L;0;
B05BB**;(Ufuldstændig ATC-kode);;Ingen fælles mængdeenhed;0;
B05BB01;Elektrolytter;;L;0;
B05BB02;Elektrolytter med kulhydrater;;L;0;
B05BC;Opløsninger til osmotisk diurese;;L;0;
B05BC01;Mannitol;;L;0;
B05C;Skyllevæsker;;L;0;
B05CA;Antiinfectiva;;L;0;
B05CA02;Chlorhexidin;;L;0;
B05CB;Saltopløsninger;;L;0;
B05CB01;Natriumchlorid;;L;0;
B05CB03;Magnesiumcitrat;;L;0;
B05CB10;Kombinationer (saltopløsninger);;L;0;
B05CX;Andre skyllevæsker;;L;0;
B05CX03;Glycin;;L;0;
B05CX10;Kombinationer (andre skyllevæsker);;L;0;
B05D;Peritonealdialysevæsker;1;L;0;
B05D***;(Ufuldstændig ATC-kode);1;L;0;
B05DA;Isotoniske opløsninger;;L;0;
B05DA**;(Ufuldstændig ATC-kode);;L;0;
B05DB;Hypertoniske opløsninger;;L;0;
B05DB**;(Ufuldstændig ATC-kode);;L;0;
B05X;Infusionskoncentrater;;L;0;
B05X***;(Ufuldstændig ATC-kode);;L;0;
B05XA;Elektrolyt-opløsninger;;L;0;
B05XA01;Kaliumchlorid;;L;0;
B05XA02;Natriumhydrogencarbonat;;L;0;
B05XA03;Natriumchlorid;;L;0;
B05XA04;Ammoniumchlorid;;L;0;
B05XA05;Magnesiumsulfat;;L;0;
B05XA06;Kaliumphosphat, incl. komb. m. andre kaliumsalte;;L;0;
B05XA07;Calciumchlorid;;L;0;
B05XA14;Natriumglycerophosphat;;L;0;
B05XA16;Kardioplegi-opløsninger;;L;0;
B05XA18;Zinksulfat;;L;0;
B05XA31;Elektrolytter i komb. med andre stoffer;;L;0;
B05XB;Aminosyrer;;L;0;
B05XB02;Alanylglutamin;;L;0;
B05XC;Vitaminer;;L;0;
B05XC**;(Ufuldstændig ATC-kode);;L;0;
B05Z;Hæmodialysevæsker og hæmofiltrater;1;L;0;
B05ZA;Hæmodialysekoncentrater;;Ingen fælles mængdeenhed;0;
B05ZA**;(Ufuldstændig ATC-kode);;Ingen fælles mængdeenhed;0;
B05ZB;Hæmofiltrater;;L;0;
B05ZB**;(Ufuldstændig ATC-kode);;L;0;
B06;Andre hæmatologiske midler;3,4;DDD;0;
B06A;Andre hæmatologiske midler;3,4;DDD;0;
B06AA;Enzymer;;Stk;0;
B06AA55;Streptokinase, kombinationer;;Stk;0;
B06AB;Hæmprodukter;3;DDD;0;
B06AB01;Hæmin;3;DDD;0;
B06AC;Midler til arvelig angioødem;;DDD;0;
B06AC01;C1-inhibitor, fra plasma;;DDD;0;
B06AC02;Icatibant;;DDD;0;
B06AC04;Conestat alfa;;DDD;0;
B06AC05;Lanadelumab;;DDD;0;
C;Kardiovaskulære system;;Ingen fælles mængdeenhed;0;
C01;Hjerteterapi;1,3;DDD;0;
C01A;Hjerteglycosider;;DDD;0;
C01AA;Digitalis-glycosider;;DDD;0;
C01AA05;Digoxin;;DDD;0;
C01B;Anti-arytmica, klasse i og iii;;DDD;0;
C01BA;Anti-arytmica, klasse i a;;DDD;0;
C01BA01;Quinidin;;DDD;0;
C01BA03;Disopyramid;;DDD;0;
C01BB;Anti-arytmica, klasse i b;;DDD;0;
C01BB01;Lidocain;;DDD;0;
C01BB02;Mexiletin;;DDD;0;
C01BC;Antiarytmica, klasse i c;;DDD;0;
C01BC03;Propafenon;;DDD;0;
C01BC04;Flecainid;;DDD;0;
C01BD;Anti-arhytmica, klasse iii;;DDD;0;
C01BD01;Amiodaron;;DDD;0;
C01BD07;Dronedaron;;DDD;0;
C01BG;Andre anti-arytmica, klasse i og iii;;DDD;0;
C01BG11;Vernakalant;;DDD;0;
C01C;Hjertestimulerende midler excl. hjerteglycosider;1;DDD;0;
C01CA;Adrenerge og dopaminerge midler;1;DDD;0;
C01CA01;Etilefrin;;DDD;0;
C01CA02;Isoprenalin;;DDD;0;
C01CA03;Noradrenalin;;DDD;0;
C01CA04;Dopamin;;DDD;0;
C01CA06;Phenylephrin;;DDD;0;
C01CA07;Dobutamin;;DDD;0;
C01CA13;Prenalterol;;DDD;0;
C01CA14;Dopexamin;;DDD;0;
C01CA17;Midodrin;;DDD;0;
C01CA24;Adrenalin;;DDD;0;
C01CA26;Efedrin;1;DDD;0;
C01CE;Phosphodiesterase hæmmere;;DDD;0;
C01CE02;Milrinon;;DDD;0;
C01CX;Andre hjertestimulerende midler;;DDD;0;
C01CX08;Levosimendan;;DDD;0;
C01D;Vasodilatorer anvendt ved hjertesygdomme;3;DDD;0;
C01DA;Organiske nitrater;3;DDD;0;
C01DA02;Glyceryltrinitrat;3;DDD;0;
C01DA08;Isosorbiddinitrat;;DDD;0;
C01DA14;Isosorbidmononitrat;;DDD;0;
C01DX;Andre vasodilatorer anvendt ved hjertesygdom;3;DDD;0;
C01DX16;Nicorandil;;DDD;0;
C01DX22;Vericiguat;3;DDD;0;
C01E;Andre midler til hjerteterapi;;DDD;0;
C01EA;Prostaglandiner;;DDD;0;
C01EA01;Alprostadil;;DDD;0;
C01EB;Andre hjertemidler;;DDD;0;
C01EB10;Adenosin;;DDD;0;
C01EB15;Trimetazidin;;DDD;0;
C01EB16;Ibuprofen;;DDD;0;
C01EB17;Ivabradin;;DDD;0;
C01EB21;Regadenoson;;DDD;0;
C02;Antihypertensiva;;DDD;0;
C02A;Antiadrenerge midler, centralt virkende;;DDD;0;
C02AB;Methyldopa;;DDD;0;
C02AB01;Methyldopa (l-form);;DDD;0;
C02AC;Imidazolin-receptor agonister;;DDD;0;
C02AC01;Clonidin;;DDD;0;
C02AC02;Guanfacin;;DDD;0;
C02AC05;Moxonidin;;DDD;0;
C02C;Antiadrenerge midler, perifert virkende;;DDD;0;
C02CA;Alfa-adrenoceptor blokerende midler;;DDD;0;
C02CA01;Prazosin;;DDD;0;
C02CA04;Doxazosin;;DDD;0;
C02D;Arteriolær glat muskulatur, midler m. virkn. på;;DDD;0;
C02DB;Hydrazinophthalazin-derivater;;DDD;0;
C02DB01;Dihydralazin;;DDD;0;
C02DB02;Hydralazin;;DDD;0;
C02DD;Nitroferricyanid-derivater;;DDD;0;
C02DD01;Nitroprussid;;DDD;0;
C02DG;Guanidin-derivater;;DDD;0;
C02DG01;Pinacidil;;DDD;0;
C02K;Andre antihypertensiva;;DDD;0;
C02KX;Antihypertensiva til pulmonal arteriel hypertension;;DDD;0;
C02KX01;Bosentan;;DDD;0;
C02KX02;Ambrisentan;;DDD;0;
C02KX03;Sitaxentan;;DDD;0;
C02KX04;Macitentan;;DDD;0;
C02KX05;Riociguat;;DDD;0;
C03;Diuretica;2;DDD;0;
C03A;Low-ceiling diuretica, thiazider;;DDD;0;
C03AA;Thiazider, usammensatte præparater;;DDD;0;
C03AA01;Bendroflumethiazid;;DDD;0;
C03AA02;Hydroflumethiazid;;DDD;0;
C03AA03;Hydrochlorthiazid;;DDD;0;
C03AA04;Chlorthiazid;;DDD;0;
C03AA05;Polythiazid;;DDD;0;
C03AB;Thiazider og kalium i kombination;;DDD;0;
C03AB01;Bendroflumethiazid og kalium;;DDD;0;
C03AB02;Hydroflumethiazid og kalium;;DDD;0;
C03B;Low-ceiling diuretica, excl. thiazider;;DDD;0;
C03BA;Sulfonamider, usammensatte;;DDD;0;
C03BA03;Clopamid;;DDD;0;
C03BA04;Chlortalidon;;DDD;0;
C03BA05;Mefrusid;;DDD;0;
C03BA08;Metolazon;;DDD;0;
C03BA11;Indapamid;;DDD;0;
C03BB;Sulfonamider og kalium i kombination;;DDD;0;
C03BB03;Clopamid og kalium;;DDD;0;
C03C;High-ceiling diuretica;;DDD;0;
C03CA;Sulfonamider, usammensatte;;DDD;0;
C03CA01;Furosemid;;DDD;0;
C03CA02;Bumetanid;;DDD;0;
C03CB;Sulfonamider og kalium i kombination;;DDD;0;
C03CB02;Bumetanid og kalium;;DDD;0;
C03D;Aldosteronantagonister og andre kaliumbesparende midler;;DDD;0;
C03DA;Aldosteron-antagonister;;DDD;0;
C03DA01;Spironolacton;;DDD;0;
C03DA02;Kaliumcanrenoat;;DDD;0;
C03DA04;Eplerenon;;DDD;0;
C03DB;Andre kaliumbesparende midler;;DDD;0;
C03DB01;Amilorid;;DDD;0;
C03E;Diuretica og kaliumbesparende midler i komb.;2;DDD;0;
C03EA;Low-ceiling diuretica og kaliumbesparende midler;2;DDD;0;
C03EA01;Hydrochlorthiazid og kaliumbesparende midler;2;DDD;0;
C03EB;High-ceiling diuretica og kaliumbesparende midler;2;DDD;0;
C03EB01;Furosemid og kaliumbesparende midler;2;DDD;0;
C03EB02;Bumetanid og kaliumbesparende midler;2;DDD;0;
C03X;Andre diuretika;;DDD;0;
C03XA;Vasopressin antagonister;;DDD;0;
C03XA01;Tolvaptan;;DDD;0;
C04;Perifere vasodilatorer;;DDD;0;
C04A;Perifere vasodilatorer;;DDD;0;
C04AB;Imidazolin-derivater;;DDD;0;
C04AB01;Phentolamin;;DDD;0;
C04AC;Nicotinsyre og derivater;;DDD;0;
C04AC01;Nicotinsyre;;DDD;0;
C04AD;Purin-derivater;;DDD;0;
C04AD03;Pentoxifyllin;;DDD;0;
C05;Vasoprotectiva;;Ingen fælles mængdeenhed;0;
C05A;Midler til behandling af hæmorider og analfissurer til lokalt brug;3,4;;0;
C05AA;Corticosteroider;3;DDD;0;
C05AA01;Hydrocortison;3;DDD;0;
C05AA05;Betamethason;3;DDD;0;
C05AA08;Fluocortolon;3;DDD;0;
C05AD;Lokalanæstetica;3;DDD;0;
C05AD01;Lidocain;3;DDD;0;
C05AD03;Benzocain;3;DDD;0;
C05AE;Muskelafslappende midler;3,4;;0;
C05AE01;Glyceryltrinitrat;3;DDD;0;
C05AE03;Diltiazem;;ml eller g (præparat);0;
C05AX;Andre midler til behandling af hæmorider og analfissurer til lokalt brug;3;DDD;0;
C05AX02;Bismuthpræparater, kombinationer;3;DDD;0;
C05B;Antivarice terapi;;ml eller g (præparat);0;
C05BA;Hepariner eller heparinoider til lokalt brug;;ml eller g (præparat);0;
C05BA01;Organo-heparinoid;;ml eller g (præparat);0;
C05BB;Scleroserende midler til lokal injektion;;ml eller g (præparat);0;
C05BB02;Polidocanol;;ml eller g (præparat);0;
C05C;Kapillærstabiliserende midler;3;DDD;0;
C05CA;Bioflavonoider;3;DDD;0;
C05CA02;Monoxerutin;3;DDD;0;
C05CA53;Diosmin, kombinationer;3;DDD;0;
C07;Beta-blokerende midler;2,3;DDD;0;
C07A;Beta-blokerende midler, usammensatte;3;DDD;0;
C07AA;Beta-blokerende midler, usammensatte, non-selekt.;;DDD;0;
C07AA01;Alprenolol;;DDD;0;
C07AA02;Oxprenolol;;DDD;0;
C07AA03;Pindolol;;DDD;0;
C07AA05;Propranolol;;DDD;0;
C07AA06;Timolol;;DDD;0;
C07AA07;Sotalol;;DDD;0;
C07AA16;Tertatolol;;DDD;0;
C07AB;Beta-blokerende midler, usammensatte, selektive;3;DDD;0;
C07AB02;Metoprolol;;DDD;0;
C07AB03;Atenolol;;DDD;0;
C07AB04;Acebutolol;;DDD;0;
C07AB05;Betaxolol;;DDD;0;
C07AB07;Bisoprolol;;DDD;0;
C07AB09;Esmolol;;DDD;0;
C07AB12;Nebivolol;;DDD;0;
C07AB14;Landiolol;3;DDD;0;
C07AG;Alfa- og beta-blokerende midler;;DDD;0;
C07AG01;Labetalol;;DDD;0;
C07AG02;Carvedilol;;DDD;0;
C07B;Beta-blokerende midler og thiazider;2;DDD;0;
C07BA;Beta-blokkere, non-selektive og thiazider;2;DDD;0;
C07BA06;Timolol og thiazider;2;DDD;0;
C07BB;Beta-blokkere, selektive, og thiazider;2;DDD;0;
C07BB02;Metoprolol og thiazider;2;DDD;0;
C07BB12;Nebivolol og thiazider;2;DDD;0;
C07C;Beta-blokkere og andre diuretica;2;DDD;0;
C07CA;Beta-blokkere, non-selektive, og andre diuretica;2;DDD;0;
C07CA03;Pindolol og andre diuretica;2;DDD;0;
C07CB;Beta-blokkere, selektive, og andre diuretica;2;DDD;0;
C07CB03;Atenolol og andre diuretica;2;DDD;0;
C07F;Beta-blokkere, andre kombinationer;2;DDD;0;
C07FB;Beta-blokerende midler og calciumantagonister;2;DDD;0;
C07FB02;Metoprolol og felodipin;2;DDD;0;
C08;Calciumantagonister;2;DDD;0;
C08C;Selektive calciumantagonister m. overv. vaskulær effekt;;DDD;0;
C08CA;Dihydropyridin-derivater;;DDD;0;
C08CA01;Amlodipin;;DDD;0;
C08CA02;Felodipin;;DDD;0;
C08CA03;Isradipin;;DDD;0;
C08CA04;Nicardipin;;DDD;0;
C08CA05;Nifedipin;;DDD;0;
C08CA06;Nimodipin;;DDD;0;
C08CA08;Nitrendipin;;DDD;0;
C08CA09;Lacidipin;;DDD;0;
C08CA10;Nilvadipin;;DDD;0;
C08CA13;Lercanidipin;;DDD;0;
C08CX;Andre selekt. calciumantagonister m. primært vasculær effekt;;DDD;0;
C08CX01;Mibefradil;;DDD;0;
C08D;Selektive calciumantagonister m. direkte cardiel effekt;2;DDD;0;
C08DA;Phenylalkylamin-derivater;2;DDD;0;
C08DA01;Verapamil;;DDD;0;
C08DA51;Verapamil, kombinationer;2;DDD;0;
C08DB;Benzothiazepin-derivater;;DDD;0;
C08DB01;Diltiazem;;DDD;0;
C09;Midler med virkning på renin-angiotensin systemet;2;DDD;0;
C09A;Ace-hæmmere, usammensatte;;DDD;0;
C09AA;Ace-hæmmere, usammensatte;;DDD;0;
C09AA01;Captopril;;DDD;0;
C09AA02;Enalapril;;DDD;0;
C09AA03;Lisinopril;;DDD;0;
C09AA04;Perindopril;;DDD;0;
C09AA05;Ramipril;;DDD;0;
C09AA06;Quinapril;;DDD;0;
C09AA07;Benazepril;;DDD;0;
C09AA09;Fosinopril;;DDD;0;
C09AA10;Trandolapril;;DDD;0;
C09AA13;Moexipril;;DDD;0;
C09AA15;Zofenopril;;DDD;0;
C09B;Ace-hæmmere, kombinationer;2;DDD;0;
C09BA;Ace-hæmmere og diuretica;2;DDD;0;
C09BA01;Captopril og diuretica;2;DDD;0;
C09BA02;Enalapril og diuretica;2;DDD;0;
C09BA03;Lisinopril og diuretica;2;DDD;0;
C09BA04;Perindopril og diuretica;2;DDD;0;
C09BA05;Ramipril og diuretica;2;DDD;0;
C09BA07;Benazepril og diuretica;2;DDD;0;
C09BA15;Zofenopril og diuretica;2;DDD;0;
C09BB;Ace-hæmmere og calciumantagonister;2;DDD;0;
C09BB02;Enalapril og lercanidipin;2;DDD;0;
C09BB04;Perindopril og amlodipin;2;DDD;0;
C09C;Angiotensin ii receptor blokkere (arbs), usammensatte;;DDD;0;
C09CA;Angiotensin ii receptor blokkere (arbs), usammensatte;;DDD;0;
C09CA01;Losartan;;DDD;0;
C09CA02;Eprosartan;;DDD;0;
C09CA03;Valsartan;;DDD;0;
C09CA04;Irbesartan;;DDD;0;
C09CA06;Candesartan;;DDD;0;
C09CA07;Telmisartan;;DDD;0;
C09CA08;Olmesartanmedoxomil;;DDD;0;
C09D;Angiotensin ii receptor blokkere (arbs), kombinationer;2;DDD;0;
C09DA;Angiotensin ii receptor blokkere (arbs) og diuretica;2;DDD;0;
C09DA01;Losartan og diuretica;2;DDD;0;
C09DA02;Eprosartan og diuretica;2;DDD;0;
C09DA03;Valsartan og diuretica;2;DDD;0;
C09DA04;Irbesartan og diuretica;2;DDD;0;
C09DA06;Candesartan og diuretica;2;DDD;0;
C09DA07;Telmisartan og diuretica;2;DDD;0;
C09DA08;Olmesartanmedoxomil og diuretica;2;DDD;0;
C09DB;Angiotensin ii receptor blokkere (arbs) og calciumantagonister (ccb);2;DDD;0;
C09DB01;Valsartan og amlodipin;2;DDD;0;
C09DX;Angiotensin ii receptor blokkere (arbs), andre kombinationer;2;DDD;0;
C09DX01;Valsartan, amlodipin og hydrochlorthiazid;2;DDD;0;
C09DX04;Valsartan og sacubitril;2;DDD;0;
C09X;Andre midler med virkn. på renin-angiotensin systemet;;DDD;0;
C09XA;Renin-inhibitorer;;DDD;0;
C09XA02;Aliskiren;;DDD;0;
C09XA52;Aliskiren og hydrochlorthiazid;;DDD;0;
C10;Lipid-modificerende midler;2;DDD;0;
C10A;Lipid-modificerende midler, usammensatte;;DDD;0;
C10AA;Hmg coa reduktase-inhibitorer;;DDD;0;
C10AA01;Simvastatin;;DDD;0;
C10AA02;Lovastatin;;DDD;0;
C10AA03;Pravastatin;;DDD;0;
C10AA04;Fluvastatin;;DDD;0;
C10AA05;Atorvastatin;;DDD;0;
C10AA06;Cerivastatin;;DDD;0;
C10AA07;Rosuvastatin;;DDD;0;
C10AB;Fibrater;;DDD;0;
C10AB01;Clofibrat;;DDD;0;
C10AB02;Bezafibrat;;DDD;0;
C10AB04;Gemfibrozil;;DDD;0;
C10AC;Galdesyrebindende midler;;DDD;0;
C10AC01;Colestyramin;;DDD;0;
C10AC02;Colestipol;;DDD;0;
C10AC04;Colesevelam;;DDD;0;
C10AD;Nicotinsyre og derivater;;DDD;0;
C10AD06;Acipimox;;DDD;0;
C10AD52;Nicotinsyre, kombinationer;;DDD;0;
C10AX;Andre lipid-modificerende midler;;DDD;0;
C10AX06;Omega-3-triglycerider inkl. andre estre og syrer;;DDD;0;
C10AX09;Ezetimib;;DDD;0;
C10AX12;Lomitapid;;DDD;0;
C10AX13;Evolocumab;;DDD;0;
C10AX14;Alirocumab;;DDD;0;
C10B;Lipid-modificerende midler, komb.;2;DDD;0;
C10BA;Lipid-modificerende midler, kombinationer;2;DDD;0;
C10BA02;Simvastatin og ezetimib;2;DDD;0;
C10BA05;Atorvastatin og ezetimibe;2;DDD;0;
D;Dermatologiske midler;;Ingen fælles mængdeenhed;0;
D01;Fungicider til dermatologisk brug;;Ingen fælles mængdeenhed;0;
D01A;Fungicider til udvortes brug;;ml eller g (præparat);0;
D01AA;Antibiotica;;ml eller g (præparat);0;
D01AA01;Nystatin;;ml eller g (præparat);0;
D01AC;Imidazol- og triazol-derivater;;ml eller g (præparat);0;
D01AC01;Clotrimazol;;ml eller g (præparat);0;
D01AC02;Miconazol;;ml eller g (præparat);0;
D01AC03;Econazol;;ml eller g (præparat);0;
D01AC08;Ketoconazol;;ml eller g (præparat);0;
D01AC10;Bifonazol;;ml eller g (præparat);0;
D01AC20;Imidazoler/triazoler i kombination med corticosteroider;;ml eller g (præparat);0;
D01AC60;Bifonazol kombinationer;;ml eller g (præparat);0;
D01AE;Andre fungicider til udvortes brug;;ml eller g (præparat);0;
D01AE02;Methylrosanilin;;ml eller g (præparat);0;
D01AE14;Ciclopirox;;ml eller g (præparat);0;
D01AE15;Terbinafin;;ml eller g (præparat);0;
D01AE16;Amorolfin;;ml eller g (præparat);0;
D01AE20;Kombinationer;;ml eller g (præparat);0;
D01B;Fungicider til systemisk brug;;DDD;0;
D01BA;Fungicider til systemisk brug;;DDD;0;
D01BA01;Griseofulvin;;DDD;0;
D01BA02;Terbinafin;;DDD;0;
D02;Blødgørende og hudbeskyttende midler;;ml eller g (præparat);0;
D02A;Blødgørende og hudbeskyttende midler;;ml eller g (præparat);0;
D02AA;Siliconepræparater;;ml eller g (præparat);0;
D02AA**;(Ufuldstændig ATC-kode);;ml eller g (præparat);0;
D02AB;Zinkoxidpræparater;;ml eller g (præparat);0;
D02AB**;(Ufuldstændig ATC-kode);;ml eller g (præparat);0;
D02AC;Vaselin og fedtstoffer;;ml eller g (præparat);0;
D02AC**;(Ufuldstændig ATC-kode);;ml eller g (præparat);0;
D02AE;Carbamidpræparater;;ml eller g (præparat);0;
D02AE01;Carbamid;;ml eller g (præparat);0;
D02AF;Salicylsyrepræparater;;ml eller g (præparat);0;
D02AF**;(Ufuldstændig ATC-kode);;ml eller g (præparat);0;
D02AX;Andre blødgørende og hudbeskyttende midler;;ml eller g (præparat);0;
D02AX**;(Ufuldstændig ATC-kode);;ml eller g (præparat);0;
D03;Midler til sårbehandling;;ml eller g (præparat);0;
D03A;Sårhelende midler;;ml eller g (præparat);0;
D03AA;Levertransalver;;ml eller g (præparat);0;
D03AA**;(Ufuldstændig ATC-kode);;ml eller g (præparat);0;
D03AX;Andre sårhelende midler;;ml eller g (præparat);0;
D03AX01;Cadexomer iod;;ml eller g (præparat);0;
D03AX03;Dexpanthenol;;ml eller g (præparat);0;
D03B;Enzymer;;ml eller g (præparat);0;
D03BA;Proteolytiske enzymer;;ml eller g (præparat);0;
D03BA03;Bromelainer;;ml eller g (præparat);0;
D04;Kløestillende midler, incl. antihistaminer, anæstetica, etc.;;ml eller g (præparat);0;
D04A;Kløestillende midler, incl. antihistaminer, anæstetica, etc.;;ml eller g (præparat);0;
D04AA;Antihistaminer til dermatologisk brug;;ml eller g (præparat);0;
D04AA02;Mepyramin;;ml eller g (præparat);0;
D04AB;Lokalanæstetica til dermatologisk brug;;ml eller g (præparat);0;
D04AB01;Lidocain;;ml eller g (præparat);0;
D04AB02;Cinchocain;;ml eller g (præparat);0;
D04AB04;Benzocain;;ml eller g (præparat);0;
D04AX;Andre kløestillende midler;;ml eller g (præparat);0;
D04AX**;(Ufuldstændig ATC-kode);;ml eller g (præparat);0;
D05;Midler mod psoriasis;;Ingen fælles mængdeenhed;0;
D05A;Midler mod psoriasis til udvortes brug;;ml eller g (præparat);0;
D05AA;Tjæreholdige præparater;;ml eller g (præparat);0;
D05AA**;(Ufuldstændig ATC-kode);;ml eller g (præparat);0;
D05AC;Antracen-derivater;;ml eller g (præparat);0;
D05AC01;Dithranol;;ml eller g (præparat);0;
D05AX;Andre midler mod psoriasis til udvortes brug;;ml eller g (præparat);0;
D05AX**;(Ufuldstændig ATC-kode);;ml eller g (præparat);0;
D05AX02;Calcipotriol;;ml eller g (præparat);0;
D05AX52;Calcipotriol, kombinationer;;ml eller g (præparat);0;
D05B;Midler mod psoriasis til systemisk brug;;DDD;0;
D05BA;Psoralener til systemisk brug;;DDD;0;
D05BA02;Methoxalen, systemisk;;DDD;0;
D05BB;Retinoider til psoriasisbehandling;;DDD;0;
D05BB02;Acitretin;;DDD;0;
D06;Antibiotica og chemotherapeutica til dermatologisk brug;;ml eller g (præparat);0;
D06A;Antibiotica til udvortes brug;;ml eller g (præparat);0;
D06AA;Tetracyclin og derivater;;ml eller g (præparat);0;
D06AA03;Oxytetracyclin;;ml eller g (præparat);0;
D06AX;Andre antibiotica til udvortes brug;;ml eller g (præparat);0;
D06AX01;Fusidinsyre;;ml eller g (præparat);0;
D06AX07;Gentamicin;;ml eller g (præparat);0;
D06AX09;Mupirocin;;ml eller g (præparat);0;
D06AX13;Retapamulin;;ml eller g (præparat);0;
D06B;Chemotherapeutica til udvortes brug;;ml eller g (præparat);0;
D06BA;Sulfonamider;;ml eller g (præparat);0;
D06BA01;Sølvsulfadiazin;;ml eller g (præparat);0;
D06BB;Antivirale midler;;ml eller g (præparat);0;
D06BB01;Idoxuridin;;ml eller g (præparat);0;
D06BB02;Tromantadin;;ml eller g (præparat);0;
D06BB03;Aciclovir;;ml eller g (præparat);0;
D06BB04;Podophyllotoxin;;ml eller g (præparat);0;
D06BB06;Penciclovir;;ml eller g (præparat);0;
D06BB10;Imiquimod;;ml eller g (præparat);0;
D06BB11;Docosanol;;ml eller g (præparat);0;
D06BB12;Sinecatechins;;ml eller g (præparat);0;
D06BB53;Aciclovir, kombinationer;;ml eller g (præparat);0;
D06BX;Andre chemotherapeutica;;ml eller g (præparat);0;
D06BX01;Metronidazol;;ml eller g (præparat);0;
D06BX02;Ingenolmebutat;;ml eller g (præparat);0;
D07;Corticosteroider til dermatologisk brug;;ml eller g (præparat);0;
D07A;Corticosteroider til udvortes brug, usammensatte;;ml eller g (præparat);0;
D07AA;Corticosteroider, svagt virk. (gruppe i);;ml eller g (præparat);0;
D07AA02;Hydrocortison;;ml eller g (præparat);0;
D07AB;Corticosteroider, middelstærkt virk. (gruppe ii);;ml eller g (præparat);0;
D07AB01;Clobetason;;ml eller g (præparat);0;
D07AB02;Hydrocortisonbutyrat;;ml eller g (præparat);0;
D07AB07;Flupredniden;;ml eller g (præparat);0;
D07AB09;Triamcinolon;;ml eller g (præparat);0;
D07AB10;Alclometason;;ml eller g (præparat);0;
D07AB11;Hydrocortisonbuteprat;;ml eller g (præparat);0;
D07AC;Corticosteroider, stærkt virk. (gruppe iii);;ml eller g (præparat);0;
D07AC01;Betamethason;;ml eller g (præparat);0;
D07AC03;Desoximetason;;ml eller g (præparat);0;
D07AC04;Fluocinolon;;ml eller g (præparat);0;
D07AC05;Fluocortolon;;ml eller g (præparat);0;
D07AC06;Diflucortolon;;ml eller g (præparat);0;
D07AC08;Fluocinonid;;ml eller g (præparat);0;
D07AC09;Budesonid;;ml eller g (præparat);0;
D07AC10;Diflorason;;ml eller g (præparat);0;
D07AC13;Mometason;;ml eller g (præparat);0;
D07AC17;Fluticason;;ml eller g (præparat);0;
D07AD;Corticosteroider, ekstra stærkt virk. (gruppe iv);;ml eller g (præparat);0;
D07AD01;Clobetasol;;ml eller g (præparat);0;
D07AD02;Halcinonid;;ml eller g (præparat);0;
D07B;Corticosteroider i kombination med antiseptica;;ml eller g (præparat);0;
D07BB;Corticosteroider (gruppe ii) og antiseptica;;ml eller g (præparat);0;
D07BB01;Flumetason og antiseptica;;ml eller g (præparat);0;
D07BB03;Triamcinolon og antiseptica;;ml eller g (præparat);0;
D07BB04;Hydrocortisonbutyrat og antiseptica;;ml eller g (præparat);0;
D07BC;Corticosteroider (gruppe iii) og antiseptica;;ml eller g (præparat);0;
D07BC01;Betamethason og antiseptica;;ml eller g (præparat);0;
D07BC02;Fluocinolon og antiseptica;;ml eller g (præparat);0;
D07C;Corticosteroider i kombination med antibiotica;;ml eller g (præparat);0;
D07CA;Corticosteroider (gruppe i) og antibiotica;;ml eller g (præparat);0;
D07CA01;Hydrocortison og antibiotica;;ml eller g (præparat);0;
D07CB;Corticosteroider (gruppe ii) og antibiotica;;ml eller g (præparat);0;
D07CB01;Triamcinolon og antibiotica;;ml eller g (præparat);0;
D07CC;Corticosteroider (gruppe iii) og antibiotica;;ml eller g (præparat);0;
D07CC01;Betamethason og antibiotica;;ml eller g (præparat);0;
D07X;Corticosteroider, andre kombinationer;;ml eller g (præparat);0;
D07XA;Corticosteroider (gruppe i), andre kombinationer;;ml eller g (præparat);0;
D07XA01;Hydrocortison;;ml eller g (præparat);0;
D07XB;Corticosteroider (gruppe ii), andre kombinationer;;ml eller g (præparat);0;
D07XB01;Flumetason;;ml eller g (præparat);0;
D07XB02;Triamcinolon;;ml eller g (præparat);0;
D07XC;Corticosteroider (gruppe iii), andre kombinationer;;ml eller g (præparat);0;
D07XC01;Betamethason;;ml eller g (præparat);0;
D07XC02;Desoximetason;;ml eller g (præparat);0;
D08;Antiseptica og desinficerende midler;;ml eller g (præparat);0;
D08A;Antiseptica og desinficerende midler;;ml eller g (præparat);0;
D08AB;Aluminiumforbindelser;;ml eller g (præparat);0;
D08AB**;(Ufuldstændig ATC-kode);;ml eller g (præparat);0;
D08AC;Biguanider og amidiner;;ml eller g (præparat);0;
D08AC02;Chlorhexidin;;ml eller g (præparat);0;
D08AD;Borsyrepræparater;;ml eller g (præparat);0;
D08AD**;(Ufuldstændig ATC-kode);;ml eller g (præparat);0;
D08AF;Furan-derivater;;ml eller g (præparat);0;
D08AF01;Nitrofural;;ml eller g (præparat);0;
D08AG;Iodpræparater;;ml eller g (præparat);0;
D08AG03;Iod;;ml eller g (præparat);0;
D08AL;Sølvforbindelser;;ml eller g (præparat);0;
D08AL01;Sølvnitrat;;ml eller g (præparat);0;
D08AX;Andre antiseptica og desinficerende midler;;ml eller g (præparat);0;
D08AX**;(Ufuldstændig ATC-kode);;ml eller g (præparat);0;
D08AX01;Hydrogenperoxid;;ml eller g (præparat);0;
D09;Medicinske forbindsstoffer;;Stk;0;
D09A;Medicinske forbindsstoffer;;Stk;0;
D09AA;Salvekompresser med antiinfectiva;;Stk;0;
D09AA01;Framycetin;;Stk;0;
D09AA02;Fusidinsyre;;Stk;0;
D09AB;Zinkbandager;;Stk;0;
D09AB01;Zinkbandage uden tilsætninger;;Stk;0;
D10;Midler mod acne;;Ingen fælles mængdeenhed;0;
D10A;Midler mod acne til udvortes brug;;ml eller g (præparat);0;
D10AA;Corticosteroider, komb. til acnebehandling;;ml eller g (præparat);0;
D10AA02;Methylprednisolon;;ml eller g (præparat);0;
D10AB;Svovlholdige acne-midler;;ml eller g (præparat);0;
D10AB02;Svovl;;ml eller g (præparat);0;
D10AD;Retinoider til udvortes brug mod acne;;ml eller g (præparat);0;
D10AD01;Tretinoin;;ml eller g (præparat);0;
D10AD03;Adapalen;;ml eller g (præparat);0;
D10AD04;Isotretinoin;;ml eller g (præparat);0;
D10AD53;Adapalen, kombinationer;;ml eller g (præparat);0;
D10AE;Peroxider;;ml eller g (præparat);0;
D10AE01;Benzoylperoxid;;ml eller g (præparat);0;
D10AF;Antiinfectiva til acne-behandling;;ml eller g (præparat);0;
D10AF01;Clindamycin;;ml eller g (præparat);0;
D10AF51;Clindamycin, komb.;;ml eller g (præparat);0;
D10AX;Andre midler mod acne til udvortes brug;;ml eller g (præparat);0;
D10AX03;Azelainsyre;;ml eller g (præparat);0;
D10B;Midler mod acne til systemisk brug;;DDD;0;
D10BA;Retinoider til behandling af acne;;DDD;0;
D10BA01;Isotretinoin;;DDD;0;
D11;Andre dermatologiske midler;;Ingen fælles mængdeenhed;0;
D11A;Andre dermatologiske midler;;Ingen fælles mængdeenhed;0;
D11AA;Antihidrotica;;ml eller g (præparat);0;
D11AA**;(Ufuldstændig ATC-kode);;ml eller g (præparat);0;
D11AC;Medicinsk shampoo;;ml eller g (præparat);0;
D11AC03;Selenforbindelser;;ml eller g (præparat);0;
D11AC30;Medicinsk shampoo, andre;;ml eller g (præparat);0;
D11AF;Midler mod vorter og ligtorne;4;ml eller g (præparat);0;
D11AF**;(Ufuldstændig ATC-kode);4;ml eller g (præparat);0;
D11AH;Midler til dermatitis, ekskl. corticosteroider;;Ingen fælles mængdeenhed;0;
D11AH01;Tacrolimus;;ml eller g (præparat);0;
D11AH02;Pimecrolimus;;ml eller g (præparat);0;
D11AH04;Alitretinoin;;DDD;0;
D11AH05;Dupilumab;;DDD;0;
D11AH07;Tralokinumab;3;DDD;0;
D11AX;Andre dermatologiske midler;;Ingen fælles mængdeenhed;0;
D11AX01;Minoxidil, udvortes;;ml eller g (præparat);0;
D11AX02;Gamolensyre;;DDD;0;
D11AX10;Finasterid;;DDD;0;
D11AX11;Hydroquinon;;ml eller g (præparat);0;
D11AX16;Eflornithin;;ml eller g (præparat);0;
D11AX18;Diclofenac;;ml eller g (præparat);0;
D11AX21;Brimonidin;;ml eller g (præparat);0;
D11AX22;Ivermectin;;ml eller g (præparat);0;
D11AX24;Deoxycholsyre;;ml eller g (præparat);0;
G;Urogenitalsystem og kønshormoner;;Ingen fælles mængdeenhed;0;
G01;Gynecologiske antiinfectiva og antiseptica;;DDD;0;
G01A;Antiinfectiva/antisept.,excl komb. m. corticost.;;DDD;0;
G01AA;Antibiotica;;DDD;0;
G01AA10;Clindamycin;;DDD;0;
G01AF;Imidazol-derivater;;DDD;0;
G01AF01;Metronidazol;;DDD;0;
G01AF02;Clotrimazol;;DDD;0;
G01AF04;Miconazol;;DDD;0;
G01AF05;Econazol;;DDD;0;
G01AG;Triazol-derivater;;DDD;0;
G01AG02;Terconazol;;DDD;0;
G01AX;Andre antiinfectiva og antiseptica;;DDD;0;
G01AX03;Metacresolsulfonsyre-formaldehyd;;DDD;0;
G02;Andre gynækologiske midler;;Ingen fælles mængdeenhed;0;
G02A;Uterotonica;;DDD;0;
G02AB;Secale-alkaloider;;DDD;0;
G02AB01;Methylergometrin;;DDD;0;
G02AD;Prostaglandiner;;DDD;0;
G02AD02;Dinoproston;;DDD;0;
G02AD03;Gemeprost;;DDD;0;
G02AD04;Carboprost;;DDD;0;
G02AD06;Misoprostol;;DDD;0;
G02B;Antikonceptionelle midler til lokal applikation;;Ingen fælles mængdeenhed;0;
G02BA;Intrauterine antikonceptionelle midler;;Stk;0;
G02BA03;Plast intrauterint indlæg med gestagen;;Stk;0;
G02BB;Intravaginale antikonceptionelle midler;3;DDD;0;
G02BB01;Vaginal ring med gestagen og østrogen;3;DDD;0;
G02C;Andre gynækologiske midler;;DDD;0;
G02CA;Sympathomimetics, labour repressants;;DDD;0;
G02CA01;Ritodrin;;DDD;0;
G02CB;Prolactin inhibitorer;;DDD;0;
G02CB03;Cabergolin;;DDD;0;
G02CB04;Quinagolid;;DDD;0;
G02CX;Andre gynækologiske midler;;DDD;0;
G02CX01;Atosiban;;DDD;0;
G03;Kønshormoner og modulatorer af genitalsystemet;2,3;DDD;0;
G03A;Hormonale antikonceptiva til systemisk brug;3;DDD;0;
G03AA;Gestagener og østrogener, faste kombinationer;3;DDD;0;
G03AA01;Etynodiol og estradiol;3;DDD;0;
G03AA03;Lynestrenol og ethinylestradiol;3;DDD;0;
G03AA05;Norethisteron og ethinylestradiol;3;DDD;0;
G03AA07;Levonorgestrel og ethinylestradiol;3;DDD;0;
G03AA09;Desogestrel og ethinylestradiol;3;DDD;0;
G03AA10;Gestoden og ethinylestradiol;3;DDD;0;
G03AA11;Norgestimat og ethinylestradiol;3;DDD;0;
G03AA12;Drospirenon og ethinylestradiol;3;DDD;0;
G03AA13;Norelgestromin og ethinylestradiol;3;DDD;0;
G03AA14;Nomegestrol og estradiol;3;DDD;0;
G03AA16;Dienogest og ethinylestradiol;3;DDD;0;
G03AB;Gestagener og østrogener, sekvenspræparater;3;DDD;0;
G03AB03;Levonorgestrel og ethinylestradiol;3;DDD;0;
G03AB04;Norethisteron og ethinylestradiol;3;DDD;0;
G03AB05;Desogestrel og ethinylestradiol;3;DDD;0;
G03AB06;Gestoden og ethinylestradiol;3;DDD;0;
G03AB08;Dienogest og estradiol;3;DDD;0;
G03AC;Gestagener;3;DDD;0;
G03AC01;Norethisteron;3;DDD;0;
G03AC02;Lynestrenol;3;DDD;0;
G03AC03;Levonorgestrel;3;DDD;0;
G03AC06;Medroxyprogesteron;;DDD;0;
G03AC08;Etonogestrel;;DDD;0;
G03AC09;Desogestrel;3;DDD;0;
G03AC10;Drospirenon;3;DDD;0;
G03AD;Nødprævention;3;DDD;0;
G03AD**;(Ufuldstændig ATC-kode);3;DDD;0;
G03AD01;Levonorgestrel;;DDD;0;
G03AD02;Ulipristal;;DDD;0;
G03B;Androgener;;DDD;0;
G03BA;3-oxoandrosten(4)-derivater;;DDD;0;
G03BA03;Testosteron;;DDD;0;
G03BB;5-androstanon(3)-derivater;;DDD;0;
G03BB01;Mesterolon;;DDD;0;
G03C;Østrogener;2,3;DDD;0;
G03CA;Naturlige og semisyntetiske østrogener, usammensatte;3;DDD;0;
G03CA03;Estradiol;;DDD;0;
G03CA04;Estriol;;DDD;0;
G03CA53;Estradiol, kombinationer;3;DDD;0;
G03CA57;Konjugerede østrogener;;DDD;0;
G03CB;Syntetiske østrogener, usammensatte;;DDD;0;
G03CB01;Dienestrol;;DDD;0;
G03CC;Østrogener, kombinationer med andre stoffer;2;DDD;0;
G03CC07;Konjugerede østrogener og bazedoxifen;2;DDD;0;
G03CX;Andre østrogener;;DDD;0;
G03CX01;Tibolon;;DDD;0;
G03D;Gestagener;;DDD;0;
G03DA;Pregnen(4)-derivater;;DDD;0;
G03DA02;Medroxyprogesteron;;DDD;0;
G03DA04;Progesteron;;DDD;0;
G03DB;Pregnadien-derivater;;DDD;0;
G03DB01;Dydrogesteron;;DDD;0;
G03DB08;Dienogest;;DDD;0;
G03DC;Estren-derivater;;DDD;0;
G03DC02;Norethisteron;;DDD;0;
G03DC03;Lynestrenol;;DDD;0;
G03F;Gestagener og østrogener i kombination;3;DDD;0;
G03FA;Gestagener og østrogener, kombinationer;3;DDD;0;
G03FA01;Norethisteron og østrogen;3;DDD;0;
G03FA11;Levonorgestrel og østrogen;3;DDD;0;
G03FA12;Medroxyprogesteron og østrogen;3;DDD;0;
G03FA15;Dienogest og østrogen;3;DDD;0;
G03FA17;Drospirenon og østrogen;3;DDD;0;
G03FB;Gestagener og østrogener, sekvenspræparater;3;DDD;0;
G03FB01;Norgestrel og østrogen;3;DDD;0;
G03FB05;Norethisteron og østrogen;3;DDD;0;
G03FB06;Medroxyprogesteron og østrogen;3;DDD;0;
G03FB09;Levonorgestrel og østrogen;3;DDD;0;
G03FB11;Trimegeston og østrogen;3;DDD;0;
G03G;Gonadotropin og andre ovulationsstimul. midler;2,3;DDD;0;
G03GA;Gonadotropiner;2,3;DDD;0;
G03GA01;Choriongonadotropin;;DDD;0;
G03GA02;Gonadotropin, human menopausal;;DDD;0;
G03GA04;Urofollitropin;;DDD;0;
G03GA05;Follitropin alfa;;DDD;0;
G03GA06;Follitropin beta;;DDD;0;
G03GA07;Lutropin alfa;;DDD;0;
G03GA08;Choriongonadotropin alfa;;DDD;0;
G03GA09;Corifollitropin alfa;;DDD;0;
G03GA10;Follitropin delta;;DDD;0;
G03GA30;Kombinationer;2,3;DDD;0;
G03GB;Ovulationsstimulerende midler, syntetiske;;DDD;0;
G03GB02;Clomifen;;DDD;0;
G03H;Antiandrogener;2,3;DDD;0;
G03HA;Antiandrogener, usammensatte;;DDD;0;
G03HA01;Cyproteron;;DDD;0;
G03HB;Antiandrogener og østrogener;2,3;DDD;0;
G03HB01;Cyproteron og østrogen;2,3;DDD;0;
G03X;Andre kønshormoner og modulatorer af genitalsyst.;;DDD;0;
G03XA;Antigonadotropiner og lignende stoffer;;DDD;0;
G03XA01;Danazol;;DDD;0;
G03XA02;Gestrinon;;DDD;0;
G03XB;Progesteron-receptormodulatorer;;DDD;0;
G03XB01;Mifepriston;;DDD;0;
G03XB02;Ulipristal;;DDD;0;
G03XC;Selektive østrogenreceptor-modulatorer;;DDD;0;
G03XC01;Raloxifen;;DDD;0;
G03XX;Andre kønshormoner og modulatorer af genitalsystemet;;DDD;0;
G03XX01;Prasteron;;DDD;0;
G04;Urologica;2,3;DDD;0;
G04B;Urologiske midler;2,3;DDD;0;
G04BD;Midler mod hyppig urinering og inkontinens;;DDD;0;
G04BD01;Emepron;;DDD;0;
G04BD02;Flavoxat;;DDD;0;
G04BD04;Oxybutynin;;DDD;0;
G04BD07;Tolterodin;;DDD;0;
G04BD08;Solifenacin;;DDD;0;
G04BD09;Trospium;;DDD;0;
G04BD10;Darifenacin;;DDD;0;
G04BD11;Fesoterodin;;DDD;0;
G04BD12;Mirabegron;;DDD;0;
G04BE;Midler anvendt ved erektionsforstyrrelser;2,3;DDD;0;
G04BE01;Alprostadil;;DDD;0;
G04BE02;Papaverin;3;DDD;0;
G04BE03;Sildenafil;;DDD;0;
G04BE04;Yohimbin;;DDD;0;
G04BE07;Apomorphin;;DDD;0;
G04BE08;Tadalafil;;DDD;0;
G04BE09;Vardenafil;;DDD;0;
G04BE10;Avanafil;;DDD;0;
G04BE30;Kombinationer;2;DDD;0;
G04BX;Andre urologica;;DDD;0;
G04BX14;Dapoxetin;;DDD;0;
G04BX15;Pentosanpolysulfatnatrium;;DDD;0;
G04C;Midler anvendt ved benign prostatahypertrofi;2;DDD;0;
G04CA;Alfa-adrenoreceptor antagonister;2;DDD;0;
G04CA01;Alfuzosin;;DDD;0;
G04CA02;Tamsulosin;;DDD;0;
G04CA03;Terazosin;;DDD;0;
G04CA52;Tamsulosin og dutasterid;2;DDD;0;
G04CA53;Tamsulosin og solifenacin;2;DDD;0;
G04CB;Testosteron-5-alfa-reduktase inhibitorer;;DDD;0;
G04CB01;Finasterid;;DDD;0;
G04CB02;Dutasterid;;DDD;0;
H;Systemiske hormonpræparater, excl. kønshormoner;3;DDD;0;
H01;Hypofyse- og hypothalamus-hormoner og analoger;3;DDD;0;
H01A;Hypofyseforlap-hormoner og analoger;3;DDD;0;
H01AA;Acth;;DDD;0;
H01AA02;Tetracosactid;;DDD;0;
H01AB;Thyrotropin;;DDD;0;
H01AB01;Thyrotropin alfa;;DDD;0;
H01AC;Somatropin og somatropin agonister;3;DDD;0;
H01AC01;Somatropin;;DDD;0;
H01AC03;Mecasermin;;DDD;0;
H01AC07;Somapacitan;3;DDD;0;
H01AX;Andre hypofyseforlap-hormoner og analoger;;DDD;0;
H01AX01;Pegvisomant;;DDD;0;
H01B;Hypofysebaglap-hormoner;;DDD;0;
H01BA;Vasopressin og analoger;;DDD;0;
H01BA01;Vasopressin (argipressin);;DDD;0;
H01BA02;Desmopressin;;DDD;0;
H01BA04;Terlipressin;;DDD;0;
H01BB;Oxytocin og analoger;;DDD;0;
H01BB02;Oxytocin;;DDD;0;
H01BB03;Carbetocin;;DDD;0;
H01C;Hypothalamus-hormoner;;DDD;0;
H01CA;Gonadotropin-releasing hormoner;;DDD;0;
H01CA02;Nafarelin;;DDD;0;
H01CB;Somatostatin og analoger;;DDD;0;
H01CB02;Octreotid;;DDD;0;
H01CB03;Lanreotid;;DDD;0;
H01CB05;Pasireotid;;DDD;0;
H01CC;Anti gonadotropin releasing hormoner;;DDD;0;
H01CC01;Ganirelix;;DDD;0;
H01CC02;Cetrorelix;;DDD;0;
H02;Corticosteroider til systemisk brug;3;DDD;0;
H02A;Corticosteroider til systemisk brug, usammensatte;3;DDD;0;
H02AA;Mineralocorticoider;;DDD;0;
H02AA02;Fludrocortison;;DDD;0;
H02AB;Glucocorticoider;3;DDD;0;
H02AB01;Betamethason;;DDD;0;
H02AB02;Dexamethason;;DDD;0;
H02AB04;Methylprednisolon;;DDD;0;
H02AB06;Prednisolon;3;DDD;0;
H02AB07;Prednison;;DDD;0;
H02AB08;Triamcinolon;;DDD;0;
H02AB09;Hydrocortison;;DDD;0;
H02AB10;Cortison;;DDD;0;
H03;Thyreoidea-terapi;;DDD;0;
H03A;Thyreoideapræparater;;DDD;0;
H03AA;Thyreoideahormoner;;DDD;0;
H03AA01;Levothyroxinnatrium;;DDD;0;
H03AA02;Liothyroninnatrium;;DDD;0;
H03AA05;Thyreoideakirtel-præparater;;DDD;0;
H03B;Antithyreoide præparater;;DDD;0;
H03BA;Thiouraciler;;DDD;0;
H03BA02;Propylthiouracil;;DDD;0;
H03BB;Svovlholdige imidazol-derivater;;DDD;0;
H03BB01;Carbimazol;;DDD;0;
H03BB02;Thiamazol;;DDD;0;
H03C;Iod-terapi;;DDD;0;
H03CA;Iod-terapi;;DDD;0;
H03CA**;(Ufuldstændig ATC-kode);;DDD;0;
H04;Pancreas-hormoner;;DDD;0;
H04A;Glycogenolytiske hormoner;;DDD;0;
H04AA;Glycogenolytiske hormoner;;DDD;0;
H04AA01;Glucagon;;DDD;0;
H05;Calciumhomeostase;;DDD;0;
H05A;Parathyroidea-hormoner og analoger;;DDD;0;
H05AA;Parathyroidea-hormoner og analoger;;DDD;0;
H05AA02;Teriparatid;;DDD;0;
H05AA03;Parathyroideahormon;;DDD;0;
H05B;Anti-parathyroide midler;;DDD;0;
H05BA;Calcitoninpræparater;;DDD;0;
H05BA01;Calcitonin (laks, syntetisk);;DDD;0;
H05BX;Andre anti-parathyroide midler;;DDD;0;
H05BX01;Cinacalcet;;DDD;0;
H05BX02;Paricalcitol;;DDD;0;
H05BX04;Etelcalcetid;;DDD;0;
J;Midler mod infektionssygdomme til systemisk brug;;Ingen fælles mængdeenhed;0;
J01;Antibakterielle midler til systemisk brug;1,2,3,5;DDD;0;
J01****;(Ufuldstændig ATC-kode);;Ingen fælles mængdeenhed;0;
J01A;Tetracycliner;;DDD;0;
J01AA;Tetracycliner;;DDD;0;
J01AA02;Doxycyclin;;DDD;0;
J01AA04;Lymecyclin;;DDD;0;
J01AA06;Oxytetracyclin;;DDD;0;
J01AA07;Tetracyclin;;DDD;0;
J01AA12;Tigecyclin;;DDD;0;
J01B;Amphenicoler;;DDD;0;
J01BA;Amphenicoler;;DDD;0;
J01BA01;Chloramphenicol;;DDD;0;
J01C;Beta-lactam antibakterica, penicilliner;5;DDD;0;
J01CA;Penicilliner med udvidet spektrum;5;DDD;0;
J01CA01;Ampicillin;5;DDD;0;
J01CA02;Pivampicillin;;DDD;0;
J01CA04;Amoxicillin;;DDD;0;
J01CA06;Bacampicillin;;DDD;0;
J01CA08;Pivmecillinam;;DDD;0;
J01CA11;Mecillinam;5;DDD;0;
J01CA12;Piperacillin;;DDD;0;
J01CA20;Kombinationer;;DDD;0;
J01CE;Beta-lactamase sensitive penicilliner;5;DDD;0;
J01CE01;Benzylpenicillin;5;DDD;0;
J01CE02;Phenoxymethylpenicillin;;DDD;0;
J01CE08;Benzathin benzylpenicillin;;DDD;0;
J01CE09;Procain penicillin;;DDD;0;
J01CF;Beta-lactamase resistente penicilliner;5;DDD;0;
J01CF01;Dicloxacillin;5;DDD;0;
J01CF02;Cloxacillin;5;DDD;0;
J01CF03;Methicillin;;DDD;0;
J01CF05;Flucloxacillin;;DDD;0;
J01CR;Komb. af penicilliner, incl. beta-lactamase inhib.;5;DDD;0;
J01CR02;Amoxicillin og beta-lactamaseinhibitor;;DDD;0;
J01CR05;Piperacillin og beta-lactamaseinhibitor;5;DDD;0;
J01D;Andre beta-lactam antibacterica;1,5;DDD;0;
J01DB;Cephalosporiner, 1. generation;;DDD;0;
J01DB01;Cefalexin;;DDD;0;
J01DB03;Cefalotin;;DDD;0;
J01DB04;Cefazolin;;DDD;0;
J01DC;Cephalosporiner, 2. generation;1,5;DDD;0;
J01DC01;Cefoxitin;;DDD;0;
J01DC02;Cefuroxim;1,5;DDD;0;
J01DD;Cephalosporiner, 3. generation;5;DDD;0;
J01DD01;Cefotaxim;5;DDD;0;
J01DD02;Ceftazidim;5;DDD;0;
J01DD04;Ceftriaxon;5;DDD;0;
J01DD13;Cefpodoxim;;DDD;0;
J01DD52;Ceftazidime og beta-lactamaseinhibitor;;DDD;0;
J01DE;Cephalosporiner, 4. generation;;DDD;0;
J01DE01;Cefepim;;DDD;0;
J01DF;Monobactamer;;DDD;0;
J01DF01;Aztreonam;;DDD;0;
J01DH;Carbapenemer;5;DDD;0;
J01DH02;Meropenem;5;DDD;0;
J01DH03;Ertapenem;5;DDD;0;
J01DH04;Doripenem;;DDD;0;
J01DH51;Imipenem og cilastatin;;DDD;0;
J01DI;Andre cephalosporiner og penemer;;DDD;0;
J01DI02;Ceftarolin fosamil;;DDD;0;
J01DI54;Ceftolozane og beta-lactamaseinhibitor;;DDD;0;
J01E;Sulfonamider og trimethoprim;2,3;DDD;0;
J01EA;Trimethoprim og derivater;;DDD;0;
J01EA01;Trimethoprim;;DDD;0;
J01EB;Sulfonamider med kort virkningstid;;DDD;0;
J01EB02;Sulfamethizol;;DDD;0;
J01EB04;Sulfapyridin;;DDD;0;
J01EC;Sulfonamider med middellang virkningstid;3;DDD;0;
J01EC02;Sulfadiazin;3;DDD;0;
J01EE;Sulfonamid og trimethoprim incl. derivater i komb.;2,3;DDD;0;
J01EE01;Sulfamethoxazol og trimethoprim;2,3;DDD;0;
J01F;Macrolider, lincosamider og streptograminer;5;DDD;0;
J01FA;Macrolider;5;DDD;0;
J01FA01;Erythromycin;5;DDD;0;
J01FA02;Spiramycin;;DDD;0;
J01FA06;Roxithromycin;;DDD;0;
J01FA09;Clarithromycin;;DDD;0;
J01FA10;Azithromycin;5;DDD;0;
J01FF;Lincosamider;5;DDD;0;
J01FF01;Clindamycin;;DDD;0;
J01G;Aminoglycosid antibacterica;5;DDD;0;
J01GB;Andre aminoglycosider;5;DDD;0;
J01GB01;Tobramycin;5;DDD;0;
J01GB03;Gentamicin;5;DDD;0;
J01GB06;Amikacin;;DDD;0;
J01GB07;Netilmicin;;DDD;0;
J01M;Quinolon antibacterica;;DDD;0;
J01MA;Fluorochinoloner;;DDD;0;
J01MA01;Ofloxacin;;DDD;0;
J01MA02;Ciprofloxacin;;DDD;0;
J01MA06;Norfloxacin;;DDD;0;
J01MA08;Fleroxacin;;DDD;0;
J01MA11;Grepafloxacin;;DDD;0;
J01MA12;Levofloxacin;;DDD;0;
J01MA13;Trovafloxacin;;DDD;0;
J01MA14;Moxifloxacin;;DDD;0;
J01MB;Andre quinoloner;;DDD;0;
J01MB02;Nalidixinsyre;;DDD;0;
J01X;Andre antibacterica;3,5;DDD;0;
J01XA;Glycopeptid antibacterica;5;DDD;0;
J01XA01;Vancomycin;5;DDD;0;
J01XA02;Teicoplanin;;DDD;0;
J01XB;Polymyxiner;5;DDD;0;
J01XB01;Colistin;5;DDD;0;
J01XC;Steroid antibacterica;5;DDD;0;
J01XC01;Fusidinsyre;5;DDD;0;
J01XD;Imidazol-derivater;5;DDD;0;
J01XD01;Metronidazol;5;DDD;0;
J01XE;Nitrofuran-derivater;3;DDD;0;
J01XE01;Nitrofurantoin;3;DDD;0;
J01XX;Andre antibacterica;;DDD;0;
J01XX01;Fosfomycin;;DDD;0;
J01XX05;Methenamin;;DDD;0;
J01XX08;Linezolid;;DDD;0;
J01XX09;Daptomycin;;DDD;0;
J01XX11;Tedizolid;;DDD;0;
J02;Antimycotica til systemisk brug;;DDD;0;
J02A;Antimycotica til systemisk brug;;DDD;0;
J02AA;Antibiotica;;DDD;0;
J02AA01;Amphotericin;;DDD;0;
J02AB;Imidazol-derivater;;DDD;0;
J02AB02;Ketoconazol;;DDD;0;
J02AC;Triazol- og tetrazolderivater;;DDD;0;
J02AC01;Fluconazol;;DDD;0;
J02AC02;Itraconazol;;DDD;0;
J02AC03;Voriconazol;;DDD;0;
J02AC04;Posaconazol;;DDD;0;
J02AC05;Isavuconazol;;DDD;0;
J02AX;Andre antimycotica til systemisk brug;;DDD;0;
J02AX01;Flucytosin;;DDD;0;
J02AX04;Caspofungin;;DDD;0;
J02AX05;Micafungin;;DDD;0;
J02AX06;Anidulafungin;;DDD;0;
J04;Antimycobacterica;2;DDD;0;
J04A;Stoffer til behandling af tuberculose;2;DDD;0;
J04AA;Aminosalicylsyre og derivater;;DDD;0;
J04AA01;Aminosalicylsyre;;DDD;0;
J04AB;Antibiotica;;DDD;0;
J04AB02;Rifampicin;;DDD;0;
J04AB04;Rifabutin;;DDD;0;
J04AC;Hydrazider;;DDD;0;
J04AC01;Isoniazid;;DDD;0;
J04AK;Andre stoffer til behandling af tuberculose;;DDD;0;
J04AK01;Pyrazinamid;;DDD;0;
J04AK02;Ethambutol;;DDD;0;
J04AK05;Bedaquilin;;DDD;0;
J04AM;Komb. af stoffer til behandling af tuberculose;2;DDD;0;
J04AM02;Rifampicin og isoniazid;2;DDD;0;
J04AM05;Rifampicin, pyrazinamid og isoniazid;2;DDD;0;
J04AM06;Rifampicin, pyrazinamid, ethambutol og isoniazid;2;DDD;0;
J04B;Midler til behandling af lepra;;DDD;0;
J04BA;Midler til behandling af lepra;;DDD;0;
J04BA02;Dapson;;DDD;0;
J05;Antivirale midler til systemisk brug;1,2,3;DDD;0;
J05A;Direkte virkende antivirale midler;1,2,3;DDD;0;
J05A***;(Ufuldstændig ATC-kode);3;DDD;0;
J05AB;Nucleosider og nucleotider excl. revers transcriptase-hæmmere;1;DDD;0;
J05AB01;Aciclovir;;DDD;0;
J05AB06;Ganciclovir;1;DDD;0;
J05AB09;Famciclovir;;DDD;0;
J05AB11;Valaciclovir;;DDD;0;
J05AB12;Cidofovir;;DDD;0;
J05AB14;Valganciclovir;;DDD;0;
J05AD;Phosphonsyre-derivater;;Ingen fælles mængdeenhed;0;
J05AD01;Foscarnet;;Ingen fælles mængdeenhed;0;
J05AE;Protease inhibitorer;;DDD;0;
J05AE01;Saquinavir;;DDD;0;
J05AE02;Indinavir;;DDD;0;
J05AE03;Ritonavir;;DDD;0;
J05AE04;Nelfinavir;;DDD;0;
J05AE05;Amprenavir;;DDD;0;
J05AE07;Fosamprenavir;;DDD;0;
J05AE08;Atazanavir;;DDD;0;
J05AE09;Tipranavir;;DDD;0;
J05AE10;Darunavir;;DDD;0;
J05AF;Nucleosid og nucleotid revers transcriptase-hæmmere;;DDD;0;
J05AF01;Zidovudin;;DDD;0;
J05AF02;Didanosin;;DDD;0;
J05AF03;Zalcitabin;;DDD;0;
J05AF04;Stavudin;;DDD;0;
J05AF05;Lamivudin;;DDD;0;
J05AF06;Abacavir;;DDD;0;
J05AF07;Tenofovir disoproxil;;DDD;0;
J05AF08;Adefovir dipivoxil;;DDD;0;
J05AF09;Emtricitabin;;DDD;0;
J05AF10;Entecavir;;DDD;0;
J05AF13;Tenofovir alafenamid;;DDD;0;
J05AG;Non-nucleosid revers transcriptase-hæmmere;;DDD;0;
J05AG01;Nevirapin;;DDD;0;
J05AG03;Efavirenz;;DDD;0;
J05AG04;Etravirin;;DDD;0;
J05AG05;Rilpivirin;;DDD;0;
J05AG06;Doravirin;;DDD;0;
J05AH;Neuraminidase-inhibitorer;;DDD;0;
J05AH01;Zanamivir;;DDD;0;
J05AH02;Oseltamivir;;DDD;0;
J05AJ;Integrasehæmmere;;DDD;0;
J05AJ01;Raltegravir;;DDD;0;
J05AJ03;Dolutegravir;;DDD;0;
J05AJ04;Cabotegravir;;DDD;0;
J05AP;Antivirale midler til behandling af hcv-infektioner;2,3;DDD;0;
J05AP01;Ribavirin;;DDD;0;
J05AP02;Telaprevir;;DDD;0;
J05AP03;Boceprevir;;DDD;0;
J05AP05;Simeprevir;;DDD;0;
J05AP07;Daclatasvir;;DDD;0;
J05AP08;Sofosbuvir;;DDD;0;
J05AP09;Dasabuvir;;DDD;0;
J05AP51;Sofosbuvir og ledipasvir;2;DDD;0;
J05AP53;Ombitasvir, paritaprevir og ritonavir;2;DDD;0;
J05AP54;Elbasvir og grazoprevir;2;DDD;0;
J05AP55;Sofosbuvir og velpatasvir;2;DDD;0;
J05AP56;Sofosbuvir, velpatasvir og voxilaprevir;2;DDD;0;
J05AP57;Glecaprevir og pibrentasvir;3;DDD;0;
J05AR;Antivirale midler til behandling af hiv-infektioner, komb.;2,3;DDD;0;
J05AR01;Zidovudin og lamivudin;2;DDD;0;
J05AR02;Lamivudin og abacavir;2;DDD;0;
J05AR03;Tenofovirdisoproxil og emtricitabin;2;DDD;0;
J05AR04;Zidovudin, lamivudin og abacavir;2;DDD;0;
J05AR06;Emtricitabin,tenofovirdisoproxil og efavirenz;2;DDD;0;
J05AR08;Emtricitabin, tenofovirdisoproxil og rilpivirin;2;DDD;0;
J05AR09;Emtricitabin, tenofovirdisoproxil, elvitegravir og cobicistat;2;DDD;0;
J05AR10;Lopinavir og ritonavir;;DDD;0;
J05AR13;Lamivudin, abacavir og dolutegravir;2;DDD;0;
J05AR14;Darunavir og cobicistat;3;DDD;0;
J05AR15;Atazanavir og cobicistat;2;DDD;0;
J05AR17;Emtricitabin og tenofovir alafenamid;2;DDD;0;
J05AR18;Emtricitabin, tenofovir alafenamid, elvitegravir og cobicistat;2;DDD;0;
J05AR19;Emtricitabin, tenofovir alafenamid og rilpivirin;2;DDD;0;
J05AR20;Emtricitabin, tenofovir alafenamid og bictegravir;2;DDD;0;
J05AR21;Dolutegravir og rilpivirin;2;DDD;0;
J05AR22;Emtricitabin, tenofovir alafenamid, darunavir og cobicistat;2;DDD;0;
J05AR24;Lamivudin, tenofovirdisoproxil og doravirin;2;DDD;0;
J05AR25;Lamivudin og dolutegravir;2;DDD;0;
J05AX;Andre antivirale midler;;DDD;0;
J05AX07;Enfuvirtid;;DDD;0;
J05AX09;Maraviroc;;DDD;0;
J05AX18;Letermovir;;DDD;0;
J06;Immunsera og immunoglobuliner;1;Stk;0;
J06****;(Ufuldstændig ATC-kode);;Stk;0;
J06A;Immunsera;;Stk;0;
J06AA;Immunsera;;Stk;0;
J06AA01;Difteri antitoxin;;Stk;0;
J06AA03;Slangegift antiserum;;Stk;0;
J06AA04;Botulinum antitoxin;;Stk;0;
J06B;Immunoglobuliner;1;Stk;0;
J06B***;(Ufuldstændig ATC-kode);;Ingen fælles mængdeenhed;0;
J06BA;Immunoglobuliner, normal human;;Stk;0;
J06BA01;Immunoglobuliner, normal human til extravasc. brug;;Stk;0;
J06BA02;Immunoglobuliner, normal human til intravasc. brug;;Stk;0;
J06BB;Specifikke immunoglobuliner;;Stk;0;
J06BB01;Anti-d (rh) immunoglobulin;;Stk;0;
J06BB02;Tetanus immunoglobulin;;Stk;0;
J06BB03;Varicella/zoster immunoglobulin;;Stk;0;
J06BB04;Hepatitis b immunoglobulin;;Stk;0;
J06BB05;Rabies immunoglobulin;;Stk;0;
J06BC;Antibakterielle monoklonale antistoffer;;Stk;0;
J06BC03;Bezlotoxumab;;Stk;0;
J06BD;Antivirale monoklonale antistoffer;;Stk;0;
J06BD01;Palivizumab;;Stk;0;
J07;Vacciner;;Stk;0;
J07A;Bacterielle vacciner;;Stk;0;
J07AC;Anthrax vacciner;;Stk;0;
J07AC01;Anthrax antigen;;Stk;0;
J07AE;Cholera vacciner;;Stk;0;
J07AE01;Cholera, inaktiveret, hele celler;;Stk;0;
J07AF;Difteri vacciner;;Stk;0;
J07AF01;Difteri toxoid;;Stk;0;
J07AG;Hemophilus influenzae b vacciner;;Stk;0;
J07AG01;Hemophilus influenzae b, purif. antig. conjugated;;Stk;0;
J07AH;Meningokok vacciner;;Stk;0;
J07AH02;Andre meningococcal monov.,purified polysac.antig.;;Stk;0;
J07AH03;Meningococcus a,c, bivalent purified polysacc. antigen;;Stk;0;
J07AH04;Meningococcus a,c,y,w-135, tetraval. purified polysacc.antigen;;Stk;0;
J07AH08;Meningococcus a,c,y,w-135, tetravalent renset polysacc. antigen konj.;;Stk;0;
J07AH09;Meningococcus b, multikomponent vaccine;;Stk;0;
J07AJ;Pertussis vacciner;;Stk;0;
J07AJ01;Pertussis, inaktiveret, hele celler;;Stk;0;
J07AJ52;Pertusiss, renset antigen, komb. med toxoider;;Stk;0;
J07AL;Pneumokok vacciner;;Stk;0;
J07AL01;Pneumococcus, purified polysaccharides antigen;;Stk;0;
J07AL02;Pneumococcus, purified polysacc. antigen conj.;;Stk;0;
J07AM;Tetanus vacciner;;Stk;0;
J07AM01;Tetanus toxoid;;Stk;0;
J07AM51;Tetanus toxoid, komb. med difteri toxoid;;Stk;0;
J07AN;Tuberculose vacciner;;Stk;0;
J07AN01;Tuberculose, levende attenueret;;Stk;0;
J07AP;Tyfus vacciner;;Stk;0;
J07AP01;Tyfus, oral, levende attenueret;;Stk;0;
J07AP03;Tyfus, renset polysaccharid antigen;;Stk;0;
J07B;Virale vacciner;;Stk;0;
J07BA;Encephalitis vacciner;;Stk;0;
J07BA01;Encephalitis, tick borne, inaktiveret, hele virus;;Stk;0;
J07BA02;Encephalitis, japansk, inaktiveret, hele virus;;Stk;0;
J07BB;Influenza vacciner;;Stk;0;
J07BB**;(Ufuldstændig ATC-kode);;Stk;0;
J07BB01;Influenza, inaktiveret, hele virus;;Stk;0;
J07BB02;Influenza, renset antigen;;Stk;0;
J07BB03;Influenza, levende svækket;;Stk;0;
J07BC;Hepatitis vacciner;;Stk;0;
J07BC01;Hepatitis b, renset antigen;;Stk;0;
J07BC02;Hepatitis a, inaktiveret, hel virus;;Stk;0;
J07BC20;Hepatitis vacciner, kombinationer;;Stk;0;
J07BD;Mæslingevacciner;;Stk;0;
J07BD01;Mæslinger, levende attenueret;;Stk;0;
J07BD52;Mæslinger, komb. m. fåresyge og rubella, levende attenueret;;Stk;0;
J07BE;Fåresygevacciner;;Stk;0;
J07BE01;Fåresyge, levende attenueret;;Stk;0;
J07BF;Poliomyelitis vacciner;;Stk;0;
J07BF03;Poliomyelitis, trivalent, inaktiveret, hele virus;;Stk;0;
J07BG;Rabies vacciner;;Stk;0;
J07BG01;Rabies, inaktiveret, hele virus;;Stk;0;
J07BH;Rota virus diarrhea vacciner;;Stk;0;
J07BH01;Rota virus, levende attenueret;;Stk;0;
J07BH02;Rota virus, pentavalent, levende, reassorted;;Stk;0;
J07BJ;Rubella vacciner;;Stk;0;
J07BJ01;Rubella, levende attenueret;;Stk;0;
J07BK;Varicella zoster vacciner;;Stk;0;
J07BK01;Varicella, levende attenueret;;Stk;0;
J07BK02;Zoster virus, levende attenueret;;Stk;0;
J07BK03;Zoster, renset antigen;;Stk;0;
J07BL;Gul feber vacciner;;Stk;0;
J07BL01;Gul feber, levende attenueret;;Stk;0;
J07BM;Papillomavirus-vacciner;;Stk;0;
J07BM01;Papillomavirus (human type 6, 11, 16, 18);;Stk;0;
J07BM02;Papillomavirus (human type 16, 18);;Stk;0;
J07BM03;Papillomavirus (human type 6, 11, 16, 18, 31, 33, 45, 52,58);;Stk;0;
J07BX;Andre virale vacciner;;Stk;0;
J07BX03;Covid-19 vacciner;;Stk;0;
J07C;Bacterielle og virale vacciner, kombinerede;;Stk;0;
J07CA;Bacterielle og virale vacciner, kombinerede;;Stk;0;
J07CA01;Difteri-poliomyelitis-tetanus;;Stk;0;
J07CA02;Difteri-pertussis-poliomyelitis-tetanus;;Stk;0;
J07CA06;Difteri-hemophilus influenzae b-pertussis-polio-tetanus;;Stk;0;
J07CA09;Difteri-hemophilus influenzae b-pertussis-polio-tetanus-hepatitis b;;Stk;0;
J07CA10;Tyfus - hepatitis a;;Stk;0;
L;Antineoplastiske og immunomodulerende midler;;Ingen fælles mængdeenhed;0;
L01;Antineoplastiske stoffer;5;Ingen fælles mængdeenhed;0;
L01****;(Ufuldstændig ATC-kode);5;Ingen fælles mængdeenhed;0;
L01A;Alkyleringsmidler;5;Ingen fælles mængdeenhed;0;
L01AA;Kvælstofsennepsgas-analoger;5;Ingen fælles mængdeenhed;0;
L01AA01;Cyclophosphamid;5;g (aktivt stof);0;
L01AA02;Chlorambucil;5;g (aktivt stof);0;
L01AA03;Melphalan;5;g (aktivt stof);0;
L01AA06;Ifosfamid;5;g (aktivt stof);0;
L01AA09;Bendamustin;5;g (aktivt stof);0;
L01AB;Alkylsulfonater;5;Ingen fælles mængdeenhed;0;
L01AB01;Busulfan;5;g (aktivt stof);0;
L01AB02;Treosulfan;5;g (aktivt stof);0;
L01AC;Ethyleniminer;5;Ingen fælles mængdeenhed;0;
L01AC01;Thiotepa;5;g (aktivt stof);0;
L01AD;Nitrosoureastoffer;5;Ingen fælles mængdeenhed;0;
L01AD01;Carmustin;5;g (aktivt stof);0;
L01AD02;Lomustin;5;g (aktivt stof);0;
L01AD04;Streptozocin;4,5;;0;
L01AX;Andre alkyleringsmidler;5;Ingen fælles mængdeenhed;0;
L01AX03;Temozolomid;5;g (aktivt stof);0;
L01AX04;Dacarbazin;5;g (aktivt stof);0;
L01B;Antimetabolitter;5;Ingen fælles mængdeenhed;0;
L01BA;Folsyre-analoger;5;Ingen fælles mængdeenhed;0;
L01BA01;Methotrexat;5;mg (aktivt stof);0;
L01BA04;Pemetrexed;5;g (aktivt stof);0;
L01BB;Purin-analoger;5;Ingen fælles mængdeenhed;0;
L01BB02;Mercaptopurin;5;g (aktivt stof);0;
L01BB04;Cladribin;5;g (aktivt stof);0;
L01BB05;Fludarabin;5;g (aktivt stof);0;
L01BB06;Clofarabin;5;g (aktivt stof);0;
L01BB07;Nelarabin;5;g (aktivt stof);0;
L01BC;Pyrimidin-analoger;5;Ingen fælles mængdeenhed;0;
L01BC01;Cytarabin;5;g (aktivt stof);0;
L01BC02;Fluoruracil;5;g (aktivt stof);0;
L01BC05;Gemcitabin;5;g (aktivt stof);0;
L01BC06;Capecitabin;5;g (aktivt stof);0;
L01BC07;Azacitidin;5;g (aktivt stof);0;
L01BC08;Decitabin;5;g (aktivt stof);0;
L01BC52;Fluoruracil, kombinationer;5;g (aktivt stof);0;
L01BC53;Tegafur, komb.;5;g (aktivt stof);0;
L01BC59;Trifluridin, kombinationer;5;g (aktivt stof);0;
L01C;Plantealkaloider og andre naturprodukter;5;Ingen fælles mængdeenhed;0;
L01CA;Vinca-alkaloider og analoger;5;Ingen fælles mængdeenhed;0;
L01CA01;Vinblastin;5;g (aktivt stof);0;
L01CA02;Vincristin;5;mg (aktivt stof);0;
L01CA04;Vinorelbin;5;g (aktivt stof);0;
L01CA05;Vinflunin;5;g (aktivt stof);0;
L01CB;Podophyllotoxin-derivater;5;Ingen fælles mængdeenhed;0;
L01CB01;Etoposid;5;g (aktivt stof);0;
L01CB02;Teniposid;5;g (aktivt stof);0;
L01CD;Taxaner;5;Ingen fælles mængdeenhed;0;
L01CD01;Paclitaxel;5;g (aktivt stof);0;
L01CD02;Docetaxel;5;g (aktivt stof);0;
L01CD04;Cabazitaxel;5;g (aktivt stof);0;
L01CE;Topoisomerase 1 hæmmere;5;Ingen fælles mængdeenhed;0;
L01CE01;Topotecan;5;mg (aktivt stof);0;
L01CE02;Irinotecan;5;g (aktivt stof);0;
L01CX;Andre plantealkaloider og naturprodukter;5;Ingen fælles mængdeenhed;0;
L01CX01;Trabectedin;5;mg (aktivt stof);0;
L01D;Cytotoksiske antibiotica og beslægtede stoffer;5;Ingen fælles mængdeenhed;0;
L01DB;Anthracycliner og beslægtede stoffer;5;Ingen fælles mængdeenhed;0;
L01DB01;Doxorubicin;1,5;g (aktivt stof);0;
L01DB02;Daunorubicin;5;g (aktivt stof);0;
L01DB03;Epirubicin;5;g (aktivt stof);0;
L01DB04;Aclarubicin;5;g (aktivt stof);0;
L01DB06;Idarubicin;5;g (aktivt stof);0;
L01DB07;Mitoxantron;5;g (aktivt stof);0;
L01DB11;Pixantron;5;g (aktivt stof);0;
L01DC;Andre cytotoxiske antibiotica;5;Ingen fælles mængdeenhed;0;
L01DC01;Bleomycin;5;Tusind enheder;0;
L01DC03;Mitomycin;5;mg (aktivt stof);0;
L01E;Proteinkinasehæmmere;5;DDD;0;
L01EA;Bcr-abl tyrosinkinasehæmmere;5;DDD;0;
L01EA01;Imatinib;5;DDD;0;
L01EA02;Dasatinib;5;DDD;0;
L01EA03;Nilotinib;5;DDD;0;
L01EA04;Bosutinib;5;DDD;0;
L01EA05;Ponatinib;5;DDD;0;
L01EB;Epidermal vækstfaktor receptor (egfr)-tyrosinkinasehæmmere;5;DDD;0;
L01EB01;Gefitinib;5;DDD;0;
L01EB02;Erlotinib;5;DDD;0;
L01EB03;Afatinib;5;DDD;0;
L01EB04;Osimertinib;5;DDD;0;
L01EC;B-raf serin-threoninkinase (braf) hæmmere;5;DDD;0;
L01EC01;Vemurafenib;5;DDD;0;
L01EC02;Dabrafenib;5;DDD;0;
L01EC03;Encorafenib;5;DDD;0;
L01ED;Anaplastisk lymfom kinase (alk) hæmmere;5;DDD;0;
L01ED01;Crizotinib;5;DDD;0;
L01ED02;Ceritinib;5;DDD;0;
L01ED03;Alectinib;5;DDD;0;
L01ED04;Brigatinib;5;DDD;0;
L01ED05;Lorlatinib;5;DDD;0;
L01EE;Mitogen-aktiverede proteinkinase (mek) hæmmere;5;DDD;0;
L01EE01;Trametinib;5;DDD;0;
L01EE02;Cobimetinib;5;DDD;0;
L01EE03;Binimetinib;5;DDD;0;
L01EF;Cyclin-afhængig kinase (cdk) hæmmere;5;DDD;0;
L01EF01;Palbociclib;5;DDD;0;
L01EF02;Ribociclib;5;DDD;0;
L01EF03;Abemaciclib;5;DDD;0;
L01EG;Mammalian target of rapamycin (mtor) kinase hæmmere;5;DDD;0;
L01EG01;Temsirolimus;5;DDD;0;
L01EG02;Everolimus;5;DDD;0;
L01EH;Human epidermal vækstfaktor receptor 2 (her2) tyrosinkinase hæmmere;5;DDD;0;
L01EH01;Lapatinib;5;DDD;0;
L01EH03;Tucatinib;5;DDD;0;
L01EJ;Janus associerede kinase (jak) hæmmere;5;DDD;0;
L01EJ01;Ruxolitinib;5;DDD;0;
L01EK;Vaskulær endotelial vækstfaktor receptor (vegfr)-tyrosinkinase hæmmere;5;DDD;0;
L01EK01;Axitinib;5;DDD;0;
L01EK03;Tivozanib;5;DDD;0;
L01EL;Bruton's tyrosinkinase (btk) hæmmere;5;DDD;0;
L01EL01;Ibrutinib;5;DDD;0;
L01EL02;Acalabrutinib;5;DDD;0;
L01EM;Phosphatidylinositol-3-kinase (pi3k) hæmmere;5;DDD;0;
L01EM01;Idelalisib;5;DDD;0;
L01EM03;Alpelisib;5;DDD;0;
L01EN;Fibroblast vækstfaktor receptor (fgfr) tyrosinkinasehæmmere;5;DDD;0;
L01EN02;Pemigatinib;5;DDD;0;
L01EX;Andre proteinkinasehæmmere;5;DDD;0;
L01EX01;Sunitinib;5;DDD;0;
L01EX02;Sorafenib;5;DDD;0;
L01EX03;Pazopanib;5;DDD;0;
L01EX04;Vandetanib;5;DDD;0;
L01EX05;Regorafenib;5;DDD;0;
L01EX07;Cabozantinib;5;DDD;0;
L01EX08;Lenvatinib;5;DDD;0;
L01EX09;Nintedanib;5;DDD;0;
L01EX10;Midostaurin;5;DDD;0;
L01EX14;Entrectinib;5;DDD;0;
L01EX18;Avapritinib;5;DDD;0;
L01EX22;Selpercatinib;5;DDD;0;
L01F;Monoklonale antistoffer og antistof-lægemiddel-konjugater;5;Ingen fælles mængdeenhed;0;
L01FA;Anti-cd20 monoklonale antistoffer;5;Ingen fælles mængdeenhed;0;
L01FA01;Rituximab;5;g (aktivt stof);0;
L01FA02;Ofatumumab;5;g (aktivt stof);0;
L01FA03;Obinutuzumab;5;g (aktivt stof);0;
L01FB;Anti-cd22 monoklonale antistoffer;5;Ingen fælles mængdeenhed;0;
L01FB01;Inotuzumab ozogamicin;5;g (aktivt stof);0;
L01FC;Anti-cd38 monoklonale antistoffer;5;Ingen fælles mængdeenhed;0;
L01FC01;Daratumumab;5;g (aktivt stof);0;
L01FD;Human epidermal vækstfaktor receptor 2 (her2) hæmmere;5;Ingen fælles mængdeenhed;0;
L01FD01;Trastuzumab;5;g (aktivt stof);0;
L01FD02;Pertuzumab;5;g (aktivt stof);0;
L01FD03;Trastuzumab emtansin;5;g (aktivt stof);0;
L01FD04;Trastuzumab deruxtecan;5;g (aktivt stof);0;
L01FE;Epidermal vækstfaktor receptor (egfr) hæmmere;5;Ingen fælles mængdeenhed;0;
L01FE01;Cetuximab;5;g (aktivt stof);0;
L01FE02;Panitumumab;5;g (aktivt stof);0;
L01FF;Pd-1/pdl-1 (programmed cell death protein 1/death ligand 1) hæmmere;5;Ingen fælles mængdeenhed;0;
L01FF01;Nivolumab;5;g (aktivt stof);0;
L01FF02;Pembrolizumab;5;g (aktivt stof);0;
L01FF03;Durvalumab;5;Ingen fælles mængdeenhed;0;
L01FF04;Avelumab;5;g (aktivt stof);0;
L01FF05;Atezolizumab;5;g (aktivt stof);0;
L01FF06;Cemiplimab;5;g (aktivt stof);0;
L01FG;Vaskulær endotelial vækstfaktor (vegf/vegfr) hæmmere;5;Ingen fælles mængdeenhed;0;
L01FG01;Bevacizumab;5;g (aktivt stof);0;
L01FG02;Ramucirumab;5;g (aktivt stof);0;
L01FX;Andre monoklonale antistoffer og antistof-lægemiddel-konjugater;5;Ingen fælles mængdeenhed;0;
L01FX02;Gemtuzumab ozogamicin;5;g (aktivt stof);0;
L01FX03;Catumaxomab;5;mg (aktivt stof);0;
L01FX04;Ipilimumab;5;g (aktivt stof);0;
L01FX05;Brentuximab vedotin;5;g (aktivt stof);0;
L01FX06;Dinutuximab beta;5;g (aktivt stof);0;
L01FX07;Blinatumomab;5;mg (aktivt stof);0;
L01FX08;Elotuzumab;5;g (aktivt stof);0;
L01FX09;Mogamulizumab;5;g (aktivt stof);0;
L01FX10;Olaratumab;5;g (aktivt stof);0;
L01FX14;Polatuzumab vedotin;5;g (aktivt stof);0;
L01X;Andre antineoplastiske stoffer;5;Ingen fælles mængdeenhed;0;
L01XA;Platin-forbindelser;5;Ingen fælles mængdeenhed;0;
L01XA01;Cisplatin;5;g (aktivt stof);0;
L01XA02;Carboplatin;5;g (aktivt stof);0;
L01XA03;Oxaliplatin;5;g (aktivt stof);0;
L01XD;Sensibilatorer til fotodynamisk/stråle-terapi;5;Ingen fælles mængdeenhed;0;
L01XD03;Methylaminolevulinat;5;g (aktivt stof);0;
L01XD04;Aminolevulinsyre;5;g (aktivt stof);0;
L01XD05;Temoporfin;5;g (aktivt stof);0;
L01XF;Retinoider til cancerbehandling;5;Ingen fælles mængdeenhed;0;
L01XF03;Bexaroten;5;g (aktivt stof);0;
L01XG;Proteasomhæmmere;5;Ingen fælles mængdeenhed;0;
L01XG01;Bortezomib;5;mg (aktivt stof);0;
L01XG02;Carfilzomib;5;g (aktivt stof);0;
L01XG03;Ixazomib;5;mg (aktivt stof);0;
L01XH;Histondeacetylase (hdac) hæmmere;5;Ingen fælles mængdeenhed;0;
L01XH03;Panobinostat;5;g (aktivt stof);0;
L01XJ;Hedgehog pathway hæmmere;5;Ingen fælles mængdeenhed;0;
L01XJ01;Vismodegib;5;g (aktivt stof);0;
L01XK;Poly (adp-ribose) polymerase (parp) hæmmere;5;Ingen fælles mængdeenhed;0;
L01XK01;Olaparib;5;g (aktivt stof);0;
L01XK02;Niraparib;5;g (aktivt stof);0;
L01XX;Andre neoplastiske stoffer;5;Ingen fælles mængdeenhed;0;
L01XX01;Amsacrin;5;g (aktivt stof);0;
L01XX02;Asparaginase;5;Tusind enheder;0;
L01XX03;Altretamin;5;g (aktivt stof);0;
L01XX05;Hydroxycarbamid;5;g (aktivt stof);0;
L01XX08;Pentostatin;5;g (aktivt stof);0;
L01XX11;Estramustin;5;g (aktivt stof);0;
L01XX23;Mitotan;5;g (aktivt stof);0;
L01XX24;Pegaspargase;5;Tusind enheder;0;
L01XX27;Arsentrioxid;5;g (aktivt stof);0;
L01XX33;Celecoxib;5;g (aktivt stof);0;
L01XX35;Anagrelid;5;g (aktivt stof);0;
L01XX41;Eribulin;5;mg (aktivt stof);0;
L01XX44;Aflibercept;5;g (aktivt stof);0;
L01XX52;Venetoclax;5;g (aktivt stof);0;
L01XX71;Tisagenlecleucel;5;Stk;0;
L01XY;Kombinationer af antineoplastiske stoffer;5;Ingen fælles mængdeenhed;0;
L01XY01;Cytarabin og daunorubicin;5;;0;
L01XY02;Pertuzumab og trastuzumab;5;g (aktivt stof);0;
L02;Endocrin terapi;;DDD;0;
L02A;Hormoner og beslægtede stoffer;;DDD;0;
L02AA;Østrogener;;DDD;0;
L02AA01;Diethylstilbestrol;;DDD;0;
L02AA02;Polyestradiolphosphat;;DDD;0;
L02AA04;Fosfestrol;;DDD;0;
L02AB;Gestagener;;DDD;0;
L02AB01;Megestrol;;DDD;0;
L02AB02;Medroxyprogesteron;;DDD;0;
L02AE;Gonadotropin-releasing hormon analoger;;DDD;0;
L02AE01;Buserelin;;DDD;0;
L02AE02;Leuprorelin;;DDD;0;
L02AE03;Goserelin;;DDD;0;
L02AE04;Triptorelin;;DDD;0;
L02AE05;Histrelin;;DDD;0;
L02B;Hormon-antagonister og lign. stoffer;;DDD;0;
L02BA;Anti-østrogener;;DDD;0;
L02BA01;Tamoxifen;;DDD;0;
L02BA03;Fulvestrant;;DDD;0;
L02BB;Anti-androgener;;DDD;0;
L02BB01;Flutamid;;DDD;0;
L02BB02;Nilutamid;;DDD;0;
L02BB03;Bicalutamid;;DDD;0;
L02BB04;Enzalutamid;;DDD;0;
L02BB05;Apalutamid;;DDD;0;
L02BB06;Darolutamid;;DDD;0;
L02BG;Aromatase inhibitorer;;DDD;0;
L02BG02;Formestan;;DDD;0;
L02BG03;Anastrozol;;DDD;0;
L02BG04;Letrozol;;DDD;0;
L02BG06;Exemestan;;DDD;0;
L02BX;Andre hormon-antagonister og lign. stoffer;;DDD;0;
L02BX02;Degarelix;;DDD;0;
L02BX03;Abirateron;;DDD;0;
L03;Immunstimulerende midler;3;DDD;0;
L03A;Immunstimulanter;3;DDD;0;
L03AA;Kolonistimulerende faktorer;;DDD;0;
L03AA02;Filgrastim;;DDD;0;
L03AA03;Molgramostim;;DDD;0;
L03AA10;Lenograstim;;DDD;0;
L03AA13;Pegfilgrastim;;DDD;0;
L03AA14;Lipegfilgrastim;;DDD;0;
L03AB;Interferoner;3;DDD;0;
L03AB01;Interferon alfa naturligt;;DDD;0;
L03AB03;Interferon gamma;;DDD;0;
L03AB04;Interferon alfa-2a;;DDD;0;
L03AB05;Interferon alfa-2b;;DDD;0;
L03AB07;Interferon beta-1a;;DDD;0;
L03AB08;Interferon beta-1b;;DDD;0;
L03AB10;Peginterferon alfa-2b;;DDD;0;
L03AB11;Peginterferon alfa-2a;;DDD;0;
L03AB13;Peginterferon beta-1a;;DDD;0;
L03AB15;Ropeginterferon alfa-2b;3;DDD;0;
L03AC;Interleukiner;;DDD;0;
L03AC01;Aldesleukin;;DDD;0;
L03AX;Andre immunstimulanter;3;DDD;0;
L03AX**;(Ufuldstændig ATC-kode);3;DDD;0;
L03AX03;Bcg vaccine;;DDD;0;
L03AX13;Glatirameracetat;;DDD;0;
L03AX16;Plerixafor;;DDD;0;
L04;Immunsuppressiva;;Ingen fælles mængdeenhed;0;
L04A;Immunsuppressiva;;Ingen fælles mængdeenhed;0;
L04AA;Selektive immunsuppressiva;;Ingen fælles mængdeenhed;0;
L04AA04;Antithymocyt immunoglobulin;;DDD;0;
L04AA06;Mycophenolsyre;;DDD;0;
L04AA10;Sirolimus;;DDD;0;
L04AA13;Leflunomid;;DDD;0;
L04AA18;Everolimus;;DDD;0;
L04AA21;Efalizumab;;DDD;0;
L04AA23;Natalizumab;;DDD;0;
L04AA24;Abatacept;;DDD;0;
L04AA25;Eculizumab;;DDD;0;
L04AA26;Belimumab;;DDD;0;
L04AA27;Fingolimod;;DDD;0;
L04AA28;Belatacept;;DDD;0;
L04AA29;Tofacitinib;;DDD;0;
L04AA31;Teriflunomid;;DDD;0;
L04AA32;Apremilast;;DDD;0;
L04AA33;Vedolizumab;;DDD;0;
L04AA34;Alemtuzumab;;Ingen fælles mængdeenhed;0;
L04AA36;Ocrelizumab;;DDD;0;
L04AA37;Baricitinib;;DDD;0;
L04AA38;Ozanimod;;DDD;0;
L04AA40;Cladribin;;DDD;0;
L04AA42;Siponimod;3;DDD;0;
L04AA43;Ravulizumab;;DDD;0;
L04AA44;Upadacitinib;;DDD;0;
L04AB;Tumor necrosis factor alpha (tnf-alfa) hæmmere;;DDD;0;
L04AB01;Etanercept;;DDD;0;
L04AB02;Infliximab;;DDD;0;
L04AB04;Adalimumab;;DDD;0;
L04AB05;Certolizumab pegol;;DDD;0;
L04AB06;Golimumab;;DDD;0;
L04AC;Interleukinhæmmere;;DDD;0;
L04AC01;Daclizumab;;DDD;0;
L04AC02;Basiliximab;;DDD;0;
L04AC03;Anakinra;;DDD;0;
L04AC05;Ustekinumab;;DDD;0;
L04AC07;Tocilizumab;;DDD;0;
L04AC08;Canakinumab;;DDD;0;
L04AC10;Secukinumab;;DDD;0;
L04AC11;Siltuximab;;DDD;0;
L04AC12;Brodalumab;;DDD;0;
L04AC13;Ixekizumab;;DDD;0;
L04AC14;Sarilumab;;DDD;0;
L04AC16;Guselkumab;;DDD;0;
L04AC17;Tildrakizumab;;DDD;0;
L04AC18;Risankizumab;;DDD;0;
L04AD;Calcineurinhæmmere;;DDD;0;
L04AD01;Ciclosporin;;DDD;0;
L04AD02;Tacrolimus;;DDD;0;
L04AX;Andre immunosuppressiva;;DDD;0;
L04AX01;Azathioprin;;DDD;0;
L04AX02;Thalidomid;;DDD;0;
L04AX03;Methotrexat;;DDD;0;
L04AX04;Lenalidomid;;DDD;0;
L04AX05;Pirfenidon;;DDD;0;
L04AX06;Pomalidomid;;DDD;0;
L04AX07;Dimethylfumarat;;DDD;0;
M;Muskulo-skeletal system;;Ingen fælles mængdeenhed;0;
M01;Antiinflammatoriske og antirheumatiske midler;3;DDD;0;
M01A;Antiinflamm./antirheum. midler, non-steroide;3;DDD;0;
M01AA;Butylpyrazolidiner;;DDD;0;
M01AA01;Phenylbutazon;;DDD;0;
M01AB;Eddikesyre-derivater og beslægtede stoffer;;DDD;0;
M01AB01;Indometacin;;DDD;0;
M01AB02;Sulindac;;DDD;0;
M01AB03;Tolmetin;;DDD;0;
M01AB05;Diclofenac;;DDD;0;
M01AB08;Etodolac;;DDD;0;
M01AB15;Ketorolac;;DDD;0;
M01AB16;Aceclofenac;;DDD;0;
M01AB55;Diclofenac, kombinationer;;DDD;0;
M01AC;Oxicamer;;DDD;0;
M01AC01;Piroxicam;;DDD;0;
M01AC02;Tenoxicam;;DDD;0;
M01AC05;Lornoxicam;;DDD;0;
M01AC06;Meloxicam;;DDD;0;
M01AE;Propionsyre-derivater;3;DDD;0;
M01AE01;Ibuprofen;;DDD;0;
M01AE02;Naproxen;;DDD;0;
M01AE03;Ketoprofen;;DDD;0;
M01AE04;Fenoprofen;;DDD;0;
M01AE05;Fenbufen;;DDD;0;
M01AE09;Flurbiprofen;;DDD;0;
M01AE11;Tiaprofensyre;;DDD;0;
M01AE14;Dexibuprofen;;DDD;0;
M01AE17;Dexketoprofen;;DDD;0;
M01AE51;Ibuprofen, kombinationer;3;DDD;0;
M01AE52;Naproxen og esomeprazol;;DDD;0;
M01AG;Fenamater;;DDD;0;
M01AG02;Tolfenamsyre;;DDD;0;
M01AH;Coxibs;;DDD;0;
M01AH01;Celecoxib;;DDD;0;
M01AH02;Rofecoxib;;DDD;0;
M01AH04;Parecoxib;;DDD;0;
M01AH05;Etoricoxib;;DDD;0;
M01AH06;Lumiracoxib;;DDD;0;
M01AX;Andre antiinflam./antirheum. midler, non-steroide;;DDD;0;
M01AX01;Nabumeton;;DDD;0;
M01AX05;Glucosamin;;DDD;0;
M01C;Specifikke antirheumatiske midler;;DDD;0;
M01CB;Guld-forbindelser;;DDD;0;
M01CB01;Aurothiomalat-natrium;;DDD;0;
M01CB03;Auranofin;;DDD;0;
M01CC;Penicillamin og lign. stoffer;;DDD;0;
M01CC01;Penicillamin;;DDD;0;
M02;Midler mod led- og muskelsmerter, udvortes brug;;ml eller g (præparat);0;
M02A;Midler mod led- og muskelsmerter, udvortes brug;;ml eller g (præparat);0;
M02AA;Antiinflammatorica, non-steroide, udvortes brug;;ml eller g (præparat);0;
M02AA05;Benzydamin;;ml eller g (præparat);0;
M02AA07;Piroxicam;;ml eller g (præparat);0;
M02AA08;Felbinac;;ml eller g (præparat);0;
M02AA10;Ketoprofen;;ml eller g (præparat);0;
M02AA13;Ibuprofen;;ml eller g (præparat);0;
M02AA15;Diclofenac;;ml eller g (præparat);0;
M03;Muskelrelaxantia;;Ingen fælles mængdeenhed;0;
M03A;Muskelrelaxantia, perifert virkende midler;;Ingen fælles mængdeenhed;0;
M03AB;Cholin-derivater;;Ingen fælles mængdeenhed;0;
M03AB01;Suxamethon;;g (aktivt stof);0;
M03AC;Andre kvaternære ammoniumforbindelser;;Ingen fælles mængdeenhed;0;
M03AC01;Pancuron;;g (aktivt stof);0;
M03AC02;Gallamin;;g (aktivt stof);0;
M03AC03;Vecuron;;g (aktivt stof);0;
M03AC04;Atracurium;;g (aktivt stof);0;
M03AC09;Rocuroniumbromid;;g (aktivt stof);0;
M03AC10;Mivacuriumchlorid;;g (aktivt stof);0;
M03AC11;Cisatracurium;;g (aktivt stof);0;
M03AX;Andre muskelrelaxantia, perifert virkende;;Ingen fælles mængdeenhed;0;
M03AX01;Botulinum toxin;;Tusind enheder;0;
M03B;Muskelrelaxantia, centralt virkende midler;;DDD;0;
M03BA;Carbaminsyre-estere;;DDD;0;
M03BA02;Carisoprodol;;DDD;0;
M03BB;Oxazol-, thiazin-, triazin-derivater;;DDD;0;
M03BB02;Chlormezanon;;DDD;0;
M03BB03;Chlorzoxazon;;DDD;0;
M03BC;Ethere, kemisk beslægtet med antihistaminer;;DDD;0;
M03BC01;Orphenadrin (citrat);;DDD;0;
M03BX;Andre muskelrelaxantia, centralt virkende;;DDD;0;
M03BX01;Baclofen;;DDD;0;
M03BX02;Tizanidin;;DDD;0;
M03C;Muskelrelaxantia, direkte virkende midler;;DDD;0;
M03CA;Dantrolen og derivater;;DDD;0;
M03CA01;Dantrolen;;DDD;0;
M04;Midler mod arthritis urica;;DDD;0;
M04A;Midler mod arthritis urica;;DDD;0;
M04AA;Midler, der hæmmer urinsyreproduktionen;;DDD;0;
M04AA01;Allopurinol;;DDD;0;
M04AA03;Febuxostat;;DDD;0;
M04AB;Midler, der øger urinsyreudskillelsen;;DDD;0;
M04AB01;Probenecid;;DDD;0;
M04AB05;Lesinurad;;DDD;0;
M04AC;Midler uden virkning på urinsyre-metabolismen;;DDD;0;
M04AC01;Colchicin;;DDD;0;
M05;Midler til behandling af knoglesygdomme;3;DDD;0;
M05B;Midler med virkning på knoglestruktur og mineralisering;3;DDD;0;
M05BA;Bisphosphonater;;DDD;0;
M05BA01;Etidronsyre;;DDD;0;
M05BA02;Clodronsyre;;DDD;0;
M05BA03;Pamidronsyre;;DDD;0;
M05BA04;Alendronsyre;;DDD;0;
M05BA06;Ibandronsyre;;DDD;0;
M05BA07;Risedronsyre;;DDD;0;
M05BA08;Zoledronsyre;;DDD;0;
M05BB;Bisphosphonater, kombinationer;;DDD;0;
M05BB01;Etidronsyre og calcium, sekvenspræparater;;DDD;0;
M05BB03;Alendronsyre og colecalciferol;;DDD;0;
M05BC;Knoglemorphogene proteiner;3;DDD;0;
M05BC01;Dibotermin alfa;3;DDD;0;
M05BC02;Eptotermin alfa;3;DDD;0;
M05BX;Andre midler med virkning på knoglestruktur og mineralisering;3;DDD;0;
M05BX03;Strontiumranelat;;DDD;0;
M05BX04;Denosumab;;DDD;0;
M05BX05;Burosumab;3;DDD;0;
M05BX06;Romosozumab;3;DDD;0;
M09;Andre midler mod forstyrrelser i det muskulo-skeletale system;3;DDD;0;
M09A;Andre midler mod forstyrrelser i det muskulo-skeletale system;3;DDD;0;
M09AB;Enzymer;;DDD;0;
M09AB02;Collagenase clostridium histolytikum;;DDD;0;
M09AX;Andre midler mod forstyrrelser i det muskulo-skeletale system;3;DDD;0;
M09AX01;Hyaluronsyre;;DDD;0;
M09AX02;Chondrocytter, autolog;3;DDD;0;
M09AX03;Ataluren;;DDD;0;
M09AX07;Nusinersen;;DDD;0;
M09AX09;Onasemnogenabeparvovec;3;DDD;0;
M09AX10;Risdiplam;3;DDD;0;
N;Nervesystemet;;Ingen fælles mængdeenhed;0;
N01;Anesthetica;;Ingen fælles mængdeenhed;0;
N01A;Anesthetica, generelle;;Ingen fælles mængdeenhed;0;
N01AB;Halogenerede kulbrinter;;ml eller g (præparat);0;
N01AB01;Halothan;;ml eller g (præparat);0;
N01AB04;Enfluran;;ml eller g (præparat);0;
N01AB06;Isofluran;;ml eller g (præparat);0;
N01AB07;Desfluran;;ml eller g (præparat);0;
N01AB08;Sevofluran;;ml eller g (præparat);0;
N01AF;Barbiturater, usammensatte;;Ingen fælles mængdeenhed;0;
N01AF01;Methohexital;;g (aktivt stof);0;
N01AF03;Thiopental;;g (aktivt stof);0;
N01AH;Opioid-anesthetica;;Ingen fælles mængdeenhed;0;
N01AH01;Fentanyl;;mg (aktivt stof);0;
N01AH02;Alfentanil;;mg (aktivt stof);0;
N01AH03;Sufentanil;;mg (aktivt stof);0;
N01AH06;Remifentanil;;mg (aktivt stof);0;
N01AX;Andre generelle anesthetica;;Ingen fælles mængdeenhed;0;
N01AX03;Ketamin;;g (aktivt stof);0;
N01AX07;Etomidat;;g (aktivt stof);0;
N01AX10;Propofol;;g (aktivt stof);0;
N01AX13;Dinitrogenoxid;;L;0;
N01AX14;Esketamin;;g (aktivt stof);0;
N01B;Lokalanesthetica;;Ingen fælles mængdeenhed;0;
N01BA;Aminobenzoesyre-estere;;ml eller g (præparat);0;
N01BA03;Tetracain;;ml eller g (præparat);0;
N01BB;Amider;1;ml eller g (præparat);0;
N01BB01;Bupivacain;;ml eller g (præparat);0;
N01BB02;Lidocain;1;ml eller g (præparat);0;
N01BB03;Mepivacain;;ml eller g (præparat);0;
N01BB04;Prilocain;;ml eller g (præparat);0;
N01BB09;Ropivacain;;ml eller g (præparat);0;
N01BB20;Kombinationer;;ml eller g (præparat);0;
N01BB51;Bupivacain, kombinationer;1;ml eller g (præparat);0;
N01BB52;Lidocain, kombinationer;;ml eller g (præparat);0;
N01BB53;Mepivacain, kombinationer;;ml eller g (præparat);0;
N01BB54;Prilocain, kombinationer;;ml eller g (præparat);0;
N01BB58;Articain, kombinationer;;ml eller g (præparat);0;
N01BC;Benzoesyre-estere;;ml eller g (præparat);0;
N01BC01;Cocain;;ml eller g (præparat);0;
N01BX;Andre lokalanesthetica;4;Stk;0;
N01BX01;Ethylchlorid;;ml eller g (præparat);0;
N01BX04;Capsaicin;;Stk;0;
N02;Analgetica;;Ingen fælles mængdeenhed;0;
N02A;Opioider;1,2,3;DDD;0;
N02A***;(Ufuldstændig ATC-kode);;Ingen fælles mængdeenhed;0;
N02AA;Naturlige opiumalkaloider;1,3;DDD;0;
N02AA01;Morphin;1;DDD;0;
N02AA03;Hydromorphon;;DDD;0;
N02AA04;Nicomorphin;;DDD;0;
N02AA05;Oxycodon;;DDD;0;
N02AA51;Morphin, kombinationer;3;DDD;0;
N02AA55;Oxycodon og naloxon;;DDD;0;
N02AB;Phenylpiperidin-derivater;3;DDD;0;
N02AB01;Ketobemidon;;DDD;0;
N02AB02;Pethidin;;DDD;0;
N02AB03;Fentanyl;;DDD;0;
N02AB72;Pethidin, komb. med psycholeptica;3;DDD;0;
N02AC;Diphenylpropylamin-derivater;;DDD;0;
N02AC04;Dextropropoxyphen;;DDD;0;
N02AD;Benzomorphan-derivater;;DDD;0;
N02AD01;Pentazocin;;DDD;0;
N02AE;Oripavine-derivater;;DDD;0;
N02AE01;Buprenorphin;;DDD;0;
N02AF;Morphinan-derivater;;DDD;0;
N02AF02;Nalbufin;;DDD;0;
N02AG;Opioider i komb. med antispasmodica;2,3;DDD;0;
N02AG01;Morphin og antispasmodica;2,3;DDD;0;
N02AG02;Ketobemidon og antispasmodica;2,3;DDD;0;
N02AJ;Opioider i kombination med non-opioide analgetica;2,3;DDD;0;
N02AJ06;Codein og paracetamol;2;DDD;0;
N02AJ07;Codein og acetylsalicylsyre;3;DDD;0;
N02AX;Andre opioider;;DDD;0;
N02AX02;Tramadol;;DDD;0;
N02AX06;Tapentadol;;DDD;0;
N02B;Andre analgetica og antipyretica;;Ingen fælles mængdeenhed;0;
N02BA;Salicylsyre-derivater;2,3;DDD;0;
N02BA01;Acetylsalicylsyre;;DDD;0;
N02BA11;Diflunisal;;DDD;0;
N02BA51;Acetylsalicylsyre, komb. excl. psycholeptica;2;DDD;0;
N02BA75;Salicylamid, kombinationer med psycholeptica;3;DDD;0;
N02BB;Pyrazoloner;;DDD;0;
N02BB51;Phenazon, kombinationer excl. psycholeptica;;DDD;0;
N02BE;Anilider;2;DDD;0;
N02BE01;Paracetamol;;DDD;0;
N02BE05;Propacetamol;;DDD;0;
N02BE51;Paracetamol, kombinationer excl. psycholeptica;2;DDD;0;
N02BG;Andre analgetica og antipyretica;;Ingen fælles mængdeenhed;0;
N02BG09;Methoxyfluran;3;DDD;0;
N02BG10;Cannabinoider;;Ingen fælles mængdeenhed;0;
N02C;Midler mod migræne;1,3;DDD;0;
N02CA;Ergot-alkaloider;1,3;DDD;0;
N02CA01;Dihydroergotamin;;DDD;0;
N02CA02;Ergotamin;;DDD;0;
N02CA04;Methysergid;;DDD;0;
N02CA52;Ergotamin, kombinationspræparater;;DDD;0;
N02CA72;Ergotamin i kombination med psycholeptica;;Ingen fælles mængdeenhed;0;
N02CC;Selektive 5ht(1)-receptor-agonister;;DDD;0;
N02CC01;Sumatriptan;;DDD;0;
N02CC02;Naratriptan;;DDD;0;
N02CC03;Zolmitriptan;;DDD;0;
N02CC04;Rizatriptan;;DDD;0;
N02CC05;Almotriptan;;DDD;0;
N02CC06;Eletriptan;;DDD;0;
N02CC07;Frovatriptan;;DDD;0;
N02CD;Calcitoningenrelaterede peptid (cgrp) -antagonister;;DDD;0;
N02CD01;Erenumab;;DDD;0;
N02CD02;Galcanezumab;;DDD;0;
N02CD03;Fremanezumab;;DDD;0;
N02CX;Andre midler mod migræne;;DDD;0;
N02CX01;Pizotifen;;DDD;0;
N02CX02;Clonidin;;DDD;0;
N03;Antiepileptica;1;DDD;0;
N03A;Antiepileptica;1;DDD;0;
N03AA;Barbiturater og derivater;1;DDD;0;
N03AA**;(Ufuldstændig ATC-kode);;Ingen fælles mængdeenhed;0;
N03AA02;Phenobarbital;;DDD;0;
N03AA03;Primidon;;DDD;0;
N03AB;Hydantoin-derivater;;DDD;0;
N03AB02;Phenytoin;;DDD;0;
N03AB05;Fosphenytoin;;DDD;0;
N03AD;Succinimid-derivater;;DDD;0;
N03AD01;Ethosuximid;;DDD;0;
N03AE;Benzodiazepin-derivater;;DDD;0;
N03AE01;Clonazepam;;DDD;0;
N03AF;Carboxamid-derivater;;DDD;0;
N03AF01;Carbamazepin;;DDD;0;
N03AF02;Oxcarbazepin;;DDD;0;
N03AF03;Rufinamid;;DDD;0;
N03AF04;Eslicarbazepin;;DDD;0;
N03AG;Fedtsyre-derivater;;DDD;0;
N03AG01;Valproinsyre;;DDD;0;
N03AG04;Vigabatrin;;DDD;0;
N03AG06;Tiagabin;;DDD;0;
N03AX;Andre antiepileptica;;DDD;0;
N03AX09;Lamotrigin;;DDD;0;
N03AX11;Topiramat;;DDD;0;
N03AX12;Gabapentin;;DDD;0;
N03AX14;Levetiracetam;;DDD;0;
N03AX15;Zonisamid;;DDD;0;
N03AX16;Pregabalin;;DDD;0;
N03AX17;Stiripentol;;DDD;0;
N03AX18;Lacosamid;;DDD;0;
N03AX21;Retigabin;;DDD;0;
N03AX22;Perampanel;;DDD;0;
N03AX23;Brivaracetam;;DDD;0;
N03AX24;Cannabidiol;;DDD;0;
N03AX25;Cenobamat;;DDD;0;
N04;Anti-parkinson midler;;DDD;0;
N04A;Anticholinerge stoffer;;DDD;0;
N04AA;Tertiære aminer med kulstofkæde;;DDD;0;
N04AA01;Trihexyphenidyl;;DDD;0;
N04AA02;Biperiden;;DDD;0;
N04AA04;Procyclidin;;DDD;0;
N04AB;Ethere, kemisk beslægtet med antihistaminer;;DDD;0;
N04AB02;Orphenadrin (chlorid);;DDD;0;
N04AC;Ethere af tropin eller tropin-derivater;;DDD;0;
N04AC01;Benzatropin;;DDD;0;
N04B;Dopaminerge stoffer;;DDD;0;
N04BA;Dopa og dopa-derivater;;DDD;0;
N04BA02;Levodopa og decarboxylase-hæmmer;;DDD;0;
N04BA03;Levodopa, decarboxylase-hæmmer og comt-hæmmer;;DDD;0;
N04BB;Adamantan-derivater;;DDD;0;
N04BB01;Amantadin;;DDD;0;
N04BC;Dopamin-agonister;;DDD;0;
N04BC01;Bromocriptin;;DDD;0;
N04BC02;Pergolid;;DDD;0;
N04BC04;Ropinirol;;DDD;0;
N04BC05;Pramipexol;;DDD;0;
N04BC06;Cabergolin;;DDD;0;
N04BC07;Apomorphin;;DDD;0;
N04BC09;Rotigotin;;DDD;0;
N04BD;Monoamin-oxidase type b hæmmere;;DDD;0;
N04BD01;Selegilin;;DDD;0;
N04BD02;Rasagilin;;DDD;0;
N04BD03;Safinamid;;DDD;0;
N04BX;Andre dopaminerge stoffer;;DDD;0;
N04BX01;Tolcapon;;DDD;0;
N04BX02;Entacapon;;DDD;0;
N04BX04;Opicapon;;DDD;0;
N05;Psycholeptica;1,3;DDD;0;
N05A;Antipsychotica;;DDD;0;
N05AA;Phenothiazin med alifatisk sidekæde;;DDD;0;
N05AA01;Chlorpromazin;;DDD;0;
N05AA02;Levomepromazin;;DDD;0;
N05AA03;Promazin;;DDD;0;
N05AA04;Acepromazin;;DDD;0;
N05AB;Phenothiazin med piperazin-struktur;;DDD;0;
N05AB01;Dixyrazin;;DDD;0;
N05AB02;Fluphenazin;;DDD;0;
N05AB03;Perphenazin;;DDD;0;
N05AB04;Prochlorperazin;;DDD;0;
N05AC;Phenothiazin med piperidin-struktur;;DDD;0;
N05AC01;Periciazin;;DDD;0;
N05AC02;Thioridazin;;DDD;0;
N05AC04;Pipotiazin;;DDD;0;
N05AD;Butyrophenon-derivater;;DDD;0;
N05AD01;Haloperidol;;DDD;0;
N05AD03;Melperon;;DDD;0;
N05AD05;Pipamperon;;DDD;0;
N05AD06;Bromperidol;;DDD;0;
N05AD08;Droperidol;;DDD;0;
N05AE;Indol-derivater;;DDD;0;
N05AE03;Sertindol;;DDD;0;
N05AE04;Ziprasidon;;DDD;0;
N05AE05;Lurasidon;;DDD;0;
N05AF;Thioxanthen-derivater;;DDD;0;
N05AF01;Flupentixol;;DDD;0;
N05AF03;Chlorprothixen;;DDD;0;
N05AF05;Zuclopenthixol;;DDD;0;
N05AG;Diphenylbutylpiperidin-derivater;;DDD;0;
N05AG02;Pimozid;;DDD;0;
N05AG03;Penfluridol;;DDD;0;
N05AH;Diazepiner, oxazepiner, thiazepiner og oxepiner;;DDD;0;
N05AH01;Loxapin;;DDD;0;
N05AH02;Clozapin;;DDD;0;
N05AH03;Olanzapin;;DDD;0;
N05AH04;Quetiapin;;DDD;0;
N05AH05;Asenapin;;DDD;0;
N05AL;Benzamider;;DDD;0;
N05AL01;Sulpirid;;DDD;0;
N05AL05;Amisulprid;;DDD;0;
N05AN;Lithium;;DDD;0;
N05AN01;Lithium;;DDD;0;
N05AX;Andre antipsychotica;;DDD;0;
N05AX08;Risperidon;;DDD;0;
N05AX12;Aripiprazol;;DDD;0;
N05AX13;Paliperidon;;DDD;0;
N05AX15;Cariprazin;;DDD;0;
N05AX16;Brexpiprazol;;DDD;0;
N05B;Anxiolytica;;DDD;0;
N05BA;Benzodiazepin-derivater;;DDD;0;
N05BA01;Diazepam;;DDD;0;
N05BA02;Chlordiazepoxid;;DDD;0;
N05BA04;Oxazepam;;DDD;0;
N05BA05;Clorazepatkalium;;DDD;0;
N05BA06;Lorazepam;;DDD;0;
N05BA08;Bromazepam;;DDD;0;
N05BA09;Clobazam;;DDD;0;
N05BA12;Alprazolam;;DDD;0;
N05BB;Diphenylmethan-derivater;;DDD;0;
N05BB01;Hydroxyzin;;DDD;0;
N05BE;Azaspirodecanedion-derivater;;DDD;0;
N05BE01;Buspiron;;DDD;0;
N05C;Hypnotica og sedativa;1,3;DDD;0;
N05CA;Barbiturater, usammensatte;;DDD;0;
N05CA01;Pentobarbital;;DDD;0;
N05CA04;Barbital;;DDD;0;
N05CC;Aldehyder og derivater;;DDD;0;
N05CC01;Chloralhydrat;;DDD;0;
N05CD;Benzodiazepin-derivater;3;DDD;0;
N05CD01;Flurazepam;;DDD;0;
N05CD02;Nitrazepam;;DDD;0;
N05CD03;Flunitrazepam;;DDD;0;
N05CD04;Estazolam;;DDD;0;
N05CD05;Triazolam;;DDD;0;
N05CD06;Lormetazepam;;DDD;0;
N05CD07;Temazepam;;DDD;0;
N05CD08;Midazolam;;DDD;0;
N05CD09;Brotizolam;;DDD;0;
N05CD14;Remimazolam;3;DDD;0;
N05CF;Benzodiazepin-relaterede midler;;DDD;0;
N05CF01;Zopiclon;;DDD;0;
N05CF02;Zolpidem;;DDD;0;
N05CF03;Zaleplon;;DDD;0;
N05CH;Melatoninreceptor-agonister;1;DDD;0;
N05CH01;Melatonin;1;DDD;0;
N05CM;Andre hypnotica og sedativa;;DDD;0;
N05CM02;Clomethiazol;;DDD;0;
N05CM18;Dexmedetomidin;;DDD;0;
N06;Psychoanaleptica;1,3;DDD;0;
N06A;Antidepressiva;;DDD;0;
N06AA;Non-selektive monoamin re-optagelse inhibitorer;;DDD;0;
N06AA02;Imipramin;;DDD;0;
N06AA03;Imipraminoxid;;DDD;0;
N06AA04;Clomipramin;;DDD;0;
N06AA05;Opipramol;;DDD;0;
N06AA06;Trimipramin;;DDD;0;
N06AA07;Lofepramin;;DDD;0;
N06AA09;Amitriptylin;;DDD;0;
N06AA10;Nortriptylin;;DDD;0;
N06AA11;Protriptylin;;DDD;0;
N06AA12;Doxepin;;DDD;0;
N06AA16;Dosulepin;;DDD;0;
N06AA17;Amoxapin;;DDD;0;
N06AA21;Maprotilin;;DDD;0;
N06AB;Selektive serotonin re-optagelse inhibitorer;;DDD;0;
N06AB03;Fluoxetin;;DDD;0;
N06AB04;Citalopram;;DDD;0;
N06AB05;Paroxetin;;DDD;0;
N06AB06;Sertralin;;DDD;0;
N06AB08;Fluvoxamin;;DDD;0;
N06AB10;Escitalopram;;DDD;0;
N06AF;Monoamin-oxidase hæmmere, non-selektive;;DDD;0;
N06AF01;Isocarboxazid;;DDD;0;
N06AG;Monoamin-oxidase type a hæmmere;;DDD;0;
N06AG02;Moclobemid;;DDD;0;
N06AX;Andre antidepressiva;;DDD;0;
N06AX03;Mianserin;;DDD;0;
N06AX06;Nefazodon;;DDD;0;
N06AX11;Mirtazapin;;DDD;0;
N06AX12;Bupropion;;DDD;0;
N06AX16;Venlafaxin;;DDD;0;
N06AX18;Reboxetin;;DDD;0;
N06AX21;Duloxetin;;DDD;0;
N06AX22;Agomelatin;;DDD;0;
N06AX26;Vortioxetin;;DDD;0;
N06AX27;Esketamin;;DDD;0;
N06B;Psychostimulantia, midler for adhd og nootropica;1,3;DDD;0;
N06BA;Centralt virkende sympathomimetica;1,3;DDD;0;
N06BA01;Amfetamin;1;DDD;0;
N06BA02;Dexamfetamin;;DDD;0;
N06BA04;Methylphenidat;;DDD;0;
N06BA07;Modafinil;;DDD;0;
N06BA09;Atomoxetin;;DDD;0;
N06BA12;Lisdexamfetamin;;DDD;0;
N06BA14;Solriamfetol;3;DDD;0;
N06BC;Xanthin-derivater;;DDD;0;
N06BC01;Caffein;;DDD;0;
N06BX;Andre psychostimulantia og nootropica;3;DDD;0;
N06BX13;Idebenon;3;DDD;0;
N06D;Midler mod demens;;DDD;0;
N06DA;Anticholinesteraser;;DDD;0;
N06DA02;Donepezil;;DDD;0;
N06DA03;Rivastigmin;;DDD;0;
N06DA04;Galantamin;;DDD;0;
N06DX;Andre midler mod demens;;DDD;0;
N06DX01;Memantin;;DDD;0;
N07;Andre midler med virkn. på centralnervesystemet;2,3;DDD;0;
N07A;Parasympatomimetica;2,3;DDD;0;
N07AA;Anticholinesteraser;2,3;DDD;0;
N07AA01;Neostigmin;;DDD;0;
N07AA02;Pyridostigmin;;DDD;0;
N07AA51;Neostigmin, kombinationer;2,3;DDD;0;
N07AB;Cholin-estere;;DDD;0;
N07AB01;Carbacholin;;DDD;0;
N07B;Midler mod afhængighedsforstyrrelser;3;DDD;0;
N07BA;Midler mod nicotinafhængighed;;DDD;0;
N07BA01;Nicotin;;DDD;0;
N07BA03;Vareniclin;;DDD;0;
N07BB;Midler mod alkoholafhængighed;3;DDD;0;
N07BB01;Disulfiram;;DDD;0;
N07BB02;Calciumcarbimid;3;DDD;0;
N07BB03;Acamprosat;;DDD;0;
N07BB04;Naltrexon;;DDD;0;
N07BB05;Nalmefen;;DDD;0;
N07BC;Midler mod opioidafhængighed;3;DDD;0;
N07BC01;Buprenorphin;;DDD;0;
N07BC02;Methadon;;DDD;0;
N07BC03;Levacetylmethadol;3;DDD;0;
N07BC06;Diamorphin;3;DDD;0;
N07BC51;Buprenorphin, komb.;;DDD;0;
N07C;Midler mod svimmelhed;;DDD;0;
N07CA;Midler mod svimmelhed;;DDD;0;
N07CA01;Betahistin;;DDD;0;
N07CA02;Cinnarizin;;DDD;0;
N07CA03;Flunarizin;;DDD;0;
N07CA52;Cinnarizin, kombinationer;;DDD;0;
N07X;Andre midler med virkn. på nervesystemet;3;DDD;0;
N07XX;Andre midler med virkning på nervesystemet;3;DDD;0;
N07XX01;Tirilazad;;DDD;0;
N07XX02;Riluzol;;DDD;0;
N07XX04;Natriumoxybat;;DDD;0;
N07XX05;Amifampridin;;DDD;0;
N07XX06;Tetrabenazin;;DDD;0;
N07XX07;Fampridin;;DDD;0;
N07XX08;Tafamidis;;DDD;0;
N07XX11;Pitolisant;;DDD;0;
N07XX12;Patisiran;3;DDD;0;
P;Antiparasitære midler, insekticider og repellanter;;Ingen fælles mængdeenhed;0;
P01;Antiprotozo-midler;2;DDD;0;
P01A;Midler mod amøbe- og andre protozo-sygdomme;;DDD;0;
P01AB;Nitroimidazol-derivater;;DDD;0;
P01AB01;Metronidazol;;DDD;0;
P01AB02;Tinidazol;;DDD;0;
P01AX;Andre midler mod amøbesygdomme;;DDD;0;
P01AX06;Atovaquon;;DDD;0;
P01AX07;Trimetrexat;;DDD;0;
P01B;Malariamidler;2;DDD;0;
P01BA;Aminochinoliner;;DDD;0;
P01BA01;Chloroquin;;DDD;0;
P01BA02;Hydroxychloroquin;;DDD;0;
P01BB;Biguanider;2;DDD;0;
P01BB01;Proguanil;;DDD;0;
P01BB51;Proguanil og atovaquon;2;DDD;0;
P01BC;Methanolquinoliner;;DDD;0;
P01BC01;Quinin;;DDD;0;
P01BC02;Mefloquin;;DDD;0;
P01BD;Diaminopyrimidiner;;DDD;0;
P01BD51;Pyrimethamin, kombinationer;;DDD;0;
P01C;Midler mod leishmaniasis og trypanosomiasis;;DDD;0;
P01CX;Andre midler mod leishmaniasis og trypanosomiasis;;DDD;0;
P01CX01;Pentamidinisethionat;;DDD;0;
P02;Anthelmintica;;DDD;0;
P02C;Antinematode-midler;;DDD;0;
P02CA;Benzimidazol-derivater;;DDD;0;
P02CA01;Mebendazol;;DDD;0;
P02CF;Avermectiner;;DDD;0;
P02CF01;Ivermectin;;DDD;0;
P02CX;Andre antinematode-midler;;DDD;0;
P02CX01;Pyrvinium;;DDD;0;
P02D;Anticestodale midler;;DDD;0;
P02DA;Salicylsyre-derivater;;DDD;0;
P02DA01;Niclosamid;;DDD;0;
P03;Ectoparasitmidler, incl scabiesmidler, insekticider og repellanter;;ml eller g (præparat);0;
P03A;Ectoparasitmidler, incl scabiesmidler;;ml eller g (præparat);0;
P03AA;Svovlholdige midler;;ml eller g (præparat);0;
P03AA**;(Ufuldstændig ATC-kode);;ml eller g (præparat);0;
P03AB;Chlorholdige midler;;ml eller g (præparat);0;
P03AB02;Lindan;;ml eller g (præparat);0;
P03AC;Pyrethriner, incl. syntetiske forbindelser;;ml eller g (præparat);0;
P03AC03;Phenothrin;;ml eller g (præparat);0;
P03AC04;Permethrin;;ml eller g (præparat);0;
P03AC51;Pyrethrum, kombinationer;;ml eller g (præparat);0;
P03AC52;Bioallethrin, kombinationer;;ml eller g (præparat);0;
P03AX;Andre ectoparasitmidler, incl. scabiesmidler;;ml eller g (præparat);0;
P03AX03;Malathion;;ml eller g (præparat);0;
R;Respirationssystemet;;Ingen fælles mængdeenhed;0;
R01;Midler mod sygdomme i næsehulen;2,3;DDD;0;
R01A;Decongestants and other nasal preparations for topical use;2,3;DDD;0;
R01AA;Sympathomimetica, usammensatte;;DDD;0;
R01AA04;Phenylephrin;;DDD;0;
R01AA05;Oxymetazolin;;DDD;0;
R01AA07;Xylometazolin;;DDD;0;
R01AB;Sympathomimetica, komb. excl. corticosteroider;3;DDD;0;
R01AB06;Xylometazolin;3;DDD;0;
R01AC;Antiallergiske midler, excl. corticosteroider;3;DDD;0;
R01AC01;Cromoglicinsyre;;DDD;0;
R01AC02;Levocabastin;;DDD;0;
R01AC03;Azelastin;;DDD;0;
R01AC51;Cromoglicinsyre, kombinationer;3;DDD;0;
R01AD;Corticosteroider;2;DDD;0;
R01AD01;Beclomethason;;DDD;0;
R01AD04;Flunisolid;;DDD;0;
R01AD05;Budesonid;;DDD;0;
R01AD08;Fluticason;;DDD;0;
R01AD09;Mometason;;DDD;0;
R01AD11;Triamcinolon;;DDD;0;
R01AD12;Fluticasonfuroat;;DDD;0;
R01AD58;Fluticason, kombinationer;2;DDD;0;
R01AX;Andre midler mod sygdomme i næsehulen;;DDD;0;
R01AX03;Ipratropiumbromid;;DDD;0;
R01B;Nasal decongestants for systemic use;;DDD;0;
R01BA;Sympathomimetica;;DDD;0;
R01BA52;Pseudoephedrin, kombinationer;;DDD;0;
R02;Halsmidler;3;DDD;0;
R02A;Halsmidler;3;DDD;0;
R02AA;Antiseptica;3;DDD;0;
R02AA03;Dichlorbenzylalkohol;3;DDD;0;
R02AA05;Chlorhexidin;;DDD;0;
R02AA20;Diverse antiseptica;3;DDD;0;
R02AD;Lokalanæstetika;3;DDD;0;
R02AD**;(Ufuldstændig ATC-kode);3;DDD;0;
R02AD02;Lidocain;3;DDD;0;
R02AX;Andre halsmidler;;DDD;0;
R02AX01;Flurbiprofen;;DDD;0;
R02AX03;Benzydamin;;DDD;0;
R03;Midler mod obstruktiv lungesygdom;2,3;DDD;0;
R03A;Adrenergica til inhalation;2,3;DDD;0;
R03AA;Alfa- og beta-adrenoceptor agonister;;DDD;0;
R03AA01;Adrenalin;;DDD;0;
R03AC;Selektive beta-2-adrenoceptor agonister;;DDD;0;
R03AC02;Salbutamol;;DDD;0;
R03AC03;Terbutalin;;DDD;0;
R03AC04;Fenoterol;;DDD;0;
R03AC05;Rimiterol;;DDD;0;
R03AC12;Salmeterol;;DDD;0;
R03AC13;Formoterol;;DDD;0;
R03AC18;Indacaterol;;DDD;0;
R03AC19;Olodaterol;;DDD;0;
R03AK;Adrenergica komb.m. corticosteroider/andre midler, ex. anticholinergica;2;DDD;0;
R03AK06;Salmeterol og fluticason;2;DDD;0;
R03AK07;Formoterol og budesonid;2;DDD;0;
R03AK08;Formoterol og beclometason;2;DDD;0;
R03AK10;Vilanterol og fluticasonfuroat;2;DDD;0;
R03AK11;Formoterol og fluticason;2;DDD;0;
R03AK14;Indacaterol og mometason;2;DDD;0;
R03AL;Adrenergica komb m anticholinergica inkl 3-stof komb m corticosteroider;2,3;DDD;0;
R03AL01;Fenoterol og ipratropiumbromid;2,3;DDD;0;
R03AL02;Salbutamol og ipratropiumbromid;2;DDD;0;
R03AL03;Vilanterol og umeclidiniumbromid;2;DDD;0;
R03AL04;Indacaterol og glycopyrroniumbromid;2;DDD;0;
R03AL05;Formoterol og aclidiniumbromid;2;DDD;0;
R03AL06;Olodaterol og tiotropiumbromid;2;DDD;0;
R03AL07;Formoterol og glycopyrroniumbromid;2;DDD;0;
R03AL08;Vilanterol, umeclidiniumbromid og fluticasonfuroat;2;DDD;0;
R03AL09;Formoterol, glycopyrroniumbromid og beclometason;2,3;DDD;0;
R03AL11;Formoterol, glycopyrroniumbromid og budesonid;2;DDD;0;
R03AL12;Indacaterol, glycopyrroiniumbromid og mometason;2;DDD;0;
R03B;Andre midler mod obstruktiv lungesygdom, inhalation;3;DDD;0;
R03BA;Glucocorticoider;;DDD;0;
R03BA01;Beclomethason;;DDD;0;
R03BA02;Budesonid;;DDD;0;
R03BA03;Flunisolid;;DDD;0;
R03BA05;Fluticason;;DDD;0;
R03BA07;Mometason;;DDD;0;
R03BA08;Ciclesonid;;DDD;0;
R03BB;Anticholinergica;3;DDD;0;
R03BB01;Ipratropiumbromid;;DDD;0;
R03BB02;Oxitropiumbromid;3;DDD;0;
R03BB04;Tiotropiumbromid;;DDD;0;
R03BB05;Aclidiniumbromid;;DDD;0;
R03BB06;Glycopyrroniumbromid;;DDD;0;
R03BB07;Umeclidiniumbromid;;DDD;0;
R03BC;Antiallergiske midler, excl corticosteroider;;DDD;0;
R03BC01;Cromoglicinsyre;;DDD;0;
R03BC03;Nedocromil;;DDD;0;
R03C;Adrenergica til systemisk brug;;DDD;0;
R03CA;Alfa- og beta-adrenoceptor agonister;;DDD;0;
R03CA02;Ephedrin;;DDD;0;
R03CB;Non-selektive beta-adrenoceptor agonister;;DDD;0;
R03CB03;Orciprenalin;;DDD;0;
R03CC;Selektive beta-2-adrenoceptor agonister;;DDD;0;
R03CC02;Salbutamol;;DDD;0;
R03CC03;Terbutalin;;DDD;0;
R03CC12;Bambuterol;;DDD;0;
R03D;Andre systemiske midler mod obstruktiv lungesygdom;;DDD;0;
R03DA;Xanthiner;;DDD;0;
R03DA02;Cholintheophyllinat;;DDD;0;
R03DA03;Proxyphyllin;;DDD;0;
R03DA04;Theophyllin;;DDD;0;
R03DA05;Aminophyllin;;DDD;0;
R03DC;Leukotrien-receptor antagonister;;DDD;0;
R03DC01;Zafirlukast;;DDD;0;
R03DC03;Montelukast;;DDD;0;
R03DX;Andre systemiske midler mod obstruktiv lungesygdom;;DDD;0;
R03DX05;Omalizumab;;DDD;0;
R03DX07;Roflumilast;;DDD;0;
R03DX08;Reslizumab;;DDD;0;
R03DX09;Mepolizumab;;DDD;0;
R03DX10;Benralizumab;;DDD;0;
R05;Midler mod hoste og forkølelse;1,3;DDD;0;
R05C;Expectorantia, excl. komb. med antitussiva;3;DDD;0;
R05CA;Expectorantia;3;DDD;0;
R05CA10;Kombinationer af expectorantia;3;DDD;0;
R05CB;Mucolytica;;DDD;0;
R05CB01;Acetylcystein;;DDD;0;
R05CB02;Bromhexin;;DDD;0;
R05CB06;Ambroxol;;DDD;0;
R05CB13;Dornase alfa (desoxiribonuclease);;DDD;0;
R05CB15;Erdostein;;DDD;0;
R05CB16;Mannitol;;DDD;0;
R05D;Antitussiva, excl. komb. m. expectorantia;3;DDD;0;
R05DA;Opiumalkaloider og derivater;;DDD;0;
R05DA01;Ethylmorphin;;DDD;0;
R05DA04;Codein;;DDD;0;
R05DA07;Noscapin;;DDD;0;
R05DA09;Dextromethorphan;;DDD;0;
R05DB;Andre antitussiva;3;DDD;0;
R05DB05;Pentoxyverin;;DDD;0;
R05DB20;Kombinationer af antitussiva;3;DDD;0;
R05F;Antitussiva og expectorantia i kombination;1,3;DDD;0;
R05FA;Opiumderivater og expectorantia;1,3;DDD;0;
R05FA02;Opiumderivater og expectorantia;1,3;DDD;0;
R06;Antihistaminer til systemisk brug;;DDD;0;
R06A;Antihistaminer til systemisk brug;;DDD;0;
R06AA;Aminoalkyl-ethere;;DDD;0;
R06AA02;Diphenhydramin;;DDD;0;
R06AA04;Clemastin;;DDD;0;
R06AA11;Dimenhydrinat;;DDD;0;
R06AB;Substituerede alkylaminer;;DDD;0;
R06AB02;Dexchlorpheniramin;;DDD;0;
R06AC;Substituerede ethylendiaminer;;DDD;0;
R06AC01;Mepyramin;;DDD;0;
R06AD;Phenothiazin-derivater;;DDD;0;
R06AD01;Alimemazin;;DDD;0;
R06AD02;Promethazin;;DDD;0;
R06AD03;Thiethylperazin;;DDD;0;
R06AD04;Methdilazin;;DDD;0;
R06AE;Piperazin-derivater;;DDD;0;
R06AE03;Cyclizin;;DDD;0;
R06AE04;Chlorcyclizin;;DDD;0;
R06AE05;Meclozin;;DDD;0;
R06AE07;Cetirizin;;DDD;0;
R06AE09;Levocetirizin;;DDD;0;
R06AX;Andre antihistaminer til systemisk brug;;DDD;0;
R06AX02;Cyproheptadin;;DDD;0;
R06AX09;Azatadin;;DDD;0;
R06AX11;Astemizol;;DDD;0;
R06AX12;Terfenadin;;DDD;0;
R06AX13;Loratadin;;DDD;0;
R06AX18;Acrivastin;;DDD;0;
R06AX22;Ebastin;;DDD;0;
R06AX25;Mizolastin;;DDD;0;
R06AX26;Fexofenadin;;DDD;0;
R06AX27;Desloratadin;;DDD;0;
R06AX28;Rupatadin;;DDD;0;
R06AX29;Bilastin;;DDD;0;
R07;Andre midler mod sygdomme i respirationssystemet;;Ingen fælles mængdeenhed;0;
R07A;Andre midler mod sygdomme i respirationssystemet;;Ingen fælles mængdeenhed;0;
R07AA;Lunge-surfactanter;;DDD;0;
R07AA01;Colfoscerilpalmitat;;DDD;0;
R07AA02;Naturlige phosholipider;;DDD;0;
R07AB;Respirationsstimulerende midler;;DDD;0;
R07AB01;Doxapram;;DDD;0;
R07AB07;Almitrin;;DDD;0;
R07AX;Andre midler med virkning på respirationssystemet;;Ingen fælles mængdeenhed;0;
R07AX01;Nitrogenoxid;;L;0;
R07AX02;Ivacaftor;;DDD;0;
R07AX30;Ivacaftor og lumacaftor;2,3;DDD;0;
R07AX31;Ivacaftor og tezacaftor;3;DDD;0;
R07AX32;Ivacaftor, tezacaftor og elexacaftor;2;DDD;0;
S;Sanseorganer;;Ingen fælles mængdeenhed;0;
S01;Oftalmologica;;Ingen fælles mængdeenhed;0;
S01A;Antiinfectiva;;Pakninger;0;
S01AA;Antibiotica;;Pakninger;0;
S01AA01;Chloramphenicol;;Pakninger;0;
S01AA02;Chlortetracyclin;;Pakninger;0;
S01AA11;Gentamicin;;Pakninger;0;
S01AA12;Tobramycin;;Pakninger;0;
S01AA13;Fusidinsyre;;Pakninger;0;
S01AA26;Azithromycin;;Pakninger;0;
S01AA27;Cefuroxim;;Pakninger;0;
S01AA30;Kombinationer af forskellige antibiotica;;Pakninger;0;
S01AB;Sulfonamider;;Pakninger;0;
S01AB01;Sulfamethizol;;Pakninger;0;
S01AB03;Sulfadicramid;;Pakninger;0;
S01AD;Antivirale midler;;Pakninger;0;
S01AD03;Aciclovir;;Pakninger;0;
S01AD08;Fomivirsen;;Pakninger;0;
S01AE;Fluoroquinoloner;;Pakninger;0;
S01AE01;Ofloxacin;;Pakninger;0;
S01AE02;Norfloxacin;;Pakninger;0;
S01AE03;Ciprofloxacin;;Pakninger;0;
S01AE04;Lomefloxacin;;Pakninger;0;
S01AE05;Levofloxacin;;Pakninger;0;
S01AE07;Moxifloxacin;;Pakninger;0;
S01AX;Andre antiinfectiva;;Pakninger;0;
S01AX02;Sølvforbindelser;;Pakninger;0;
S01AX03;Zinkforbindelser;;Pakninger;0;
S01AX06;Resorcinol;;Pakninger;0;
S01AX07;Natriumborat;;Pakninger;0;
S01B;Antiinflammatoriske stoffer;;Pakninger;0;
S01BA;Corticosteroider, usammensatte;;Pakninger;0;
S01BA01;Dexamethason;;Pakninger;0;
S01BA02;Hydrocortison;;Pakninger;0;
S01BA04;Prednisolon;;Pakninger;0;
S01BA05;Triamcinolon;;Pakninger;0;
S01BA07;Fluormetholon;;Pakninger;0;
S01BA13;Rimexolon;;Pakninger;0;
S01BA15;Fluocinolonacetonid;;Pakninger;0;
S01BC;Antiinflammatoriske midler, non-steroide;;Pakninger;0;
S01BC01;Indometacin;;Pakninger;0;
S01BC03;Diclofenac;;Pakninger;0;
S01BC04;Flurbiprofen;;Pakninger;0;
S01BC05;Ketorolac;;Pakninger;0;
S01BC10;Nepafenac;;Pakninger;0;
S01BC11;Bromfenac;;Pakninger;0;
S01C;Antiinflammatorica og antiinfectiva i kombination;;Pakninger;0;
S01CA;Corticosteroider og antiinfectiva i kombination;;Pakninger;0;
S01CA01;Dexamethason og antiinfectiva;;Pakninger;0;
S01E;Antiglaucom-midler og miotica;3;DDD;0;
S01EA;Sympathomimetica til glaucombehandling;3;DDD;0;
S01EA02;Dipivefrin;;DDD;0;
S01EA03;Apraclonidin;;DDD;0;
S01EA05;Brimonidin;;DDD;0;
S01EA51;Adrenalin, kombinationer;3;DDD;0;
S01EB;Parasympathomimetica;3;DDD;0;
S01EB01;Pilocarpin;;DDD;0;
S01EB02;Carbachol;;DDD;0;
S01EB51;Pilocarpin, kombinationer;3;DDD;0;
S01EC;Carbo-anhydrase inhibitorer;3;DDD;0;
S01EC01;Acetazolamid;;DDD;0;
S01EC02;Diclofenamid;;DDD;0;
S01EC03;Dorzolamid;;DDD;0;
S01EC04;Brinzolamid;;DDD;0;
S01EC54;Brinzolamid, kombinationer;3;DDD;0;
S01ED;Beta-blokerende midler;3;DDD;0;
S01ED01;Timolol;;DDD;0;
S01ED02;Betaxolol;;DDD;0;
S01ED03;Levobunolol;;DDD;0;
S01ED05;Carteolol;;DDD;0;
S01ED51;Timolol, kombinationer;3;DDD;0;
S01EE;Prostaglandin-analoger;;DDD;0;
S01EE01;Latanoprost;;DDD;0;
S01EE03;Bimatoprost;;DDD;0;
S01EE04;Travoprost;;DDD;0;
S01EE05;Tafluprost;;DDD;0;
S01F;Mydriatica og cycloplegica;;Ingen fælles mængdeenhed;0;
S01FA;Anticholinergica;;Ingen fælles mængdeenhed;0;
S01FA01;Atropin;;Ingen fælles mængdeenhed;0;
S01FA02;Scopolamin;;Pakninger;0;
S01FA04;Cyclopentolat;;Pakninger;0;
S01FA05;Homatropin;;Pakninger;0;
S01FA06;Tropicamid;;Pakninger;0;
S01FA56;Tropicamid, kombinationer;;Pakninger;0;
S01FB;Sympathomimetica excl. antiglaucom-midler;4;Pakninger;0;
S01FB01;Phenylephrin;4;Pakninger;0;
S01G;Decongestantica og antiallergica;3;DDD;0;
S01GA;Sympathomimetica anvendt som decongestantica;3;DDD;0;
S01GA02;Tetryzolin;3;DDD;0;
S01GA51;Naphazolin, kombinationer;3;DDD;0;
S01GA55;Phenylephrin, kombinationer;3;DDD;0;
S01GX;Andre antiallergica;3;DDD;0;
S01GX01;Cromoglicinsyre;3;DDD;0;
S01GX02;Levocabastin;3;DDD;0;
S01GX04;Nedocromil;3;DDD;0;
S01GX05;Lodoxamid;3;DDD;0;
S01GX06;Emedastin;3;DDD;0;
S01GX07;Azelastin;3;DDD;0;
S01GX08;Ketotifen;3;DDD;0;
S01GX09;Olopatadin;3;DDD;0;
S01H;Lokalanæstetika;;Ingen fælles mængdeenhed;0;
S01HA;Lokalanæstetika;;Ingen fælles mængdeenhed;0;
S01HA01;Cocain;;Pakninger;0;
S01HA02;Oxybuprocain;;Ingen fælles mængdeenhed;0;
S01HA03;Tetracain;;Ingen fælles mængdeenhed;0;
S01HA06;Cinchocain;;Ingen fælles mængdeenhed;0;
S01J;Diagnostica;;Stk;0;
S01JA;Farvestoffer;;Stk;0;
S01JA01;Fluorescein;;Stk;0;
S01JA51;Fluorescein, kombinationer;;Stk;0;
S01K;Kirurgiske hjælpemidler;;Pakninger;0;
S01KA;Viscoelastiske substanser;;Pakninger;0;
S01KA01;Hyaluronsyre;;Pakninger;0;
S01L;Midler mod okular vaskulær lidelse;3;DDD;0;
S01LA;Antineovaskularisationsmidler;3;DDD;0;
S01LA01;Verteporfin;3;DDD;0;
S01LA03;Pegaptanib;3;DDD;0;
S01LA04;Ranibizumab;3;DDD;0;
S01LA05;Aflibercept;3;DDD;0;
S01LA06;Brolucizumab;3;DDD;0;
S01X;Andre ophthalmologiske midler;1,4;ml eller g (præparat);0;
S01XA;Andre ophthalmologiske midler;1,4;ml eller g (præparat);0;
S01XA**;(Ufuldstændig ATC-kode);1;ml eller g (præparat);0;
S01XA03;Natriumchlorid, hypertonisk;;ml eller g (præparat);0;
S01XA05;Natriumedetat;;ml eller g (præparat);0;
S01XA18;Ciclosporin;;ml eller g (præparat);0;
S01XA19;Limbale stamceller, autologe;;Pakninger;0;
S01XA20;Kunstig tårevæske og andre indifferente midler;4;ml eller g (præparat);0;
S01XA21;Mercaptamin;;ml eller g (præparat);0;
S01XA22;Ocriplasmin;;Pakninger;0;
S01XA27;Voretigenneparvovec;;Pakninger;0;
S02;Otologica;;Pakninger;0;
S02A;Antiinfectiva;;Pakninger;0;
S02AA;Antiinfectiva;;Pakninger;0;
S02AA01;Chloramphenicol;;Pakninger;0;
S02AA15;Ciprofloxacin;;Pakninger;0;
S02AA30;Antiinfectiva, kombinationer;;Pakninger;0;
S02B;Corticosteroider;;Pakninger;0;
S02BA;Corticosteroider;;Pakninger;0;
S02BA08;Fluocinolonacetonid;;Pakninger;0;
S02C;Corticosteroider og antiinfectiva i kombination;;Pakninger;0;
S02CA;Corticosteroider og antiinfectiva i kombination;;Pakninger;0;
S02CA02;Flumetason og antiinfectiva;;Pakninger;0;
S02CA03;Hydrocortison og antiinfectiva;;Pakninger;0;
S02CA05;Fluocinolonacetonid og antiinfectiva;;Pakninger;0;
S02CA06;Dexamethason og antiinfectiva;;Pakninger;0;
S03;Ophthalmologica og otologica;;Pakninger;0;
S03A;Antiinfectiva;;Pakninger;0;
S03AA;Antiinfectiva;;Pakninger;0;
S03AA30;Antiinfectiva, kombinationer;;Pakninger;0;
S03B;Corticosteroider;;Pakninger;0;
S03BA;Corticosteroider;;Pakninger;0;
S03BA01;Dexamethason;;Pakninger;0;
S03C;Corticosteroider og antiinfectiva i kombination;;Pakninger;0;
S03CA;Corticosteroider og antiinfectiva i kombination;;Pakninger;0;
S03CA01;Dexamethason og antiinfectiva;;Pakninger;0;
S03CA04;Hydrocortison og antiinfectiva;;Pakninger;0;
V;Diverse;;Ingen fælles mængdeenhed;0;
V01;Allergener;;Ingen fælles mængdeenhed;0;
V01A;Allergener;;Ingen fælles mængdeenhed;0;
V01AA;Allergenekstrakter;;Ingen fælles mængdeenhed;0;
V01AA02;Græspollen;;Ingen fælles mængdeenhed;0;
V01AA03;Husstøvmider;;Ingen fælles mængdeenhed;0;
V01AA05;Træpollen;;Ingen fælles mængdeenhed;0;
V01AA07;Insekter;;Stk;0;
V01AA10;Blomster;;Stk;0;
V01AA11;Dyr;;Stk;0;
V03;Alle andre terapeutiske produkter;;Ingen fælles mængdeenhed;0;
V03A;Alle andre terapeutiske produkter;;Ingen fælles mængdeenhed;0;
V03AB;Antidoter;1;Stk;0;
V03AB01;Ipecacuanha;;Stk;0;
V03AB06;Thiosulfat;;Stk;0;
V03AB08;Natriumnitrit;;Stk;0;
V03AB09;Dimercaprol;;Stk;0;
V03AB13;Obidoxim;;Stk;0;
V03AB14;Protamin;;Stk;0;
V03AB15;Naloxon;;Stk;0;
V03AB17;Methylthioninchlorid;;Stk;0;
V03AB18;Kaliumpermanganat;;Stk;0;
V03AB19;Physostigmin;;Stk;0;
V03AB21;Kaliumiodid;;Stk;0;
V03AB22;Amylnitrit;;Stk;0;
V03AB23;Acetylcystein;;Ingen fælles mængdeenhed;0;
V03AB25;Flumazenil;;Stk;0;
V03AB33;Hydroxocobalamin;;Stk;0;
V03AB35;Sugammadex;;Stk;0;
V03AB37;Idarucizumab;;Stk;0;
V03AC;Jern-chelaterende midler;;Stk;0;
V03AC01;Deferoxamin;;Stk;0;
V03AC02;Deferipron;;Stk;0;
V03AC03;Deferasirox;;Stk;0;
V03AE;Midler t. behandl. af hyperkaliæmi og hyperphosphatæmi;1,2;DDD;0;
V03AE01;Polystyrensulfonat;;DDD;0;
V03AE02;Sevelamer;;DDD;0;
V03AE03;Lanthancarbonat;;DDD;0;
V03AE04;Calciumacetat og magnesiumcarbonat;2;DDD;0;
V03AE05;Sucroferrioxyhydroxid;;DDD;0;
V03AE07;Calciumacetat;1,4;DDD;0;
V03AE09;Patiromercalcium;;DDD;0;
V03AE10;Natriumzirconiumcyclosilicat;;DDD;0;
V03AF;Afgiftningsmidler ved cytostatica-behandling;;Ingen fælles mængdeenhed;0;
V03AF01;Mesna;;g (aktivt stof);0;
V03AF02;Dexrazoxan;;DDD;0;
V03AF03;Calciumfolinat;;DDD;0;
V03AF04;Calciumlevofolinat;;DDD;0;
V03AF05;Amifostin;;DDD;0;
V03AF07;Rasburicase;;DDD;0;
V03AF08;Palifermin;;DDD;0;
V03AG;Midler til behandling af hypercalcæmi;3;DDD;0;
V03AG01;Natriumcellulosephosphat;3;DDD;0;
V03AN;Medicinske gasser;1;L;0;
V03AN01;Oxygen;1;L;0;
V03AX;Andre terapeutiske produkter;3;DDD;0;
V03AX**;(Ufuldstændig ATC-kode);3;DDD;0;
V03AX03;Cobicistat;;DDD;0;
V04;Diagnostica;;Stk;0;
V04C;Andre diagnostica;;Stk;0;
V04CA;Tests for diabetes;;Stk;0;
V04CA02;Glucose;;Stk;0;
V04CC;Tests for bile duct patency;;Stk;0;
V04CC02;Magnesiumsulfat;;Stk;0;
V04CD;Tests for hypofysefunktion;;Stk;0;
V04CD01;Metyrapon;;Stk;0;
V04CD05;Somatorelin;;Stk;0;
V04CE;Tests for leverfunktionskapacitet;;Stk;0;
V04CE01;Galactose;;Stk;0;
V04CF;Tuberkulose-diagnostica;;Stk;0;
V04CF01;Tuberculin;;Stk;0;
V04CG;Tests for gastrisk sekretion;;Stk;0;
V04CG03;Histaminphosphat;;Stk;0;
V04CH;Tests for nyrefunktion og ureterlæsioner;;Stk;0;
V04CH02;Indigocarmin;;Stk;0;
V04CJ;Tests for thyreoidea-funktion;;Stk;0;
V04CJ02;Protirelin;;Stk;0;
V04CL;Tests for allergiske sygdomme;;Stk;0;
V04CL**;(Ufuldstændig ATC-kode);;Stk;0;
V04CX;Andre diagnostica;;Stk;0;
V04CX**;(Ufuldstændig ATC-kode);;Stk;0;
V04CX04;Mannitol;;Stk;0;
V04CX05;13-c-urea;;Stk;0;
V04CX06;Hexaminolevulinat;;Stk;0;
V07;Alle andre non-terapeutiske produkter;;ml;0;
V07A;Alle andre non-terapeutiske produkter;;ml;0;
V07AB;Opløsnings-og fortyndingsmidler, incl. skyllevæsker;;ml;0;
V07AB**;(Ufuldstændig ATC-kode);;ml;0;
V08;Kontrastmidler;;Ingen fælles mængdeenhed;0;
V08A;Røntgenkontrastmidler, ioderede;;g (iod);0;
V08AA;Vandopl.,nefrotrope,højosm. røntgenkontrastmidl.;;g (iod);0;
V08AA01;Diatrizoinsyre;;g (iod);0;
V08AA02;Metrizoinsyre;;g (iod);0;
V08AA05;Ioxitalamsyre;;g (iod);0;
V08AB;Vandopl.,nefrotrope,lavosm. røntgenkontrastmidl.;;g (iod);0;
V08AB02;Iohexol;;g (iod);0;
V08AB03;Ioxaglinsyre;;g (iod);0;
V08AB04;Iopamidol;;g (iod);0;
V08AB05;Iopromid;;g (iod);0;
V08AB06;Iotrolan;;g (iod);0;
V08AB07;Ioversol;;g (iod);0;
V08AB09;Iodixanol;;g (iod);0;
V08AB10;Iomeprol;;g (iod);0;
V08AB11;Iobitridol;;g (iod);0;
V08AD;Ikke-vandopløselige røntgenkontrastmidler;;g (iod);0;
V08AD01;Ethylestere af ioderede fedtsyrer;;g (iod);0;
V08B;Røntgenkontrastmidler, ikke-ioderede;;Ingen fælles mængdeenhed;0;
V08BA;Bariumsulfat-holdige røntgenkontrastmidler;;Ingen fælles mængdeenhed;0;
V08BA01;Bariumsulfat med suspensionsmidler;;g (aktivt stof);0;
V08BA02;Bariumsulfat uden suspensionsmidler;;g (aktivt stof);0;
V08C;Kontrastmidler til magnetisk resonans imaging;3,4;DDD;0;
V08CA;Paramagnetiske kontrastmidler;3;DDD;0;
V08CA01;Gadopentetinsyre;3;DDD;0;
V08CA02;Gadoterinsyre;3;DDD;0;
V08CA03;Gadodiamid;3;DDD;0;
V08CA04;Gadoteridol;3;DDD;0;
V08CA05;Mangafodipir;3;DDD;0;
V08CA06;Gadoversetamid;3;DDD;0;
V08CA08;Gadobensyre;3;DDD;0;
V08CA09;Gadobutrol;3;DDD;0;
V08CA10;Gadoxetinsyre;3;DDD;0;
V08CA11;Gadofosveset;3;DDD;0;
V08CB;Superparamagnetiske kontrastmidler;;Ingen fælles mængdeenhed;0;
V08CB01;Ferumoxsil;;g (aktivt stof);0;
V08CB02;Ferristen;;g (aktivt stof);0;
V08CB03;Jernoxid, nanopartikler;;g (aktivt stof);0;
V08D;Ultralyd kontrastmidler;;Ingen fælles mængdeenhed;0;
V08DA;Ultralyd kontrastmidler;;Ingen fælles mængdeenhed;0;
V08DA01;Perflutren, human albumin mikrosfærer;;g (aktivt stof);0;
V08DA02;Mikropartikler af galactose;;g (aktivt stof);0;
V08DA05;Svovlhexafluorid, phospholipid mikrosfærer;;g (aktivt stof);0;
V09;Radiofarmaka til diagnostisk brug;;Ingen fælles mængdeenhed;0;
V09A;Centralnervesystemet;;Ingen fælles mængdeenhed;0;
V09A***;(Ufuldstændig ATC-kode);;Ingen fælles mængdeenhed;0;
V09B;Skelet;;Ingen fælles mængdeenhed;0;
V09B***;(Ufuldstændig ATC-kode);;Ingen fælles mængdeenhed;0;
V09C;Renale system;;Ingen fælles mængdeenhed;0;
V09C***;(Ufuldstændig ATC-kode);;Ingen fælles mængdeenhed;0;
V09D;Hepatiske og reticulo-endotheliale system;;Ingen fælles mængdeenhed;0;
V09D***;(Ufuldstændig ATC-kode);;Ingen fælles mængdeenhed;0;
V09E;Respirationssystemet;;Ingen fælles mængdeenhed;0;
V09E***;(Ufuldstændig ATC-kode);;Ingen fælles mængdeenhed;0;
V09F;Thyroid;;Ingen fælles mængdeenhed;0;
V09F***;(Ufuldstændig ATC-kode);;Ingen fælles mængdeenhed;0;
V09G;Kardiovaskulære system;;Ingen fælles mængdeenhed;0;
V09G***;(Ufuldstændig ATC-kode);;Ingen fælles mængdeenhed;0;
V09H;Inflammations- og infektionsdetektion;;Ingen fælles mængdeenhed;0;
V09H***;(Ufuldstændig ATC-kode);;Ingen fælles mængdeenhed;0;
V09I;Tumordetektion;;Ingen fælles mængdeenhed;0;
V09I***;(Ufuldstændig ATC-kode);;Ingen fælles mængdeenhed;0;
V09X;Andre radiofarmaka til diagnostisk brug;;Ingen fælles mængdeenhed;0;
V09X***;(Ufuldstændig ATC-kode);;Ingen fælles mængdeenhed;0;
V10;Radiofarmaka til terapeutisk brug;;Ingen fælles mængdeenhed;0;
V10A;Anitinflammatorica;;Ingen fælles mængdeenhed;0;
V10A***;(Ufuldstændig ATC-kode);;Ingen fælles mængdeenhed;0;
V10B;Smertepalliation (knogle-opsøgende midler);;Ingen fælles mængdeenhed;0;
V10B***;(Ufuldstændig ATC-kode);;Ingen fælles mængdeenhed;0;
V10X;Andre radiofarmaka til terapeutisk brug;;Ingen fælles mængdeenhed;0;
V10X***;(Ufuldstændig ATC-kode);;Ingen fælles mængdeenhed;0;
V10XX;Diverse radiofarmaka til terapeutisk brug;;Ingen fælles mængdeenhed;0;
V10XX02;Ibritumomab tiuxetan (90-y);;Ingen fælles mængdeenhed;0;
X;Alle lægemidler;;Ingen fælles mængdeenhed;0;
A;Alimentary tract and metabolism;;No common unit for volume;1;
A01;Stomatological preparations;;No common unit for volume;1;
A01A;Stomatological preparations;;No common unit for volume;1;
A01AA;Caries prophylactic agents;;Packages;1;
A01AA01;Sodium fluoride;;Packages;1;
A01AB;Antiinfectives for local oral treatment;4;DDD;1;
A01AB02;Hydrogenperoxide;;ml or g (preparation);1;
A01AB03;Chlorhexidine;;DDD;1;
A01AB04;Amphotericin;;DDD;1;
A01AB09;Miconazole;;DDD;1;
A01AB13;Tetracycline;;Items;1;
A01AB17;Metronidazole;;ml or g (preparation);1;
A01AB22;Doxycycline;;ml or g (preparation);1;
A01AC;Corticosteroids for local oral treatment;;ml or g (preparation);1;
A01AC01;Triamcinolone;;ml or g (preparation);1;
A01AD;Other agents for local oral treatment;4;DDD;1;
A01AD01;Epinephrine;;Items;1;
A01AD02;Benzydamine;;DDD;1;
A01AD11;Various;;ml or g (preparation);1;
A02;Drugs for acid related disorders;3;DDD;1;
A02A;Antacids;3;DDD;1;
A02AA;Magnesium compounds;;DDD;1;
A02AA04;Magnesium hydroxide;;DDD;1;
A02AB;Aluminium compounds;3;DDD;1;
A02AB01;Aluminium oxide;3;DDD;1;
A02AB04;Dihydroxialumini sodium carbonate;;DDD;1;
A02AB05;Aluminiumacetoacetate;3;DDD;1;
A02AC;Calcium compounds;;DDD;1;
A02AC02;Calcium silicate;;DDD;1;
A02AD;Combinations and complexes of aluminium, calcium and magnesium compounds;;DDD;1;
A02AD01;Ordinary salt combinations;;DDD;1;
A02AF;Antacids with antiflatulents;3;DDD;1;
A02AF**;;3;DDD;1;
A02AH;Antacids with sodium bicarbonate;3;DDD;1;
A02AH**;;3;DDD;1;
A02B;Drugs for peptic ulcer and gastro-oesophageal reflux disease (gord);3;DDD;1;
A02BA;H2-receptor antagonists;;DDD;1;
A02BA01;Cimetidine;;DDD;1;
A02BA02;Ranitidine;;DDD;1;
A02BA03;Famotidine;;DDD;1;
A02BA04;Nizatidine;;DDD;1;
A02BA07;Ranitidine bismuth citrate;;DDD;1;
A02BB;Prostaglandins;;DDD;1;
A02BB01;Misoprostol;;DDD;1;
A02BC;Proton pump inhibitors;;DDD;1;
A02BC01;Omeprazole;;DDD;1;
A02BC02;Pantoprazole;;DDD;1;
A02BC03;Lansoprazole;;DDD;1;
A02BC04;Rabeprazole;;DDD;1;
A02BC05;Esomeprazole;;DDD;1;
A02BX;Other drugs peptic ulcer and gastro-oesophageal reflux disease (gord);3;DDD;1;
A02BX02;Sucralfate;;DDD;1;
A02BX05;Bismuth subcitrate;;DDD;1;
A02BX13;Alginic acid;3;DDD;1;
A03;Drugs for functional gastrointestinal disorders;;DDD;1;
A03A;Drugs for functional gastrointestinal disorders;;DDD;1;
A03AA;Synt anticholin,esters with tertiary amino group;;DDD;1;
A03AA04;Mebeverine;;DDD;1;
A03AB;Synth. anticholinergics, quatern. ammonium comp.;;DDD;1;
A03AB02;Glycopyrronium;;DDD;1;
A03AB05;Propantheline;;DDD;1;
A03AD;Papaverine and derivatives;;DDD;1;
A03AD01;Papaverine;;DDD;1;
A03AX;Other drugs for functional gastrointestinal disorders;;DDD;1;
A03AX13;Silicones;;DDD;1;
A03B;Belladonna and derivatives, plain;;DDD;1;
A03BA;Belladonna alkaloids, tertiary amines;;DDD;1;
A03BA01;Atropine;;DDD;1;
A03BA03;Hyoscyamine;;DDD;1;
A03BB;Belladonna alkaloids semisynt,quater ammonium comp;;DDD;1;
A03BB01;Butylscopolamine;;DDD;1;
A03F;Propulsives;;DDD;1;
A03FA;Propulsives;;DDD;1;
A03FA01;Metoclopramide;;DDD;1;
A03FA02;Cisapride;;DDD;1;
A03FA03;Domperidone;;DDD;1;
A04;Antiemetics and antinauseants;;No common unit for volume;1;
A04A;Antiemetics and antinauseants;;No common unit for volume;1;
A04AA;Serotonin (5ht3) antagonists;2;DDD;1;
A04AA01;Ondansetron;;DDD;1;
A04AA02;Granisetron;;DDD;1;
A04AA03;Tropisetron;;DDD;1;
A04AA05;Palonosetron;;DDD;1;
A04AA55;Palonosetron, combinations;2;DDD;1;
A04AD;Other antiemetics;;No common unit for volume;1;
A04AD01;Scopolamine;3;DDD;1;
A04AD05;Metopimazine;;DDD;1;
A04AD10;Dronabinol;;mg (active substance);1;
A04AD11;Nabilone;;DDD;1;
A04AD12;Aprepitant;;DDD;1;
A04AD54;Chlorobutanol, combinations;3;DDD;1;
A05;Bile and liver therapy;3;DDD;1;
A05A;Bile therapy;3;DDD;1;
A05AA;Bile acids and derivatives;3;DDD;1;
A05AA02;Ursodeoxycholic acid;;DDD;1;
A05AA03;Cholic acid;3;DDD;1;
A05AA04;Obeticholic acid;;DDD;1;
A06;Drugs for constipation;1,2,3;DDD;1;
A06A;Drugs for constipation;1,2,3;DDD;1;
A06A***;;3;DDD;1;
A06AB;Contact laxatives;2,3;DDD;1;
A06AB02;Bisacodyl;;DDD;1;
A06AB06;Senna glycosides;3;DDD;1;
A06AB08;Sodium picosulfate;;DDD;1;
A06AB20;Contact laxatives in combination;3;DDD;1;
A06AB58;Sodium picosulfate, combinations;2;DDD;1;
A06AC;Bulk-forming laxatives;3;DDD;1;
A06AC01;Ispaghula (psylla seeds);;DDD;1;
A06AC51;Ispaghula, combinations;3;DDD;1;
A06AD;Osmotically acting laxatives;2,3;DDD;1;
A06AD**;;3;DDD;1;
A06AD02;Magnesium oxide;;DDD;1;
A06AD11;Lactulose;;DDD;1;
A06AD12;Lactitol;;DDD;1;
A06AD65;Macrogol, combinations;2,3;DDD;1;
A06AG;Enemas;1,3;DDD;1;
A06AG01;Sodium phosphate;3;DDD;1;
A06AG02;Bisacodyl;3;DDD;1;
A06AG06;Oil;3;DDD;1;
A06AG10;Docusate sodium, incl combinations;1,3;DDD;1;
A06AG11;Sodium lauryl sulfoacetate, incl. combinations;3;DDD;1;
A06AH;Peripheral opioid receptor antagonists;;DDD;1;
A06AH01;Methylnaltrexone bromide;;DDD;1;
A06AH03;Naloxegol;;DDD;1;
A06AX;Other drugs for constipation;3;DDD;1;
A06AX01;Glycerol;3;DDD;1;
A06AX04;Linaclotide;;DDD;1;
A06AX05;Prucalopride;;DDD;1;
A07;Antidiarr.,intest. antiinfl./antiinfect. agents;2,3;DDD;1;
A07A;Intestinal antiinfectives;;DDD;1;
A07AA;Antibiotics;;DDD;1;
A07AA02;Nystatin;;DDD;1;
A07AA09;Vancomycin;;DDD;1;
A07AA11;Rifaximin;;DDD;1;
A07AA12;Fidaxomicin;;DDD;1;
A07AC;Imidazole derivatives;;DDD;1;
A07AC01;Miconazole;;DDD;1;
A07B;Intestinal adsorbents;3;DDD;1;
A07BA;Charcoal preparations;;DDD;1;
A07BA01;Medicinal charcoal;;DDD;1;
A07BB;Bismuth preparations;3;DDD;1;
A07BB**;;3;DDD;1;
A07C;Electrolytes with carbohydrates;3;DDD;1;
A07CA;Oral rehydration salt formulations;3;DDD;1;
A07CA**;;3;DDD;1;
A07D;Antipropulsives;2;DDD;1;
A07DA;Antipropulsives;2;DDD;1;
A07DA01;Diphenoxylate;;DDD;1;
A07DA02;Opium;;DDD;1;
A07DA03;Loperamide;;DDD;1;
A07DA06;Eluxadoline;;DDD;1;
A07DA53;Loperamide, combinations;2;DDD;1;
A07E;Intestinal antiinflammatory agents;3;DDD;1;
A07EA;Corticosteroids acting locally;3;DDD;1;
A07EA01;Prednisolone;3;DDD;1;
A07EA02;Hydrocortisone;3;DDD;1;
A07EA06;Budesonide;3;DDD;1;
A07EB;Antiallergic agents, excl corticosteroids;;DDD;1;
A07EB01;Cromoglicic acid;;DDD;1;
A07EC;Aminosalicylic acid and similar agents;;DDD;1;
A07EC01;Sulfasalazine;;DDD;1;
A07EC02;Mesalazine;;DDD;1;
A07EC03;Olsalazine;;DDD;1;
A07EC04;Balsalazide;;DDD;1;
A07F;Antidiarrheal microorganisms;3;DDD;1;
A07FA;Antidiarrheal microorganisms;3;DDD;1;
A07FA01;Lactic acid producing organisms;3;DDD;1;
A07FA02;Saccharomyces boulardii;;DDD;1;
A07X;Other antidiarrheals;3;DDD;1;
A07XA;Other antidiarrheals;3;DDD;1;
A07XA04;Racecadotril;3;DDD;1;
A08;Antiobesity preparations, excl diet products;2,3;DDD;1;
A08A;Antiobesity preparations, excl diet products;2,3;DDD;1;
A08AA;Centrally acting antiobesity products;2,3;DDD;1;
A08AA02;Fenfluramine;;DDD;1;
A08AA03;Amfepramone;;DDD;1;
A08AA04;Dexfenfluramine;;DDD;1;
A08AA10;Sibutramine;;DDD;1;
A08AA56;Ephedrine, combinations;3;DDD;1;
A08AA62;Bupropion and naltrexone;2;DDD;1;
A08AB;Peripherally acting antiobesity products;;DDD;1;
A08AB01;Orlistat;;DDD;1;
A08AX;Other antiobesity drugs;;DDD;1;
A08AX01;Rimonabant;;DDD;1;
A09;Digestives, incl enzymes;2,3;DDD;1;
A09A;Digestives, incl enzymes;2,3;DDD;1;
A09AA;Enzyme preparations;2,3;DDD;1;
A09AA02;Multienzymes (lipase, protease etc);2,3;DDD;1;
A10;Drugs used in diabetes;2;DDD;1;
A10A;Insulins and analogues;;DDD;1;
A10AB;Insulins and analogues for injection, fast-acting;;DDD;1;
A10AB01;Insulin (human);;DDD;1;
A10AB04;Insulin lispro;;DDD;1;
A10AB05;Insulin aspart;;DDD;1;
A10AB06;Insulin glulisine;;DDD;1;
A10AC;Insulins and analogues for injection, intermediate-acting;;DDD;1;
A10AC01;Insulin (human);;DDD;1;
A10AD;Insulins and analog. for inj., interm.-/ long-act. comb. w. fast-acting;;DDD;1;
A10AD01;Insulin (human);;DDD;1;
A10AD04;Insulin lispro;;DDD;1;
A10AD05;Insulin aspart;;DDD;1;
A10AD06;Insulin degludec and insulin aspart;;DDD;1;
A10AE;Insulins and analogues for injection, long-acting;;DDD;1;
A10AE01;Insulin (human);;DDD;1;
A10AE04;Insulin glargine;;DDD;1;
A10AE05;Insulin detemir;;DDD;1;
A10AE06;Insulin degludec;;DDD;1;
A10AE54;Insulin glargine and lixisenatide;;DDD;1;
A10AE56;Insulin degludec and liraglutide;;DDD;1;
A10B;Blood glucose lowering drugs, excl. insulins;2;DDD;1;
A10BA;Biguanides;;DDD;1;
A10BA02;Metformin;;DDD;1;
A10BB;Sulfonylureas;;DDD;1;
A10BB01;Glibenclamide;;DDD;1;
A10BB03;Tolbutamide;;DDD;1;
A10BB07;Glipizide;;DDD;1;
A10BB09;Gliclazide;;DDD;1;
A10BB12;Glimepiride;;DDD;1;
A10BD;Comb. of oral blood glucose lowering drugs;2;DDD;1;
A10BD03;Metformin and rosiglitazone;2;DDD;1;
A10BD04;Glimepiride and rosiglitazone;2;DDD;1;
A10BD07;Metformin and sitagliptin;2;DDD;1;
A10BD08;Metformin and vildagliptin;2;DDD;1;
A10BD09;Pioglitazone and alogliptin;2;DDD;1;
A10BD10;Metformin and saxagliptin;2;DDD;1;
A10BD11;Metformin and linagliptin;2;DDD;1;
A10BD13;Metformin and alogliptin;2;DDD;1;
A10BD15;Metformin and dapagliflozin;2;DDD;1;
A10BD16;Metformin and canagliflozin;2;DDD;1;
A10BD19;Linagliptin and empagliflozin;2;DDD;1;
A10BD20;Metformin and empagliflozin;2;DDD;1;
A10BD21;Saxagliptin and dapagliflozin;2;DDD;1;
A10BD23;Metformin and ertugliflozin;2;DDD;1;
A10BD24;Sitagliptin and ertugliflozin;2;DDD;1;
A10BF;Alpha glucosidase inhibitors;;DDD;1;
A10BF01;Acarbose;;DDD;1;
A10BG;Thiazolinediones;;DDD;1;
A10BG02;Rosiglitazone;;DDD;1;
A10BG03;Pioglitazone;;DDD;1;
A10BH;Dipeptidyl peptidase 4 (dpp-4) inhibitors;;DDD;1;
A10BH01;Sitagliptin;;DDD;1;
A10BH02;Vildagliptin;;DDD;1;
A10BH03;Saxagliptin;;DDD;1;
A10BH04;Alogliptin;;DDD;1;
A10BH05;Linagliptin;;DDD;1;
A10BJ;Glucagon-like peptide-1 receptor (glp-1) analogues;;DDD;1;
A10BJ01;Exenatide;;DDD;1;
A10BJ02;Liraglutide;;DDD;1;
A10BJ03;Lixisenatide;;DDD;1;
A10BJ05;Dulaglutide;;DDD;1;
A10BJ06;Semaglutide;;DDD;1;
A10BK;Sodium-glucose co-transporter 2 (sglt2) inhibitors;;DDD;1;
A10BK01;Dapagliflozin;;DDD;1;
A10BK02;Canagliflozin;;DDD;1;
A10BK03;Empagliflozin;;DDD;1;
A10BK04;Ertugliflozin;;DDD;1;
A10BX;Other  blood glucose lowering drugs, excl. insulins;;DDD;1;
A10BX02;Repaglinide;;DDD;1;
A10BX03;Nateglinide;;DDD;1;
A11;Vitamins;1,3;DDD;1;
A11A;Multivitamins, combinations;;DDD;1;
A11AA;Multivitamins with minerals;;DDD;1;
A11AA03;Multivit and other minerals, incl combinations;;DDD;1;
A11B;Multivitamins, plain;3;DDD;1;
A11BA;Multivitamins, plain;3;DDD;1;
A11BA**;;3;DDD;1;
A11C;Vit a and d, incl combinations of the two;1,3;DDD;1;
A11CA;Vitamin a, plain;;DDD;1;
A11CA01;Retinol (vit a);;DDD;1;
A11CB;Vitamin a and d in combination;3;DDD;1;
A11CB**;;3;DDD;1;
A11CC;Vitamin d and analogues;1,3;DDD;1;
A11CC01;Ergocalciferol;1,3;DDD;1;
A11CC02;Dihydrotachysterol;;DDD;1;
A11CC03;Alfacalcidol;;DDD;1;
A11CC04;Calcitriol;;DDD;1;
A11CC05;Colecalciferol;3;DDD;1;
A11D;Vit b1,plain and in comb with vitamin b6 and b12;;DDD;1;
A11DA;Thiamine (vit b1), plain;;DDD;1;
A11DA01;Thiamine (vit b1);;DDD;1;
A11E;Vitamin b-complex, incl combinations;3;DDD;1;
A11E***;;3;DDD;1;
A11EA;Vitamin b-complex, plain;3;DDD;1;
A11EA**;;3;DDD;1;
A11G;Ascorbic acid (vit c), incl combinations;;DDD;1;
A11GA;Ascorbic acid (vit c), plain;;DDD;1;
A11GA01;Ascorbic acid (vit c);;DDD;1;
A11H;Other plain vitamin preparations;3;DDD;1;
A11HA;Other plain vitamin preparations;3;DDD;1;
A11HA02;Pyridoxine (vit b6);;DDD;1;
A11HA03;Tocopherol (vit e);;DDD;1;
A11HA04;Riboflavin (vit b2);3;DDD;1;
A11HA05;Biotin;3;DDD;1;
A11HA08;Tocofersolan;;DDD;1;
A12;Mineral supplements;1,2,3;DDD;1;
A12A;Calcium;1,2,3;DDD;1;
A12AA;Calcium;1;DDD;1;
A12AA**;;;No common unit for volume;1;
A12AA01;Calcium phosphate;;DDD;1;
A12AA02;Calcium glubionate;;DDD;1;
A12AA04;Calcium carbonate;;DDD;1;
A12AA06;Calcium lactate gluconate;;DDD;1;
A12AA07;Calcium chloride;;DDD;1;
A12AX;Calcium, combinations with vitamin d and/or other drugs;2,3;DDD;1;
A12AX**;;2,3;DDD;1;
A12B;Potassium;;DDD;1;
A12BA;Potassium;;DDD;1;
A12BA01;Potassium chloride;;DDD;1;
A12BA02;Potassium citrate;;DDD;1;
A12C;Other mineral supplements;3;DDD;1;
A12CA;Sodium;;DDD;1;
A12CA01;Sodium chloride;;DDD;1;
A12CB;Zinc;;DDD;1;
A12CB01;Zinc sulphate;;DDD;1;
A12CC;Magnesium;3;DDD;1;
A12CC04;Magnesium citrate;;DDD;1;
A12CC30;Magnesium (different salts in combination);3;DDD;1;
A12CE;Selenium;;DDD;1;
A12CE02;Sodium selenite;;DDD;1;
A14;Anabolic agents for systemic use;;DDD;1;
A14A;Anabolic steroids;;DDD;1;
A14AB;Estren derivatives;;DDD;1;
A14AB01;Nandrolone;;DDD;1;
A16;Other alimentary tract and metabolism products;3;DDD;1;
A16A;Other alimentary tract and metabolism products;3;DDD;1;
A16AA;Amino acids and derivatives;;DDD;1;
A16AA04;Mercaptamine;;DDD;1;
A16AA05;Carglumic acid;;DDD;1;
A16AA06;Betaine;;DDD;1;
A16AB;Enzymes;3;DDD;1;
A16AB02;Imiglucerase;;DDD;1;
A16AB03;Agalsidase alfa;;DDD;1;
A16AB04;Agalsidase beta;;DDD;1;
A16AB05;Laronidase;;DDD;1;
A16AB07;Alglucosidase alfa;;DDD;1;
A16AB08;Galsulfase;3;DDD;1;
A16AB09;Idursulfase;3;DDD;1;
A16AB10;Velaglucerase alfa;;DDD;1;
A16AB12;Elosulfase alfa;;DDD;1;
A16AB13;Asfotase alfa;3;DDD;1;
A16AB15;Velmanase alfa;;DDD;1;
A16AX;Various alimentary tract and metabolism products;3;DDD;1;
A16AX03;Sodium phenylbutyrate;;DDD;1;
A16AX04;Nitisinone;;DDD;1;
A16AX05;Zinc acetate;;DDD;1;
A16AX06;Miglustat;;DDD;1;
A16AX07;Sapropterin;3;DDD;1;
A16AX08;Teduglutide;;DDD;1;
A16AX09;Glycerol phenylbutyrate;;DDD;1;
A16AX10;Eliglustat;;DDD;1;
A16AX12;Trientine;;DDD;1;
A16AX14;Migalastat;;DDD;1;
A16AX15;Telotristat;;DDD;1;
B;Blood and blood forming organs;;No common unit for volume;1;
B01;Antithrombotic agents;1,2,3;DDD;1;
B01A;Antithrombotic agents;1,2,3;DDD;1;
B01AA;Vitamin k antagonists;;DDD;1;
B01AA03;Warfarin;;DDD;1;
B01AA04;Phenprocoumon;;DDD;1;
B01AB;Heparin group;1;DDD;1;
B01AB01;Heparin;1;DDD;1;
B01AB02;Antithrombin;;DDD;1;
B01AB04;Dalteparin;;DDD;1;
B01AB05;Enoxaparin;;DDD;1;
B01AB06;Nadroparin;;DDD;1;
B01AB08;Reviparin;;DDD;1;
B01AB10;Tinzaparin;;DDD;1;
B01AC;Platelet aggregation inhibitors excl. heparin;2,3;DDD;1;
B01AC04;Clopidogrel;;DDD;1;
B01AC06;Acetylsalicylic acid;;DDD;1;
B01AC07;Dipyridamole;;DDD;1;
B01AC09;Epoprostenol;3;DDD;1;
B01AC11;Iloprost;;DDD;1;
B01AC13;Abciximab;;DDD;1;
B01AC16;Eptifibatide;;DDD;1;
B01AC17;Tirofiban;;DDD;1;
B01AC21;Treprostinil;;DDD;1;
B01AC22;Prasugrel;;DDD;1;
B01AC24;Ticagrelor;;DDD;1;
B01AC25;Cangrelor;;DDD;1;
B01AC27;Selexipag;;DDD;1;
B01AC30;Combinations;2;DDD;1;
B01AD;Enzymes;1,3;DDD;1;
B01AD01;Streptokinase;;DDD;1;
B01AD02;Alteplase;1;DDD;1;
B01AD04;Urokinase;;DDD;1;
B01AD07;Reteplase;;DDD;1;
B01AD10;Drotrecogin alfa (activated);;DDD;1;
B01AD11;Tenecteplase;;DDD;1;
B01AD12;Protein c;3;DDD;1;
B01AE;Direct thrombin inhibitors;;DDD;1;
B01AE02;Lepirudin;;DDD;1;
B01AE03;Argatroban;;DDD;1;
B01AE04;Melagatran;;DDD;1;
B01AE05;Ximelagatran;;DDD;1;
B01AE06;Bivalirudin;;DDD;1;
B01AE07;Dabigatran etexilate;;DDD;1;
B01AF;Direct factor xa inhibitors;;DDD;1;
B01AF01;Rivaroxaban;;DDD;1;
B01AF02;Apixaban;;DDD;1;
B01AF03;Edoxaban;;DDD;1;
B01AX;Other antithrombotic agents;;DDD;1;
B01AX01;Defibrotide;;DDD;1;
B01AX05;Fondaparinux;;DDD;1;
B01AX07;Caplacizumab;;DDD;1;
B02;Antihemorrhagics;;No common unit for volume;1;
B02A;Antifibrinolytics;;DDD;1;
B02AA;Amino acids;;DDD;1;
B02AA02;Tranexamic acid;;DDD;1;
B02AB;Proteinase inhibitors;;DDD;1;
B02AB01;Aprotinin;;DDD;1;
B02AB02;Alfa1 antitrypsin;;DDD;1;
B02B;Vitamin k and other hemostatics;;No common unit for volume;1;
B02BA;Vitamin k;;DDD;1;
B02BA01;Phytomenadione;;DDD;1;
B02BB;Fibrinogen;;DDD;1;
B02BB01;Human fibrinogen;;DDD;1;
B02BC;Local hemostatics;;Items;1;
B02BC**;;;Items;1;
B02BC01;Absorbable gelatin sponge;;Items;1;
B02BC02;Oxidized cellulose;;Items;1;
B02BC05;Adrenalone;;Items;1;
B02BC30;Combinations;;Items;1;
B02BD;Blood coagulation factors;;No common unit for volume;1;
B02BD01;Coagulation factor ix, ii, vii and x in comb;;Thousand units;1;
B02BD02;Coagulation factor viii;4;Thousand units;1;
B02BD03;Factor viii inhibitor bypassing activity;;Thousand units;1;
B02BD04;Coagulation factor ix;;Thousand units;1;
B02BD06;Von willebrand + factor viii in comb.;;Thousand units;1;
B02BD07;Coagulation factor xiii;;Thousand units;1;
B02BD08;Coagulation factor viia;;Thousand units;1;
B02BD10;Von willebrand factor;;Thousand units;1;
B02BD11;Catridecacog;;Thousand units;1;
B02BX;Other systemic hemostatics;;DDD;1;
B02BX04;Romiplostim;;DDD;1;
B02BX05;Eltrombopag;;DDD;1;
B02BX06;Emicizumab;;DDD;1;
B02BX08;Avatrombopag;;DDD;1;
B03;Antianemic preparations;3;DDD;1;
B03A;Iron preparations;3;DDD;1;
B03AA;Iron bivalent, oral preparations;;DDD;1;
B03AA01;Ferrous glycine sulphate;;DDD;1;
B03AA03;Ferrous gluconate;;DDD;1;
B03AA06;Ferrous succinate;;DDD;1;
B03AA07;Ferrous sulphate;;DDD;1;
B03AA08;Ferrous tartrate;;DDD;1;
B03AB;Iron trivalent, oral preparations;;DDD;1;
B03AB05;Ferric oxide polymaltose complexes;;DDD;1;
B03AB10;Ferric maltol;;DDD;1;
B03AC;Iron, parenteral preparations;;DDD;1;
B03AC**;;;DDD;1;
B03AE;Iron in other combinations;3;DDD;1;
B03AE02;Iron, multivitamins and folic acid;3;DDD;1;
B03B;Vitamin b12 and folic acid;3;DDD;1;
B03BA;Vitamin b12 (cyanocobalamin and derivatives);;DDD;1;
B03BA01;Cyanocobalamin;;DDD;1;
B03BA02;Cyanocobalamin tannin complex;;DDD;1;
B03BA03;Hydroxocobalamin;;DDD;1;
B03BB;Folic acid and derivatives;3;DDD;1;
B03BB01;Folic acid;3;DDD;1;
B03X;Other antianemic preparations;;DDD;1;
B03XA;Other antianemic preparations;;DDD;1;
B03XA01;Erythropoietin;;DDD;1;
B03XA02;Darbepoetin alfa;;DDD;1;
B03XA03;Methoxy polyethylene glycol-epoetin beta;;DDD;1;
B03XA06;Luspatercept;;DDD;1;
B05;Blood substitutes and perfusion solutions;1;L;1;
B05A;Blood and related products;;L;1;
B05AA;Blood substitutes and plasma protein fractions;;L;1;
B05AA**;;;L;1;
B05AA01;Albumin;;L;1;
B05AA05;Dextran;;L;1;
B05AA06;Gelatin agents;;L;1;
B05AA07;Hydroxyethylstarch;;L;1;
B05B;I.v. solutions;1;L;1;
B05BA;Solutions for parenteral nutrition;1;L;1;
B05BA**;;;No common unit for volume;1;
B05BA01;Amino acids;;L;1;
B05BA02;Fat emulsions;;L;1;
B05BA03;Carbohydrates;;L;1;
B05BA10;Combinations;;L;1;
B05BB;Solutions affecting the electrolyte balance;1;L;1;
B05BB**;;;No common unit for volume;1;
B05BB01;Electrolytes;;L;1;
B05BB02;Electrolytes with carbohydrates;;L;1;
B05BC;Solutions producing osmotic diuresis;;L;1;
B05BC01;Mannitol;;L;1;
B05C;Irrigating solutions;;L;1;
B05CA;Antiinfectives;;L;1;
B05CA02;Chlorhexidine;;L;1;
B05CB;Salt solutions;;L;1;
B05CB01;Sodium chloride;;L;1;
B05CB03;Magnesium citrate;;L;1;
B05CB10;Combinations;;L;1;
B05CX;Other irrigating solutions;;L;1;
B05CX03;Glycine;;L;1;
B05CX10;Combinations;;L;1;
B05D;Peritoneal dialytics;1;L;1;
B05D***;;1;L;1;
B05DA;Isotonic solutions;;L;1;
B05DA**;;;L;1;
B05DB;Hypertonic solutions;;L;1;
B05DB**;;;L;1;
B05X;I.v. solution additives;;L;1;
B05X***;;;L;1;
B05XA;Electrolyte solutions;;L;1;
B05XA01;Potassium chloride;;L;1;
B05XA02;Sodium bicarbonate;;L;1;
B05XA03;Sodium chloride;;L;1;
B05XA04;Ammonium chloride;;L;1;
B05XA05;Magnesium sulphate;;L;1;
B05XA06;K-phosphate, incl comb with other k-salts;;L;1;
B05XA07;Calcium chloride;;L;1;
B05XA14;Sodium glycerolophosphate;;L;1;
B05XA16;Cardioplegia solutions;;L;1;
B05XA18;Zinc sulfate;;L;1;
B05XA31;Electrolytes in comb with other drugs;;L;1;
B05XB;Amino acids;;L;1;
B05XB02;Alanyl glutamine;;L;1;
B05XC;Vitamins;;L;1;
B05XC**;;;L;1;
B05Z;Hemodialytics and hemofiltrates;1;L;1;
B05ZA;Hemodialytics, concentrates;;No common unit for volume;1;
B05ZA**;;;No common unit for volume;1;
B05ZB;Hemofiltrates;;L;1;
B05ZB**;;;L;1;
B06;Other hematological agents;3,4;DDD;1;
B06A;Other hematological agents;3,4;DDD;1;
B06AA;Enzymes;;Items;1;
B06AA55;Streptokinase, combinations;;Items;1;
B06AB;Heme products;3;DDD;1;
B06AB01;Hemin;3;DDD;1;
B06AC;Drugs used in hereditary angioedema;;DDD;1;
B06AC01;C1-inhibitor, plasma derived;;DDD;1;
B06AC02;Icatibant;;DDD;1;
B06AC04;Conestat alfa;;DDD;1;
B06AC05;Lanadelumab;;DDD;1;
C;Cardiovascular system;;No common unit for volume;1;
C01;Cardiac therapy;1,3;DDD;1;
C01A;Cardiac glycosides;;DDD;1;
C01AA;Digitalis glycosides;;DDD;1;
C01AA05;Digoxin;;DDD;1;
C01B;Antiarrhythmics, class i and iii;;DDD;1;
C01BA;Antiarrhythmics, class ia;;DDD;1;
C01BA01;Quinidine;;DDD;1;
C01BA03;Disopyramide;;DDD;1;
C01BB;Antiarrhythmics, class ib;;DDD;1;
C01BB01;Lidocaine;;DDD;1;
C01BB02;Mexiletine;;DDD;1;
C01BC;Antiarrhythmics, class ic;;DDD;1;
C01BC03;Propafenone;;DDD;1;
C01BC04;Flecainide;;DDD;1;
C01BD;Antiarrhythmics, class iii;;DDD;1;
C01BD01;Amiodarone;;DDD;1;
C01BD07;Dronedarone;;DDD;1;
C01BG;Other antiarrhythmics, class i and iii;;DDD;1;
C01BG11;Vernakalant;;DDD;1;
C01C;Cardiac stimulants excl. cardiac glycosides;1;DDD;1;
C01CA;Adrenergic and dopaminergic agents;1;DDD;1;
C01CA01;Etilefrine;;DDD;1;
C01CA02;Isoprenaline;;DDD;1;
C01CA03;Norepinephrine;;DDD;1;
C01CA04;Dopamine;;DDD;1;
C01CA06;Phenylephrine;;DDD;1;
C01CA07;Dobutamine;;DDD;1;
C01CA13;Prenalterol;;DDD;1;
C01CA14;Dopexamine;;DDD;1;
C01CA17;Midodrine;;DDD;1;
C01CA24;Epinephrine;;DDD;1;
C01CA26;Ephedrine;1;DDD;1;
C01CE;Phosphodiesterase inhibitors;;DDD;1;
C01CE02;Milrinone;;DDD;1;
C01CX;Other cardiac stimulants;;DDD;1;
C01CX08;Levosimendan;;DDD;1;
C01D;Vasodilators used in cardiac diseases;3;DDD;1;
C01DA;Organic nitrates;3;DDD;1;
C01DA02;Glyceryl trinitrate;3;DDD;1;
C01DA08;Isosorbide dinitrate;;DDD;1;
C01DA14;Isosorbide mononitrate;;DDD;1;
C01DX;Other vasodilators used in cardiac diseases;3;DDD;1;
C01DX16;Nicorandil;;DDD;1;
C01DX22;Vericiguat;3;DDD;1;
C01E;Other cardiac preparations;;DDD;1;
C01EA;Prostaglandins;;DDD;1;
C01EA01;Alprostadil;;DDD;1;
C01EB;Other cardiac preparations;;DDD;1;
C01EB10;Adenosine;;DDD;1;
C01EB15;Trimetazidine;;DDD;1;
C01EB16;Ibuprofen;;DDD;1;
C01EB17;Ivabradine;;DDD;1;
C01EB21;Regadenoson;;DDD;1;
C02;Antihypertensives;;DDD;1;
C02A;Antiadrenergic agents, centrally acting;;DDD;1;
C02AB;Methyldopa;;DDD;1;
C02AB01;Methyldopa (levorotatory);;DDD;1;
C02AC;Imidazoline receptor agonists;;DDD;1;
C02AC01;Clonidine;;DDD;1;
C02AC02;Guanfacine;;DDD;1;
C02AC05;Moxonidine;;DDD;1;
C02C;Antiadrenergic agents, peripherally acting;;DDD;1;
C02CA;Alpha - adrenoceptor blocking agents;;DDD;1;
C02CA01;Prazosin;;DDD;1;
C02CA04;Doxazosin;;DDD;1;
C02D;Arteriolar smooth muscle, agents acting on;;DDD;1;
C02DB;Hydrazinophthalazine derivatives;;DDD;1;
C02DB01;Dihydralazine;;DDD;1;
C02DB02;Hydralazine;;DDD;1;
C02DD;Nitroferricyanide derivatives;;DDD;1;
C02DD01;Nitroprusside;;DDD;1;
C02DG;Guanidine derivatives;;DDD;1;
C02DG01;Pinacidil;;DDD;1;
C02K;Other antihypertensives;;DDD;1;
C02KX;Antihypertensives for pulmonary arterial hypertension;;DDD;1;
C02KX01;Bosentan;;DDD;1;
C02KX02;Ambrisentan;;DDD;1;
C02KX03;Sitaxentan;;DDD;1;
C02KX04;Macitentan;;DDD;1;
C02KX05;Riociguat;;DDD;1;
C03;Diuretics;2;DDD;1;
C03A;Low-ceiling diuretics, thiazides;;DDD;1;
C03AA;Thiazides, plain;;DDD;1;
C03AA01;Bendroflumethiazide;;DDD;1;
C03AA02;Hydroflumethiazide;;DDD;1;
C03AA03;Hydrochlorothiazide;;DDD;1;
C03AA04;Chlorothiazide;;DDD;1;
C03AA05;Polythiazide;;DDD;1;
C03AB;Thiazides and potassium in combination;;DDD;1;
C03AB01;Bendroflumethiazide and potassium;;DDD;1;
C03AB02;Hydroflumethiazide and potassium;;DDD;1;
C03B;Low-ceiling diuretics, excl thiazides;;DDD;1;
C03BA;Sulfonamides, plain;;DDD;1;
C03BA03;Clopamide;;DDD;1;
C03BA04;Chlortalidone;;DDD;1;
C03BA05;Mefruside;;DDD;1;
C03BA08;Metolazone;;DDD;1;
C03BA11;Indapamide;;DDD;1;
C03BB;Sulfonamides and potassium in combination;;DDD;1;
C03BB03;Clopamide and potassium;;DDD;1;
C03C;High-ceiling diuretics;;DDD;1;
C03CA;Sulfonamides, plain;;DDD;1;
C03CA01;Furosemide;;DDD;1;
C03CA02;Bumetanide;;DDD;1;
C03CB;Sulfonamides and potassium in combination;;DDD;1;
C03CB02;Bumetanide and potassium;;DDD;1;
C03D;Aldosterone antagonists and other potassium-sparing agents;;DDD;1;
C03DA;Aldosterone antagonists;;DDD;1;
C03DA01;Spironolactone;;DDD;1;
C03DA02;Potassium canrenoate;;DDD;1;
C03DA04;Eplerenone;;DDD;1;
C03DB;Other potassium-sparing agents;;DDD;1;
C03DB01;Amiloride;;DDD;1;
C03E;Diuretics and potassium-sparing agents in comb;2;DDD;1;
C03EA;Low-ceiling diuretics and potassium-sparing agents;2;DDD;1;
C03EA01;Hydrochlorothiazide and potassium-sparing agents;2;DDD;1;
C03EB;High-ceiling diuretics and potassium-sparing agent;2;DDD;1;
C03EB01;Furosemide and potassium-sparing agents;2;DDD;1;
C03EB02;Bumetanide and potassium-sparing agents;2;DDD;1;
C03X;Other diuretics;;DDD;1;
C03XA;Vasopressin antagonists;;DDD;1;
C03XA01;Tolvaptan;;DDD;1;
C04;Peripheral vasodilators;;DDD;1;
C04A;Peripheral vasodilators;;DDD;1;
C04AB;Imidazoline derivatives;;DDD;1;
C04AB01;Phentolamine;;DDD;1;
C04AC;Nicotinic acid and derivatives;;DDD;1;
C04AC01;Nicotinic acid;;DDD;1;
C04AD;Purine derivatives;;DDD;1;
C04AD03;Pentoxifylline;;DDD;1;
C05;Vasoprotectives;;No common unit for volume;1;
C05A;Agents for treatment of hemorrhoids and anal fissures for topical use;3,4;;1;
C05AA;Corticosteroids;3;DDD;1;
C05AA01;Hydrocortisone;3;DDD;1;
C05AA05;Betamethasone;3;DDD;1;
C05AA08;Fluocortolone;3;DDD;1;
C05AD;Local anesthetics;3;DDD;1;
C05AD01;Lidocaine;3;DDD;1;
C05AD03;Benzocaine;3;DDD;1;
C05AE;Musclerelaxants;3,4;;1;
C05AE01;Glyceryl trinitrate;3;DDD;1;
C05AE03;Diltiazem;;ml or g (preparation);1;
C05AX;Other agents for treatment of hemorrhoids and anal fissures for topical use;3;DDD;1;
C05AX02;Bismuth preparations, combinations;3;DDD;1;
C05B;Antivaricose therapy;;ml or g (preparation);1;
C05BA;Heparins or heparinoids for topical use;;ml or g (preparation);1;
C05BA01;Organo-heparinoid;;ml or g (preparation);1;
C05BB;Sclerosing agents for local injection;;ml or g (preparation);1;
C05BB02;Polidocanol;;ml or g (preparation);1;
C05C;Capillary stabilizing agents;3;DDD;1;
C05CA;Bioflavonoids;3;DDD;1;
C05CA02;Monoxerutin;3;DDD;1;
C05CA53;Diosmin, combinations;3;DDD;1;
C07;Beta blocking agents;2,3;DDD;1;
C07A;Beta blocking agents, plain;3;DDD;1;
C07AA;Beta blocking agents, plain, non-selective;;DDD;1;
C07AA01;Alprenolol;;DDD;1;
C07AA02;Oxprenolol;;DDD;1;
C07AA03;Pindolol;;DDD;1;
C07AA05;Propranolol;;DDD;1;
C07AA06;Timolol;;DDD;1;
C07AA07;Sotalol;;DDD;1;
C07AA16;Tertatolol;;DDD;1;
C07AB;Beta blocking agents, plain, selective;3;DDD;1;
C07AB02;Metoprolol;;DDD;1;
C07AB03;Atenolol;;DDD;1;
C07AB04;Acebutolol;;DDD;1;
C07AB05;Betaxolol;;DDD;1;
C07AB07;Bisoprolol;;DDD;1;
C07AB09;Esmolol;;DDD;1;
C07AB12;Nebivolol;;DDD;1;
C07AB14;Landiolol;3;DDD;1;
C07AG;Alpha- and beta blocking agents;;DDD;1;
C07AG01;Labetalol;;DDD;1;
C07AG02;Carvedilol;;DDD;1;
C07B;Beta blocking agents and thiazides;2;DDD;1;
C07BA;Beta blocking agents, non-selective, and thiazides;2;DDD;1;
C07BA06;Timolol and thiazides;2;DDD;1;
C07BB;Beta blocking agents, selective, and thiazides;2;DDD;1;
C07BB02;Metoprolol and thiazides;2;DDD;1;
C07BB12;Nebivolol and thiazides;2;DDD;1;
C07C;Beta blocking agents and other diuretics;2;DDD;1;
C07CA;Beta blocking agents,non-selective,other diuretics;2;DDD;1;
C07CA03;Pindolol and other diuretics;2;DDD;1;
C07CB;Beta blocking agents,selective,and other diuretics;2;DDD;1;
C07CB03;Atenolol and other diuretics;2;DDD;1;
C07F;Beta blocking agents, other combinations;2;DDD;1;
C07FB;Beta blocking agents and calcium channel blockers;2;DDD;1;
C07FB02;Metoprolol and felodipine;2;DDD;1;
C08;Calcium channel blockers;2;DDD;1;
C08C;Selective calcium channel blockers with mainly vascular effects;;DDD;1;
C08CA;Dihydropyridine derivatives;;DDD;1;
C08CA01;Amlodipine;;DDD;1;
C08CA02;Felodipine;;DDD;1;
C08CA03;Isradipine;;DDD;1;
C08CA04;Nicardipine;;DDD;1;
C08CA05;Nifedipine;;DDD;1;
C08CA06;Nimodipine;;DDD;1;
C08CA08;Nitrendipine;;DDD;1;
C08CA09;Lacidipine;;DDD;1;
C08CA10;Nilvadipine;;DDD;1;
C08CA13;Lercanidipine;;DDD;1;
C08CX;Other selective calcium channel blockers w. mainly vascular effects;;DDD;1;
C08CX01;Mibefradil;;DDD;1;
C08D;Selective calcium channel blockers with direct cardiac effects;2;DDD;1;
C08DA;Phenylalkylamine derivatives;2;DDD;1;
C08DA01;Verapamil;;DDD;1;
C08DA51;Verapamil, combinations;2;DDD;1;
C08DB;Benzothiazepine derivatives;;DDD;1;
C08DB01;Diltiazem;;DDD;1;
C09;Agents acting on the renin-angiotensin system;2;DDD;1;
C09A;Ace-inhibitors, plain;;DDD;1;
C09AA;Ace-inhibitors, plain;;DDD;1;
C09AA01;Captopril;;DDD;1;
C09AA02;Enalapril;;DDD;1;
C09AA03;Lisinopril;;DDD;1;
C09AA04;Perindopril;;DDD;1;
C09AA05;Ramipril;;DDD;1;
C09AA06;Quinapril;;DDD;1;
C09AA07;Benazepril;;DDD;1;
C09AA09;Fosinopril;;DDD;1;
C09AA10;Trandolapril;;DDD;1;
C09AA13;Moexipril;;DDD;1;
C09AA15;Zofenopril;;DDD;1;
C09B;Ace-inhibitors, combinations;2;DDD;1;
C09BA;Ace-inhibitors and diuretics;2;DDD;1;
C09BA01;Captopril and diuretics;2;DDD;1;
C09BA02;Enalapril and diuretics;2;DDD;1;
C09BA03;Lisinopril and diuretics;2;DDD;1;
C09BA04;Perindopril and diuretics;2;DDD;1;
C09BA05;Ramipril and diuretics;2;DDD;1;
C09BA07;Benazepril and diuretics;2;DDD;1;
C09BA15;Zofenapril and diuretics;2;DDD;1;
C09BB;Ace-inhibitors and calcium channel blockers;2;DDD;1;
C09BB02;Enalapril and lercanipine;2;DDD;1;
C09BB04;Perindopril and amlodipine;2;DDD;1;
C09C;Angiotensin ii receptor blockers (arbs), plain;;DDD;1;
C09CA;Angiotensin ii receptor blockers (arbs), plain;;DDD;1;
C09CA01;Losartan;;DDD;1;
C09CA02;Eprosartan;;DDD;1;
C09CA03;Valsartan;;DDD;1;
C09CA04;Irbesartan;;DDD;1;
C09CA06;Candesartan;;DDD;1;
C09CA07;Telmisartan;;DDD;1;
C09CA08;Olmesartan medoxomil;;DDD;1;
C09D;Angiotensin ii receptor blockers (arbs), combinations;2;DDD;1;
C09DA;Angiotensin ii receptor blockers (arbs) and diuretics;2;DDD;1;
C09DA01;Losartan and diuretics;2;DDD;1;
C09DA02;Eprosartan and diuretics;2;DDD;1;
C09DA03;Valsartan and diuretics;2;DDD;1;
C09DA04;Irbesartan and diuretics;2;DDD;1;
C09DA06;Candesartan and diuretics;2;DDD;1;
C09DA07;Telmisartan and diuretics;2;DDD;1;
C09DA08;Olmesartan medoxomil and diuretics;2;DDD;1;
C09DB;Angiotensin ii receptor blockers (arbs) and calcium channel blockers;2;DDD;1;
C09DB01;Valsartan and amlodipine;2;DDD;1;
C09DX;Angiotensin ii receptor blockers (arbs), other combinations;2;DDD;1;
C09DX01;Valsartan, amlodipine and hydrochlorothiazide;2;DDD;1;
C09DX04;Valsartan and sacubitril;2;DDD;1;
C09X;Other agents acting on the renin-angiotensin system;;DDD;1;
C09XA;Renin-inhibitors;;DDD;1;
C09XA02;Aliskiren;;DDD;1;
C09XA52;Aliskiren and hydrochlorothiazide;;DDD;1;
C10;Lipid modifying agents;2;DDD;1;
C10A;Lipid modifying agents, plain;;DDD;1;
C10AA;Hmg coa reductase inhibitors;;DDD;1;
C10AA01;Simvastatin;;DDD;1;
C10AA02;Lovastatin;;DDD;1;
C10AA03;Pravastatin;;DDD;1;
C10AA04;Fluvastatin;;DDD;1;
C10AA05;Atorvastatin;;DDD;1;
C10AA06;Cerivastatin;;DDD;1;
C10AA07;Rosuvastatin;;DDD;1;
C10AB;Fibrates;;DDD;1;
C10AB01;Clofibrate;;DDD;1;
C10AB02;Bezafibrate;;DDD;1;
C10AB04;Gemfibrozil;;DDD;1;
C10AC;Bile acid sequestrants;;DDD;1;
C10AC01;Colestyramine;;DDD;1;
C10AC02;Colestipol;;DDD;1;
C10AC04;Colesevelam;;DDD;1;
C10AD;Nicotinic acid and derivatives;;DDD;1;
C10AD06;Acipimox;;DDD;1;
C10AD52;Nicotinic acid, combinations;;DDD;1;
C10AX;Other lipid modifying agents;;DDD;1;
C10AX06;Omega-3-triglycerides incl. other esters and acids;;DDD;1;
C10AX09;Ezetimibe;;DDD;1;
C10AX12;Lomitapide;;DDD;1;
C10AX13;Evolocumab;;DDD;1;
C10AX14;Alirocumab;;DDD;1;
C10B;Lipid modifying agents, comb.;2;DDD;1;
C10BA;Combinations of various lipid modifying agents;2;DDD;1;
C10BA02;Simvastatin and ezetimibe;2;DDD;1;
C10BA05;Atorvastatin and ezetimibe;2;DDD;1;
D;Dermatologicals;;No common unit for volume;1;
D01;Antifungals for dermatological use;;No common unit for volume;1;
D01A;Antifungals for topical use;;ml or g (preparation);1;
D01AA;Antibiotics;;ml or g (preparation);1;
D01AA01;Nystatin;;ml or g (preparation);1;
D01AC;Imidazole and triazole derivatives;;ml or g (preparation);1;
D01AC01;Clotrimazole;;ml or g (preparation);1;
D01AC02;Miconazole;;ml or g (preparation);1;
D01AC03;Econazole;;ml or g (preparation);1;
D01AC08;Ketoconazole;;ml or g (preparation);1;
D01AC10;Bifonazole;;ml or g (preparation);1;
D01AC20;Imidazoles/triazoles in combination with corticosteroids;;ml or g (preparation);1;
D01AC60;Bifonazole combinations;;ml or g (preparation);1;
D01AE;Other antifungals for topical use;;ml or g (preparation);1;
D01AE02;Methylrosaniline;;ml or g (preparation);1;
D01AE14;Ciclopirox;;ml or g (preparation);1;
D01AE15;Terbinafine;;ml or g (preparation);1;
D01AE16;Amorolfine;;ml or g (preparation);1;
D01AE20;Combinations;;ml or g (preparation);1;
D01B;Antifungals for systemic use;;DDD;1;
D01BA;Antifungals for systemic use;;DDD;1;
D01BA01;Griseofulvin;;DDD;1;
D01BA02;Terbinafine;;DDD;1;
D02;Emollients and protectives;;ml or g (preparation);1;
D02A;Emollients and protectives;;ml or g (preparation);1;
D02AA;Silicone products;;ml or g (preparation);1;
D02AA**;;;ml or g (preparation);1;
D02AB;Zinc oxide products;;ml or g (preparation);1;
D02AB**;;;ml or g (preparation);1;
D02AC;Soft paraffin and fat products;;ml or g (preparation);1;
D02AC**;;;ml or g (preparation);1;
D02AE;Carbamide products;;ml or g (preparation);1;
D02AE01;Carbamide;;ml or g (preparation);1;
D02AF;Salicylic acid preparations;;ml or g (preparation);1;
D02AF**;;;ml or g (preparation);1;
D02AX;Other emollients and protectives;;ml or g (preparation);1;
D02AX**;;;ml or g (preparation);1;
D03;Preparations for treatment of wounds & ulcers;;ml or g (preparation);1;
D03A;Cicatrizants;;ml or g (preparation);1;
D03AA;Cod-liver oil ointments;;ml or g (preparation);1;
D03AA**;;;ml or g (preparation);1;
D03AX;Other cicatrizants;;ml or g (preparation);1;
D03AX01;Cadexomer iodine;;ml or g (preparation);1;
D03AX03;Dexpanthenol;;ml or g (preparation);1;
D03B;Enzymes;;ml or g (preparation);1;
D03BA;Proteolytic enzymes;;ml or g (preparation);1;
D03BA03;Bromelains;;ml or g (preparation);1;
D04;Antipruritics,incl antihist,anesthet,etc.;;ml or g (preparation);1;
D04A;Antipruritics,incl antihist,anesthet,etc.;;ml or g (preparation);1;
D04AA;Antihistamines for topical use;;ml or g (preparation);1;
D04AA02;Mepyramine;;ml or g (preparation);1;
D04AB;Anesthetics for topical use;;ml or g (preparation);1;
D04AB01;Lidocaine;;ml or g (preparation);1;
D04AB02;Cinchocaine;;ml or g (preparation);1;
D04AB04;Benzocaine;;ml or g (preparation);1;
D04AX;Other antipruritics;;ml or g (preparation);1;
D04AX**;;;ml or g (preparation);1;
D05;Antipsoriatics;;No common unit for volume;1;
D05A;Antipsoriatics for topical use;;ml or g (preparation);1;
D05AA;Tars;;ml or g (preparation);1;
D05AA**;;;ml or g (preparation);1;
D05AC;Antracen derivatives;;ml or g (preparation);1;
D05AC01;Dithranol;;ml or g (preparation);1;
D05AX;Other antipsoriatics for topical use;;ml or g (preparation);1;
D05AX**;;;ml or g (preparation);1;
D05AX02;Calcipotriol;;ml or g (preparation);1;
D05AX52;Calcipotriol, combinations;;ml or g (preparation);1;
D05B;Antipsoriatics for systemic use;;DDD;1;
D05BA;Psoralens for systemic use;;DDD;1;
D05BA02;Methoxalen, systemic;;DDD;1;
D05BB;Retinoids for treatment of psoriasis;;DDD;1;
D05BB02;Acitretin;;DDD;1;
D06;Antibiotics and chemother. for dermatological use;;ml or g (preparation);1;
D06A;Antibiotics for topical use;;ml or g (preparation);1;
D06AA;Tetracycline and derivatives;;ml or g (preparation);1;
D06AA03;Oxytetracycline;;ml or g (preparation);1;
D06AX;Other antibiotics for topical use;;ml or g (preparation);1;
D06AX01;Fusidic acid;;ml or g (preparation);1;
D06AX07;Gentamicin;;ml or g (preparation);1;
D06AX09;Mupirocin;;ml or g (preparation);1;
D06AX13;Retapamulin;;ml or g (preparation);1;
D06B;Chemotherapeutics for topical use;;ml or g (preparation);1;
D06BA;Sulfonamides;;ml or g (preparation);1;
D06BA01;Silver sulfadiazine;;ml or g (preparation);1;
D06BB;Antivirals;;ml or g (preparation);1;
D06BB01;Idoxuridine;;ml or g (preparation);1;
D06BB02;Tromantadine;;ml or g (preparation);1;
D06BB03;Aciclovir;;ml or g (preparation);1;
D06BB04;Podophyllotoxin;;ml or g (preparation);1;
D06BB06;Penciclovir;;ml or g (preparation);1;
D06BB10;Imiquimod;;ml or g (preparation);1;
D06BB11;Docosanol;;ml or g (preparation);1;
D06BB12;Sinecatechins;;ml or g (preparation);1;
D06BB53;Aciclovir, combinations;;ml or g (preparation);1;
D06BX;Other chemotherapeutics;;ml or g (preparation);1;
D06BX01;Metronidazole;;ml or g (preparation);1;
D06BX02;Ingenol mebutate;;ml or g (preparation);1;
D07;Corticosteroids, dermatological preparations;;ml or g (preparation);1;
D07A;Corticosteroids, plain;;ml or g (preparation);1;
D07AA;Corticosteroids, weak (group i);;ml or g (preparation);1;
D07AA02;Hydrocortisone;;ml or g (preparation);1;
D07AB;Corticosteroids, moderately potent (group ii);;ml or g (preparation);1;
D07AB01;Clobetasone;;ml or g (preparation);1;
D07AB02;Hydrocortisone butyrate;;ml or g (preparation);1;
D07AB07;Fluprednidene;;ml or g (preparation);1;
D07AB09;Triamcinolone;;ml or g (preparation);1;
D07AB10;Alclometasone;;ml or g (preparation);1;
D07AB11;Hydrocortisone buteprate;;ml or g (preparation);1;
D07AC;Corticosteroids, potent (group iii);;ml or g (preparation);1;
D07AC01;Betamethasone;;ml or g (preparation);1;
D07AC03;Desoximetasone;;ml or g (preparation);1;
D07AC04;Fluocinolone;;ml or g (preparation);1;
D07AC05;Fluocortolone;;ml or g (preparation);1;
D07AC06;Diflucortolone;;ml or g (preparation);1;
D07AC08;Fluocinonide;;ml or g (preparation);1;
D07AC09;Budesonide;;ml or g (preparation);1;
D07AC10;Diflorasone;;ml or g (preparation);1;
D07AC13;Mometasone;;ml or g (preparation);1;
D07AC17;Fluticasone;;ml or g (preparation);1;
D07AD;Corticosteroids, very potent (group iv);;ml or g (preparation);1;
D07AD01;Clobetasol;;ml or g (preparation);1;
D07AD02;Halcinonide;;ml or g (preparation);1;
D07B;Corticosteroids, comb with antiseptics;;ml or g (preparation);1;
D07BB;Corticosteroids, moderat. potent, comb w/antisept.;;ml or g (preparation);1;
D07BB01;Flumetasone and antiseptics;;ml or g (preparation);1;
D07BB03;Triamcinolone and antiseptics;;ml or g (preparation);1;
D07BB04;Hydrocortisone butyrate and antiseptics;;ml or g (preparation);1;
D07BC;Corticosteroids, potent, comb with antiseptics;;ml or g (preparation);1;
D07BC01;Betamethasone and antiseptics;;ml or g (preparation);1;
D07BC02;Fluocinolone and antiseptics;;ml or g (preparation);1;
D07C;Corticosteroids, comb with antibiotics;;ml or g (preparation);1;
D07CA;Corticosteroids, weak, comb with antibiotics;;ml or g (preparation);1;
D07CA01;Hydrocortisone and antibiotics;;ml or g (preparation);1;
D07CB;Corticosteroids, moderat. potent, comb w/antibiot.;;ml or g (preparation);1;
D07CB01;Triamcinolone and antibiotics;;ml or g (preparation);1;
D07CC;Corticosteroids, potent, comb with antibiotics;;ml or g (preparation);1;
D07CC01;Betamethasone and antibiotics;;ml or g (preparation);1;
D07X;Corticosteroids, other combinations;;ml or g (preparation);1;
D07XA;Corticosteroids, weak, other combinations;;ml or g (preparation);1;
D07XA01;Hydrocortisone;;ml or g (preparation);1;
D07XB;Corticosteroids, moderately potent, other comb.;;ml or g (preparation);1;
D07XB01;Flumetasone;;ml or g (preparation);1;
D07XB02;Triamcinolone;;ml or g (preparation);1;
D07XC;Corticosteroids, potent, other combinations;;ml or g (preparation);1;
D07XC01;Betamethasone;;ml or g (preparation);1;
D07XC02;Desoximetasone;;ml or g (preparation);1;
D08;Antiseptics and disinfectants;;ml or g (preparation);1;
D08A;Antiseptics and disinfectants;;ml or g (preparation);1;
D08AB;Aluminium agents;;ml or g (preparation);1;
D08AB**;;;ml or g (preparation);1;
D08AC;Biguanides and amidines;;ml or g (preparation);1;
D08AC02;Chlorhexidine;;ml or g (preparation);1;
D08AD;Boric acid products;;ml or g (preparation);1;
D08AD**;;;ml or g (preparation);1;
D08AF;Furan derivatives;;ml or g (preparation);1;
D08AF01;Nitrofural;;ml or g (preparation);1;
D08AG;Iodine products;;ml or g (preparation);1;
D08AG03;Iodine;;ml or g (preparation);1;
D08AL;Silver compounds;;ml or g (preparation);1;
D08AL01;Silver nitrate;;ml or g (preparation);1;
D08AX;Other antiseptics and disinfectants;;ml or g (preparation);1;
D08AX**;;;ml or g (preparation);1;
D08AX01;Hydrogen peroxide;;ml or g (preparation);1;
D09;Medicated dressings;;Items;1;
D09A;Medicated dressings;;Items;1;
D09AA;Ointment dressings with antiinfectives;;Items;1;
D09AA01;Framycetin;;Items;1;
D09AA02;Fusidic acid;;Items;1;
D09AB;Zinc bandages;;Items;1;
D09AB01;Zinc bandage without supplements;;Items;1;
D10;Anti-acne preparations;;No common unit for volume;1;
D10A;Anti-acne preparations for topical use;;ml or g (preparation);1;
D10AA;Corticosteroids,combinations for treatment of acne;;ml or g (preparation);1;
D10AA02;Methylprednisolone;;ml or g (preparation);1;
D10AB;Preparations containing sulphur;;ml or g (preparation);1;
D10AB02;Sulphur;;ml or g (preparation);1;
D10AD;Retinoids for topical use in acne;;ml or g (preparation);1;
D10AD01;Tretinoin;;ml or g (preparation);1;
D10AD03;Adapalene;;ml or g (preparation);1;
D10AD04;Isotretinoin;;ml or g (preparation);1;
D10AD53;Adapalene, combinations;;ml or g (preparation);1;
D10AE;Peroxides;;ml or g (preparation);1;
D10AE01;Benzoyl peroxide;;ml or g (preparation);1;
D10AF;Antiinfectives for treatment of acne;;ml or g (preparation);1;
D10AF01;Clindamycin;;ml or g (preparation);1;
D10AF51;Clindamycin, comb.;;ml or g (preparation);1;
D10AX;Other anti-acne preparations for topical use;;ml or g (preparation);1;
D10AX03;Azelaic acid;;ml or g (preparation);1;
D10B;Anti-acne preparations for systemic use;;DDD;1;
D10BA;Retinoids for treatment of acne;;DDD;1;
D10BA01;Isotretinoin;;DDD;1;
D11;Other dermatological preparations;;No common unit for volume;1;
D11A;Other dermatological preparations;;No common unit for volume;1;
D11AA;Antihidrotics;;ml or g (preparation);1;
D11AA**;;;ml or g (preparation);1;
D11AC;Medicated shampoos;;ml or g (preparation);1;
D11AC03;Selenium compounds;;ml or g (preparation);1;
D11AC30;Others;;ml or g (preparation);1;
D11AF;Wart and anti-corn preparations;4;ml or g (preparation);1;
D11AF**;;4;ml or g (preparation);1;
D11AH;Agents for dermatitis, excluding corticosteroids;;No common unit for volume;1;
D11AH01;Tacrolimus;;ml or g (preparation);1;
D11AH02;Pimecrolimus;;ml or g (preparation);1;
D11AH04;Alitretinoin;;DDD;1;
D11AH05;Dupilumab;;DDD;1;
D11AH07;Tralokinumab;3;DDD;1;
D11AX;Other dermatologicals;;No common unit for volume;1;
D11AX01;Minoxidil, topical;;ml or g (preparation);1;
D11AX02;Gamolenic acid;;DDD;1;
D11AX10;Finasteride;;DDD;1;
D11AX11;Hydroquinone;;ml or g (preparation);1;
D11AX16;Eflornithine;;ml or g (preparation);1;
D11AX18;Diclofenac;;ml or g (preparation);1;
D11AX21;Brimonidine;;ml or g (preparation);1;
D11AX22;Ivermectin;;ml or g (preparation);1;
D11AX24;Deoxycholic acid;;ml or g (preparation);1;
G;Genito urinary system and sex hormones;;No common unit for volume;1;
G01;Gynecological antiinfectives and antiseptics;;DDD;1;
G01A;Antiinfectives/antisept.,excl comb with corticost.;;DDD;1;
G01AA;Antibiotics;;DDD;1;
G01AA10;Clindamycin;;DDD;1;
G01AF;Imidazole derivatives;;DDD;1;
G01AF01;Metronidazole;;DDD;1;
G01AF02;Clotrimazole;;DDD;1;
G01AF04;Miconazole;;DDD;1;
G01AF05;Econazole;;DDD;1;
G01AG;Triazole derivatives;;DDD;1;
G01AG02;Terconazole;;DDD;1;
G01AX;Other antiinfectives and antiseptics;;DDD;1;
G01AX03;Metacresolsulphonic acid formaldehyde;;DDD;1;
G02;Other gynecologicals;;No common unit for volume;1;
G02A;Uterotonics;;DDD;1;
G02AB;Ergot alkaloids;;DDD;1;
G02AB01;Methylergometrine;;DDD;1;
G02AD;Prostaglandins;;DDD;1;
G02AD02;Dinoprostone;;DDD;1;
G02AD03;Gemeprost;;DDD;1;
G02AD04;Carboprost;;DDD;1;
G02AD06;Misoprostol;;DDD;1;
G02B;Contraceptives for local use;;No common unit for volume;1;
G02BA;Intrauterine contraceptives;;Items;1;
G02BA03;Plastic IUD with progestogen;;Items;1;
G02BB;Intravaginal contraceptives;3;DDD;1;
G02BB01;Vaginal ring with progestogen and estrogen;3;DDD;1;
G02C;Other gynecologicals;;DDD;1;
G02CA;Sympathomimetics, labour repressants;;DDD;1;
G02CA01;Ritodrine;;DDD;1;
G02CB;Prolactine inhibitors;;DDD;1;
G02CB03;Cabergoline;;DDD;1;
G02CB04;Quinagolide;;DDD;1;
G02CX;Other gynecologicals;;DDD;1;
G02CX01;Atosiban;;DDD;1;
G03;Sex hormones and modulators of the genital system;2,3;DDD;1;
G03A;Hormonal contraceptives for systemic use;3;DDD;1;
G03AA;Progestogens and estrogens, fixed combinations;3;DDD;1;
G03AA01;Etynodiol and ethinylestradiol;3;DDD;1;
G03AA03;Lynestrenol and ethinylestradiol;3;DDD;1;
G03AA05;Norethisterone and ethinylestradiol;3;DDD;1;
G03AA07;Levonorgestrel and ethinylestradiol;3;DDD;1;
G03AA09;Desogestrel and ethinylestradiol;3;DDD;1;
G03AA10;Gestodene and ethinylestradiol;3;DDD;1;
G03AA11;Norgestimate and ethinylestradiol;3;DDD;1;
G03AA12;Drospirenone and ethinylestradiol;3;DDD;1;
G03AA13;Norelgestromin and ethinylestradiol;3;DDD;1;
G03AA14;Nomegestrol and estradiol;3;DDD;1;
G03AA16;Dienogest and ethinylestradiol;3;DDD;1;
G03AB;Progestogens and estrogens,sequential preparations;3;DDD;1;
G03AB03;Levonorgestrel and ethinylestradiol;3;DDD;1;
G03AB04;Norethisterone and ethinylestradiol;3;DDD;1;
G03AB05;Desogestrel and ethinylestradiol;3;DDD;1;
G03AB06;Gestodene and ethinylestradiol;3;DDD;1;
G03AB08;Dienogest and estradiol;3;DDD;1;
G03AC;Progestogens;3;DDD;1;
G03AC01;Norethisterone;3;DDD;1;
G03AC02;Lynestrenol;3;DDD;1;
G03AC03;Levonorgestrel;3;DDD;1;
G03AC06;Medroxyprogesterone;;DDD;1;
G03AC08;Etonogestrel;;DDD;1;
G03AC09;Desogestrel;3;DDD;1;
G03AC10;Drospirenone;3;DDD;1;
G03AD;Emergency contraceptives;3;DDD;1;
G03AD**;;3;DDD;1;
G03AD01;Levonorgestrel;;DDD;1;
G03AD02;Ulipristal;;DDD;1;
G03B;Androgens;;DDD;1;
G03BA;3-oxoandrosten (4) derivatives;;DDD;1;
G03BA03;Testosterone;;DDD;1;
G03BB;5-androstanon (3) derivatives;;DDD;1;
G03BB01;Mesterolone;;DDD;1;
G03C;Estrogens;2,3;DDD;1;
G03CA;Natural and semisynthetic estrogens, plain;3;DDD;1;
G03CA03;Estradiol;;DDD;1;
G03CA04;Estriol;;DDD;1;
G03CA53;Estradiol, combinations;3;DDD;1;
G03CA57;Conjugated estrogens;;DDD;1;
G03CB;Synthetic estrogens, plain;;DDD;1;
G03CB01;Dienestrol;;DDD;1;
G03CC;Estrogens, combinations with other drugs;2;DDD;1;
G03CC07;Conjugated estrogens and bazedoxifene;2;DDD;1;
G03CX;Other estrogens;;DDD;1;
G03CX01;Tibolone;;DDD;1;
G03D;Progestogens;;DDD;1;
G03DA;Pregnen (4) derivatives;;DDD;1;
G03DA02;Medroxyprogesterone;;DDD;1;
G03DA04;Progesterone;;DDD;1;
G03DB;Pregnadien derivatives;;DDD;1;
G03DB01;Dydrogesterone;;DDD;1;
G03DB08;Dienogest;;DDD;1;
G03DC;Estren derivatives;;DDD;1;
G03DC02;Norethisterone;;DDD;1;
G03DC03;Lynestrenol;;DDD;1;
G03F;Progestogens and estrogens in combination;3;DDD;1;
G03FA;Progestogens and estrogens, combinations;3;DDD;1;
G03FA01;Norethisterone and estrogen;3;DDD;1;
G03FA11;Levonorgestrel and estrogen;3;DDD;1;
G03FA12;Medroxyprogesterone and estrogen;3;DDD;1;
G03FA15;Dienogest and estrogen;3;DDD;1;
G03FA17;Drospirenone and estrogen;3;DDD;1;
G03FB;Progestogens and estrogens,sequential preparations;3;DDD;1;
G03FB01;Norgestrel and estrogen;3;DDD;1;
G03FB05;Norethisterone and estrogen;3;DDD;1;
G03FB06;Medroxyprogesterone and estrogen;3;DDD;1;
G03FB09;Levonorgestrel and estrogen;3;DDD;1;
G03FB11;Trimegestone and estrogen;3;DDD;1;
G03G;Gonadotropins and other ovulation stimulants;2,3;DDD;1;
G03GA;Gonadotropins;2,3;DDD;1;
G03GA01;Chorionic gonadotropine;;DDD;1;
G03GA02;Human menopausal gonadotrophin;;DDD;1;
G03GA04;Urofollitrophin;;DDD;1;
G03GA05;Follitropin alfa;;DDD;1;
G03GA06;Follitropin beta;;DDD;1;
G03GA07;Lutropin alfa;;DDD;1;
G03GA08;Choriogonadotropin alfa;;DDD;1;
G03GA09;Corifollitropin alfa;;DDD;1;
G03GA10;Follitropin delta;;DDD;1;
G03GA30;Combinations;2,3;DDD;1;
G03GB;Ovulation stimulants, synthetic;;DDD;1;
G03GB02;Clomifene;;DDD;1;
G03H;Antiandrogens;2,3;DDD;1;
G03HA;Antiandrogens, plain preparations;;DDD;1;
G03HA01;Cyproterone;;DDD;1;
G03HB;Antiandrogens and estrogens;2,3;DDD;1;
G03HB01;Cyproterone and estrogen;2,3;DDD;1;
G03X;Other sex horm. & modulators of the genital system;;DDD;1;
G03XA;Antigonadotrophins and similar agents;;DDD;1;
G03XA01;Danazol;;DDD;1;
G03XA02;Gestrinone;;DDD;1;
G03XB;Progesterone receptor modulators;;DDD;1;
G03XB01;Mifepristone;;DDD;1;
G03XB02;Ulipristal;;DDD;1;
G03XC;Selective estrogen receptor modulators;;DDD;1;
G03XC01;Raloxifene;;DDD;1;
G03XX;Other sex hormones and modulators of the genital system;;DDD;1;
G03XX01;Prasterone;;DDD;1;
G04;Urologicals;2,3;DDD;1;
G04B;Urologicals;2,3;DDD;1;
G04BD;Drugs for urinary frequency and incontinence;;DDD;1;
G04BD01;Emepronium;;DDD;1;
G04BD02;Flavoxate;;DDD;1;
G04BD04;Oxybutynin;;DDD;1;
G04BD07;Tolterodine;;DDD;1;
G04BD08;Solifenacin;;DDD;1;
G04BD09;Trospium;;DDD;1;
G04BD10;Darifenacin;;DDD;1;
G04BD11;Fesoterodine;;DDD;1;
G04BD12;Mirabegron;;DDD;1;
G04BE;Drugs used in erectile dysfunction;2,3;DDD;1;
G04BE01;Alprostadil;;DDD;1;
G04BE02;Papaverine;3;DDD;1;
G04BE03;Sildenafil;;DDD;1;
G04BE04;Yohimbin;;DDD;1;
G04BE07;Apomorphine;;DDD;1;
G04BE08;Tadalafil;;DDD;1;
G04BE09;Vardenafil;;DDD;1;
G04BE10;Avanafil;;DDD;1;
G04BE30;Combinations;2;DDD;1;
G04BX;Other urologicals;;DDD;1;
G04BX14;Dapoxetine;;DDD;1;
G04BX15;Pentosan polysulfate sodium;;DDD;1;
G04C;Drugs used in benign prostatic hypertrophy;2;DDD;1;
G04CA;Alpha-adrenoreceptor antagonists;2;DDD;1;
G04CA01;Alfuzosin;;DDD;1;
G04CA02;Tamsulosin;;DDD;1;
G04CA03;Terazosin;;DDD;1;
G04CA52;Tamsulosin and dutasteride;2;DDD;1;
G04CA53;Tamsulosin and solifenacin;2;DDD;1;
G04CB;Testosterone-5-alpha reductase inhibitors;;DDD;1;
G04CB01;Finasteride;;DDD;1;
G04CB02;Dutasteride;;DDD;1;
H;Systemic hormonal prep, excl sex hormones;3;DDD;1;
H01;Pituitary, hypothalamic hormones and analogues;3;DDD;1;
H01A;Anterior pituitary lobe hormones and analogues;3;DDD;1;
H01AA;Acth;;DDD;1;
H01AA02;Tetracosactide;;DDD;1;
H01AB;Thyrotrophin;;DDD;1;
H01AB01;Thyrotropin alfa;;DDD;1;
H01AC;Somatropin and somatropin agonists;3;DDD;1;
H01AC01;Somatropin;;DDD;1;
H01AC03;Mecasermin;;DDD;1;
H01AC07;Somapacitan;3;DDD;1;
H01AX;Other anterior pituitary hormones and analogues;;DDD;1;
H01AX01;Pegvisomant;;DDD;1;
H01B;Posterior pituitary lobe hormones;;DDD;1;
H01BA;Vasopressin and analogues;;DDD;1;
H01BA01;Vasopressin (argipressin);;DDD;1;
H01BA02;Desmopressin;;DDD;1;
H01BA04;Terlipressin;;DDD;1;
H01BB;Oxytocin and analogues;;DDD;1;
H01BB02;Oxytocin;;DDD;1;
H01BB03;Carbetocin;;DDD;1;
H01C;Hypothalamic hormones;;DDD;1;
H01CA;Gonadotrophin-releasing hormones;;DDD;1;
H01CA02;Nafarelin;;DDD;1;
H01CB;Somatostatin and analogues;;DDD;1;
H01CB02;Octreotide;;DDD;1;
H01CB03;Lanreotide;;DDD;1;
H01CB05;Pasireotide;;DDD;1;
H01CC;Anti gonadotropin releasing hormones;;DDD;1;
H01CC01;Ganirelix;;DDD;1;
H01CC02;Cetrorelix;;DDD;1;
H02;Corticosteroids for systemic use;3;DDD;1;
H02A;Corticosteroids for systemic use, plain;3;DDD;1;
H02AA;Mineralocorticoids;;DDD;1;
H02AA02;Fludrocortisone;;DDD;1;
H02AB;Glucocorticoids;3;DDD;1;
H02AB01;Betamethasone;;DDD;1;
H02AB02;Dexamethasone;;DDD;1;
H02AB04;Methylprednisolone;;DDD;1;
H02AB06;Prednisolone;3;DDD;1;
H02AB07;Prednisone;;DDD;1;
H02AB08;Triamcinolone;;DDD;1;
H02AB09;Hydrocortisone;;DDD;1;
H02AB10;Cortisone;;DDD;1;
H03;Thyroid therapy;;DDD;1;
H03A;Thyroid preparations;;DDD;1;
H03AA;Thyroid hormones;;DDD;1;
H03AA01;Levothyroxine sodium;;DDD;1;
H03AA02;Liothyronine sodium;;DDD;1;
H03AA05;Thyroid gland preparations;;DDD;1;
H03B;Antithyroid preparations;;DDD;1;
H03BA;Thiouracils;;DDD;1;
H03BA02;Propylthiouracil;;DDD;1;
H03BB;Sulphur-containing imidazole derivatives;;DDD;1;
H03BB01;Carbimazole;;DDD;1;
H03BB02;Thiamazole;;DDD;1;
H03C;Iodine therapy;;DDD;1;
H03CA;Iodine therapy;;DDD;1;
H03CA**;;;DDD;1;
H04;Pancreatic hormones;;DDD;1;
H04A;Glycogenolytic hormones;;DDD;1;
H04AA;Glycogenolytic hormones;;DDD;1;
H04AA01;Glucagon;;DDD;1;
H05;Calcium homeostasis;;DDD;1;
H05A;Parathyroid hormones and analogues;;DDD;1;
H05AA;Parathyroid hormones and analogues;;DDD;1;
H05AA02;Teriparatide;;DDD;1;
H05AA03;Parathyroid hormone;;DDD;1;
H05B;Anti-parathyroid agents;;DDD;1;
H05BA;Calcitonin preparations;;DDD;1;
H05BA01;Calcitonin (salmon synthetic);;DDD;1;
H05BX;Other anti-parathyroid agents;;DDD;1;
H05BX01;Cinacalcet;;DDD;1;
H05BX02;Paricalcitol;;DDD;1;
H05BX04;Etelcalcetide;;DDD;1;
J;General antiinfectives for systemic use;;No common unit for volume;1;
J01;Antibacterials for systemic use;1,2,3,5;DDD;1;
J01****;;;No common unit for volume;1;
J01A;Tetracyclines;;DDD;1;
J01AA;Tetracyclines;;DDD;1;
J01AA02;Doxycycline;;DDD;1;
J01AA04;Lymecycline;;DDD;1;
J01AA06;Oxytetracycline;;DDD;1;
J01AA07;Tetracycline;;DDD;1;
J01AA12;Tigecycline;;DDD;1;
J01B;Amphenicols;;DDD;1;
J01BA;Amphenicols;;DDD;1;
J01BA01;Chloramphenicol;;DDD;1;
J01C;Beta-lactam antibacterials, penicillins;5;DDD;1;
J01CA;Penicillins with extended spectrum;5;DDD;1;
J01CA01;Ampicillin;5;DDD;1;
J01CA02;Pivampicillin;;DDD;1;
J01CA04;Amoxicillin;;DDD;1;
J01CA06;Bacampicillin;;DDD;1;
J01CA08;Pivmecillinam;;DDD;1;
J01CA11;Mecillinam;5;DDD;1;
J01CA12;Piperacillin;;DDD;1;
J01CA20;Combinations;;DDD;1;
J01CE;Beta-lactamase sensitive penicillins;5;DDD;1;
J01CE01;Benzylpenicillin;5;DDD;1;
J01CE02;Phenoxymethylpenicillin;;DDD;1;
J01CE08;Benzathine benzylpenicillin;;DDD;1;
J01CE09;Procain penicillin;;DDD;1;
J01CF;Beta-lactamase resistant penicillins;5;DDD;1;
J01CF01;Dicloxacillin;5;DDD;1;
J01CF02;Cloxacillin;5;DDD;1;
J01CF03;Methicillin;;DDD;1;
J01CF05;Flucloxacillin;;DDD;1;
J01CR;Comb of penicillins, incl. beta-lactamase inhib.;5;DDD;1;
J01CR02;Amoxicillin and beta-lactamase inhibitor;;DDD;1;
J01CR05;Piperacillin and beta-lactamase inhibitor;5;DDD;1;
J01D;Other beta-lactam antibacterials;1,5;DDD;1;
J01DB;First-generation cephalosporins;;DDD;1;
J01DB01;Cefalexin;;DDD;1;
J01DB03;Cefalotin;;DDD;1;
J01DB04;Cefazolin;;DDD;1;
J01DC;Second-generation cephalosporins;1,5;DDD;1;
J01DC01;Cefoxitin;;DDD;1;
J01DC02;Cefuroxime;1,5;DDD;1;
J01DD;Third-generation cephalosporins;5;DDD;1;
J01DD01;Cefotaxime;5;DDD;1;
J01DD02;Ceftazidime;5;DDD;1;
J01DD04;Ceftriaxone;5;DDD;1;
J01DD13;Cefpodoxime;;DDD;1;
J01DD52;Ceftazidime and beta-lactamase inhibitor;;DDD;1;
J01DE;Fourth-generation cephalosporins;;DDD;1;
J01DE01;Cefepime;;DDD;1;
J01DF;Monobactams;;DDD;1;
J01DF01;Aztreonam;;DDD;1;
J01DH;Carbapenems;5;DDD;1;
J01DH02;Meropenem;5;DDD;1;
J01DH03;Ertapenem;5;DDD;1;
J01DH04;Doripenem;;DDD;1;
J01DH51;Imipenem and cilastatin;;DDD;1;
J01DI;Other cephalosporins and penems;;DDD;1;
J01DI02;Ceftaroline fosamil;;DDD;1;
J01DI54;Ceftolozane and beta-lactamase inhibitor;;DDD;1;
J01E;Sulfonamides and trimethoprim;2,3;DDD;1;
J01EA;Trimethoprim and derivatives;;DDD;1;
J01EA01;Trimethoprim;;DDD;1;
J01EB;Short-acting sulfonamides;;DDD;1;
J01EB02;Sulfamethizole;;DDD;1;
J01EB04;Sulfapyridine;;DDD;1;
J01EC;Intermediate-acting sulfonamides;3;DDD;1;
J01EC02;Sulfadiazine;3;DDD;1;
J01EE;Comb.sulfonamides & trimethoprim incl. derivatives;2,3;DDD;1;
J01EE01;Sulfamethoxazole and trimethoprim;2,3;DDD;1;
J01F;Macrolides, lincosamides and streptogramins;5;DDD;1;
J01FA;Macrolides;5;DDD;1;
J01FA01;Erythromycin;5;DDD;1;
J01FA02;Spiramycin;;DDD;1;
J01FA06;Roxithromycin;;DDD;1;
J01FA09;Clarithromycin;;DDD;1;
J01FA10;Azithromycin;5;DDD;1;
J01FF;Lincosamides;5;DDD;1;
J01FF01;Clindamycin;;DDD;1;
J01G;Aminoglycoside antibacterials;5;DDD;1;
J01GB;Other aminoglycosides;5;DDD;1;
J01GB01;Tobramycin;5;DDD;1;
J01GB03;Gentamicin;5;DDD;1;
J01GB06;Amikacin;;DDD;1;
J01GB07;Netilmicin;;DDD;1;
J01M;Quinolone antibacterials;;DDD;1;
J01MA;Fluoroquinolones;;DDD;1;
J01MA01;Ofloxacin;;DDD;1;
J01MA02;Ciprofloxacin;;DDD;1;
J01MA06;Norfloxacin;;DDD;1;
J01MA08;Fleroxacin;;DDD;1;
J01MA11;Grepafloxacin;;DDD;1;
J01MA12;Levofloxacin;;DDD;1;
J01MA13;Trovafloxacin;;DDD;1;
J01MA14;Moxifloxacin;;DDD;1;
J01MB;Other quinolones;;DDD;1;
J01MB02;Nalidixic acid;;DDD;1;
J01X;Other antibacterials;3,5;DDD;1;
J01XA;Glycopeptide antibacterials;5;DDD;1;
J01XA01;Vancomycin;5;DDD;1;
J01XA02;Teicoplanin;;DDD;1;
J01XB;Polymyxins;5;DDD;1;
J01XB01;Colistin;5;DDD;1;
J01XC;Steroid antibacterials;5;DDD;1;
J01XC01;Fusidic acid;5;DDD;1;
J01XD;Imidazole derivatives;5;DDD;1;
J01XD01;Metronidazole;5;DDD;1;
J01XE;Nitrofuran derivatives;3;DDD;1;
J01XE01;Nitrofurantoin;3;DDD;1;
J01XX;Other antibacterials;;DDD;1;
J01XX01;Fosfomycin;;DDD;1;
J01XX05;Methenamine;;DDD;1;
J01XX08;Linezolid;;DDD;1;
J01XX09;Daptomycin;;DDD;1;
J01XX11;Tedizolid;;DDD;1;
J02;Antimycotics for systemic use;;DDD;1;
J02A;Antimycotics for systemic use;;DDD;1;
J02AA;Antibiotics;;DDD;1;
J02AA01;Amphotericin;;DDD;1;
J02AB;Imidazole derivatives;;DDD;1;
J02AB02;Ketoconazole;;DDD;1;
J02AC;Triazole and tetrazole derivatives;;DDD;1;
J02AC01;Fluconazole;;DDD;1;
J02AC02;Itraconazole;;DDD;1;
J02AC03;Voriconazole;;DDD;1;
J02AC04;Posaconazole;;DDD;1;
J02AC05;Isavuconazole;;DDD;1;
J02AX;Other antimycotics for systemic use;;DDD;1;
J02AX01;Flucytosine;;DDD;1;
J02AX04;Caspofungin;;DDD;1;
J02AX05;Micafungin;;DDD;1;
J02AX06;Anidulafungin;;DDD;1;
J04;Antimycobacterials;2;DDD;1;
J04A;Drugs for treatment of tuberculosis;2;DDD;1;
J04AA;Aminosalicylic acid and derivatives;;DDD;1;
J04AA01;Aminosalicylic acid;;DDD;1;
J04AB;Antibiotics;;DDD;1;
J04AB02;Rifampicin;;DDD;1;
J04AB04;Rifabutin;;DDD;1;
J04AC;Hydrazides;;DDD;1;
J04AC01;Isoniazid;;DDD;1;
J04AK;Other drugs for treatment of tuberculosis;;DDD;1;
J04AK01;Pyrazinamide;;DDD;1;
J04AK02;Ethambutol;;DDD;1;
J04AK05;Bedaquiline;;DDD;1;
J04AM;Comb. of drugs for treatment of tuberculosis;2;DDD;1;
J04AM02;Rifampicin and isoniazid;2;DDD;1;
J04AM05;Rifampicin, pyrazinamide and isoniazid;2;DDD;1;
J04AM06;Rifampicin, pyrazinamide, ethambutol and isoniazid;2;DDD;1;
J04B;Drugs for treatment of lepra;;DDD;1;
J04BA;Drugs for treatment of lepra;;DDD;1;
J04BA02;Dapsone;;DDD;1;
J05;Antivirals for systemic use;1,2,3;DDD;1;
J05A;Direct acting antivirals;1,2,3;DDD;1;
J05A***;;3;DDD;1;
J05AB;Nucleosides and nucleotides excl. reverse transcriptase inhibitors;1;DDD;1;
J05AB01;Aciclovir;;DDD;1;
J05AB06;Ganciclovir;1;DDD;1;
J05AB09;Famciclovir;;DDD;1;
J05AB11;Valaciclovir;;DDD;1;
J05AB12;Cidofovir;;DDD;1;
J05AB14;Valganciclovir;;DDD;1;
J05AD;Phosphonic acid derivatives;;No common unit for volume;1;
J05AD01;Foscarnet;;No common unit for volume;1;
J05AE;Protease inhibitors;;DDD;1;
J05AE01;Saquinavir;;DDD;1;
J05AE02;Indinavir;;DDD;1;
J05AE03;Ritonavir;;DDD;1;
J05AE04;Nelfinavir;;DDD;1;
J05AE05;Amprenavir;;DDD;1;
J05AE07;Fosamprenavir;;DDD;1;
J05AE08;Atazanavir;;DDD;1;
J05AE09;Tipranavir;;DDD;1;
J05AE10;Darunavir;;DDD;1;
J05AF;Nucleoside and nucleotide reverse transcriptase inhibitors;;DDD;1;
J05AF01;Zidovudine;;DDD;1;
J05AF02;Didanosine;;DDD;1;
J05AF03;Zalcitabine;;DDD;1;
J05AF04;Stavudine;;DDD;1;
J05AF05;Lamivudine;;DDD;1;
J05AF06;Abacavir;;DDD;1;
J05AF07;Tenofovir disoproxil;;DDD;1;
J05AF08;Adefovir dipivoxil;;DDD;1;
J05AF09;Emtricitabine;;DDD;1;
J05AF10;Entecavir;;DDD;1;
J05AF13;Tenofovir alafenamide;;DDD;1;
J05AG;Non-nucleoside reverse transcriptase inhibitors;;DDD;1;
J05AG01;Nevirapine;;DDD;1;
J05AG03;Efavirenz;;DDD;1;
J05AG04;Etravirine;;DDD;1;
J05AG05;Rilpivirine;;DDD;1;
J05AG06;Doravirine;;DDD;1;
J05AH;Neuraminidase inhibitors;;DDD;1;
J05AH01;Zanamivir;;DDD;1;
J05AH02;Oseltamivir;;DDD;1;
J05AJ;Integrase inhibitors;;DDD;1;
J05AJ01;Raltegravir;;DDD;1;
J05AJ03;Dolutegravir;;DDD;1;
J05AJ04;Cabotegravir;;DDD;1;
J05AP;Antivirals for treatment of hcv infections;2,3;DDD;1;
J05AP01;Ribavirin;;DDD;1;
J05AP02;Telaprevir;;DDD;1;
J05AP03;Boceprevir;;DDD;1;
J05AP05;Simeprevir;;DDD;1;
J05AP07;Daclatasvir;;DDD;1;
J05AP08;Sofosbuvir;;DDD;1;
J05AP09;Dasabuvir;;DDD;1;
J05AP51;Sofosbuvir and ledipasvir;2;DDD;1;
J05AP53;Ombitasvir, paritaprevir and ritonavir;2;DDD;1;
J05AP54;Elbasvir and grazoprevir;2;DDD;1;
J05AP55;Sofosbuvir and velpatasvir;2;DDD;1;
J05AP56;Sofosbuvir, velpatasvir and voxilaprevir;2;DDD;1;
J05AP57;Glecaprevir and pibrentasvir;3;DDD;1;
J05AR;Antivirals for treatment of hiv infections, comb.;2,3;DDD;1;
J05AR01;Zidovudine and lamivudine;2;DDD;1;
J05AR02;Lamivudine and abacavir;2;DDD;1;
J05AR03;Tenofovir disoproxil and emtricitabine;2;DDD;1;
J05AR04;Zidovudine, lamivudine and abacavir;2;DDD;1;
J05AR06;Emtricitabine, tenofovir disoproxil and efavirenz;2;DDD;1;
J05AR08;Emtricitabine, tenofovir disoproxil and rilpivirine;2;DDD;1;
J05AR09;Emtricitabine, tenofovir disoproxil, elvitegravir and cobicistat;2;DDD;1;
J05AR10;Lopinavir and ritonavir;;DDD;1;
J05AR13;Lamivudine, abacavir and dolutegravir;2;DDD;1;
J05AR14;Darunavir and cobicistat;3;DDD;1;
J05AR15;Atazanavir and cobicistat;2;DDD;1;
J05AR17;Emtricitabine and tenofovir alafenamide;2;DDD;1;
J05AR18;Emtricitabine, tenofovir alafenamide, elvitegravir and cobicistat;2;DDD;1;
J05AR19;Emtricitabine, tenofovir alafenamide and rilpivirine;2;DDD;1;
J05AR20;Emtricitabine, tenofovir alafenamide and bictegravir;2;DDD;1;
J05AR21;Dolutegravir and rilpivirine;2;DDD;1;
J05AR22;Emtricitabine, tenofovir alafenamide, darunavir and cobicistat;2;DDD;1;
J05AR24;Lamivudine, tenofovir disoproxil and doravirine;2;DDD;1;
J05AR25;Lamivudine and dolutegravir;2;DDD;1;
J05AX;Other antivirals;;DDD;1;
J05AX07;Enfuvirtide;;DDD;1;
J05AX09;Maraviroc;;DDD;1;
J05AX18;Letermovir;;DDD;1;
J06;Immune sera and immunoglobulins;1;Items;1;
J06****;;;Items;1;
J06A;Immune sera;;Items;1;
J06AA;Immune sera;;Items;1;
J06AA01;Diphteria antitoxin;;Items;1;
J06AA03;Snake venom antiserum;;Items;1;
J06AA04;Botulinum antitoxin;;Items;1;
J06B;Immunoglobulins;1;Items;1;
J06B***;;;No common unit for volume;1;
J06BA;Immunoglobulins, normal human;;Items;1;
J06BA01;Immunoglobulins, normal human for extravasc. use;;Items;1;
J06BA02;Immunoglobulins, normal human, for intravasc. use;;Items;1;
J06BB;Specific immunoglobulins;;Items;1;
J06BB01;Anti-d (rh) immunoglobulin;;Items;1;
J06BB02;Tetanus immunoglobulin;;Items;1;
J06BB03;Varicella/zoster immunoglobulin;;Items;1;
J06BB04;Hepatitis b immunoglobulin;;Items;1;
J06BB05;Rabies immunoglobulin;;Items;1;
J06BC;Antibacterial monoclonal antibodies;;Items;1;
J06BC03;Bezlotoxumab;;Items;1;
J06BD;Antiviral monoclonal antibodies;;Items;1;
J06BD01;Palivizumab;;Items;1;
J07;Vaccines;;Items;1;
J07A;Bacterial vaccines;;Items;1;
J07AC;Anthrax vaccines;;Items;1;
J07AC01;Anthrax antigen;;Items;1;
J07AE;Cholera vaccines;;Items;1;
J07AE01;Cholera, inactivated whole cell;;Items;1;
J07AF;Diphtheria vaccines;;Items;1;
J07AF01;Diphtheria toxoid;;Items;1;
J07AG;Hemophilus influenza b vaccines;;Items;1;
J07AG01;Hemophilus influenza b, purified antig.conjugated;;Items;1;
J07AH;Meningococcal vaccines;;Items;1;
J07AH02;Other meningococcal monov.,purified polysac.antig.;;Items;1;
J07AH03;Meningococcus a,c, bivalent purified polysacc. antigen;;Items;1;
J07AH04;Meningococcus a,c,y,w-135, tetravalent purified polysaccharides antigen;;Items;1;
J07AH08;Meningococcus a,c,y,w-135, tetravalent purified polysaccharides antigen conjugated;;Items;1;
J07AH09;Meningococcus b, multicomponent vaccine;;Items;1;
J07AJ;Pertussis vaccines;;Items;1;
J07AJ01;Pertussis, inactivated, whole cell;;Items;1;
J07AJ52;Pertusiss, purified antigen, comb. with toxoids;;Items;1;
J07AL;Pneumococcal vaccines;;Items;1;
J07AL01;Pneumococcus, purified polysaccharides antigen;;Items;1;
J07AL02;Pneumococcus, purified polysacc. antigen conj.;;Items;1;
J07AM;Tetanus vaccines;;Items;1;
J07AM01;Tetanus toxoid;;Items;1;
J07AM51;Tetanus toxoid, comb. with diphtheria toxoid;;Items;1;
J07AN;Tuberculosis vaccines;;Items;1;
J07AN01;Tuberculosis, live attenuated;;Items;1;
J07AP;Typhoid vaccines;;Items;1;
J07AP01;Typhoid, oral, live attenuated;;Items;1;
J07AP03;Typhoid, purified polysaccharide antigen;;Items;1;
J07B;Viral vaccines;;Items;1;
J07BA;Encephalitis vaccines;;Items;1;
J07BA01;Encephalitis, tick borne, inactivated, whole virus;;Items;1;
J07BA02;Encephalitis, japanese,inactivated, whole virus;;Items;1;
J07BB;Influenza vaccines;;Items;1;
J07BB**;;;Items;1;
J07BB01;Influenza, inactivated, whole virus;;Items;1;
J07BB02;Influenza, purified antigen;;Items;1;
J07BB03;Influenza, live attenuated;;Items;1;
J07BC;Hepatitis vaccines;;Items;1;
J07BC01;Hepatitis b, purified antigen;;Items;1;
J07BC02;Hepatitis a, inactivated, whole virus;;Items;1;
J07BC20;Combinations;;Items;1;
J07BD;Measles vaccines;;Items;1;
J07BD01;Measles, live attenuated;;Items;1;
J07BD52;Measles, comb. w. mumps and rubella, live attenuated;;Items;1;
J07BE;Mumps vaccines;;Items;1;
J07BE01;Mumps, live attenuated;;Items;1;
J07BF;Poliomyelitis vaccines;;Items;1;
J07BF03;Poliomyelitis, trivalent, inactivated, whole virus;;Items;1;
J07BG;Rabies vaccines;;Items;1;
J07BG01;Rabies, inactivated, whole virus;;Items;1;
J07BH;Rota virus diarrhea vaccines;;Items;1;
J07BH01;Rota virus, live attenuated;;Items;1;
J07BH02;Rota virus, pentavalent, live, reassorted;;Items;1;
J07BJ;Rubella, vaccines;;Items;1;
J07BJ01;Rubella, live attenuated;;Items;1;
J07BK;Varicella zoster vaccines;;Items;1;
J07BK01;Varicella, live attenuated;;Items;1;
J07BK02;Zoster, live attenuated;;Items;1;
J07BK03;Zoster, purified antigen;;Items;1;
J07BL;Yellow fever vaccines;;Items;1;
J07BL01;Yellow fever, live attenuated;;Items;1;
J07BM;Papillomavirus vaccines;;Items;1;
J07BM01;Papillomavirus (human types 6, 11, 16, 18);;Items;1;
J07BM02;Papillomavirus (human types 16, 18);;Items;1;
J07BM03;Papillomavirus (human types 6, 11, 16, 18, 31, 33, 45, 52,58);;Items;1;
J07BX;Other viral vaccines;;Items;1;
J07BX03;Covid-19 vaccines;;Items;1;
J07C;Bacterial and viral vaccines, combined;;Items;1;
J07CA;Bacterial and viral vaccines, combined;;Items;1;
J07CA01;Diphtheria-poliomyelitis-tetanus;;Items;1;
J07CA02;Diphtheria-pertussis-poliomyelitis-tetanus;;Items;1;
J07CA06;Diphteria-hemophilus influenzae b-pertussis-poliomyelitis-tetanus;;Items;1;
J07CA09;Diphteria-hemophilus influenzae b-pertussis-poliomyelitis-tetanus-hepatitis b;;Items;1;
J07CA10;Typhoid - hepatitis a;;Items;1;
L;Antineoplastic and immunomodulating agents;;No common unit for volume;1;
L01;Antineoplastic agents;5;No common unit for volume;1;
L01****;;5;No common unit for volume;1;
L01A;Alkylating agents;5;No common unit for volume;1;
L01AA;Nitrogen mustard analogues;5;No common unit for volume;1;
L01AA01;Cyclophosphamide;5;g (active substance);1;
L01AA02;Chlorambucil;5;g (active substance);1;
L01AA03;Melphalan;5;g (active substance);1;
L01AA06;Ifosfamide;5;g (active substance);1;
L01AA09;Bendamustine;5;g (active substance);1;
L01AB;Alkyl sulphonates;5;No common unit for volume;1;
L01AB01;Busulfan;5;g (active substance);1;
L01AB02;Treosulfan;5;g (active substance);1;
L01AC;Ethylene imines;5;No common unit for volume;1;
L01AC01;Thiotepa;5;g (active substance);1;
L01AD;Nitrosoureas;5;No common unit for volume;1;
L01AD01;Carmustine;5;g (active substance);1;
L01AD02;Lomustine;5;g (active substance);1;
L01AD04;Streptozocin;4,5;;1;
L01AX;Other alkylating agents;5;No common unit for volume;1;
L01AX03;Temozolomide;5;g (active substance);1;
L01AX04;Dacarbazine;5;g (active substance);1;
L01B;Antimetabolites;5;No common unit for volume;1;
L01BA;Folic acid analogues;5;No common unit for volume;1;
L01BA01;Methotrexate;5;mg (active substance);1;
L01BA04;Pemetrexed;5;g (active substance);1;
L01BB;Purine analogues;5;No common unit for volume;1;
L01BB02;Mercaptopurine;5;g (active substance);1;
L01BB04;Cladribine;5;g (active substance);1;
L01BB05;Fludarabine;5;g (active substance);1;
L01BB06;Clofarabine;5;g (active substance);1;
L01BB07;Nelarabine;5;g (active substance);1;
L01BC;Pyrimidine analogues;5;No common unit for volume;1;
L01BC01;Cytarabine;5;g (active substance);1;
L01BC02;Fluorouracil;5;g (active substance);1;
L01BC05;Gemcitabine;5;g (active substance);1;
L01BC06;Capecitabine;5;g (active substance);1;
L01BC07;Azacitidine;5;g (active substance);1;
L01BC08;Decitabine;5;g (active substance);1;
L01BC52;Fluorouracil, combinations;5;g (active substance);1;
L01BC53;Tegafur, comb.;5;g (active substance);1;
L01BC59;Trifluridine, combinations;5;g (active substance);1;
L01C;Plant alkaloids and other natural products;5;No common unit for volume;1;
L01CA;Vinca alkaloids and analogues;5;No common unit for volume;1;
L01CA01;Vinblastine;5;g (active substance);1;
L01CA02;Vincristine;5;mg (active substance);1;
L01CA04;Vinorelbine;5;g (active substance);1;
L01CA05;Vinflunine;5;g (active substance);1;
L01CB;Podophyllotoxin derivatives;5;No common unit for volume;1;
L01CB01;Etoposide;5;g (active substance);1;
L01CB02;Teniposide;5;g (active substance);1;
L01CD;Taxanes;5;No common unit for volume;1;
L01CD01;Paclitaxel;5;g (active substance);1;
L01CD02;Docetaxel;5;g (active substance);1;
L01CD04;Cabazitaxel;5;g (active substance);1;
L01CE;Topoisomerase 1 inhibitors;5;No common unit for volume;1;
L01CE01;Topotecan;5;mg (active substance);1;
L01CE02;Irinotecan;5;g (active substance);1;
L01CX;Other plant alkaloids and natural products;5;No common unit for volume;1;
L01CX01;Trabectedin;5;mg (active substance);1;
L01D;Cytotoxic antibiotics and related substances;5;No common unit for volume;1;
L01DB;Anthracyclines and related substances;5;No common unit for volume;1;
L01DB01;Doxorubicin;1,5;g (active substance);1;
L01DB02;Daunorubicin;5;g (active substance);1;
L01DB03;Epirubicin;5;g (active substance);1;
L01DB04;Aclarubicin;5;g (active substance);1;
L01DB06;Idarubicin;5;g (active substance);1;
L01DB07;Mitoxantrone;5;g (active substance);1;
L01DB11;Pixantrone;5;g (active substance);1;
L01DC;Other cytotoxic antibiotics;5;No common unit for volume;1;
L01DC01;Bleomycin;5;Thousand units;1;
L01DC03;Mitomycin;5;mg (active substance);1;
L01E;Protein kinase inhibitors;5;DDD;1;
L01EA;Bcr-abl tyrosine kinase inhibitors;5;DDD;1;
L01EA01;Imatinib;5;DDD;1;
L01EA02;Dasatinib;5;DDD;1;
L01EA03;Nilotinib;5;DDD;1;
L01EA04;Bosutinib;5;DDD;1;
L01EA05;Ponatinib;5;DDD;1;
L01EB;Epidermal growth factor receptor (egfr)-tyrosine kinase inhibitors;5;DDD;1;
L01EB01;Gefitinib;5;DDD;1;
L01EB02;Erlotinib;5;DDD;1;
L01EB03;Afatinib;5;DDD;1;
L01EB04;Osimertinib;5;DDD;1;
L01EC;B-raf serine-threonine kinase (braf) inhibitors;5;DDD;1;
L01EC01;Vemurafenib;5;DDD;1;
L01EC02;Dabrafenib;5;DDD;1;
L01EC03;Encorafenib;5;DDD;1;
L01ED;Anaplastic lymphoma kinase (alk) inhibitors;5;DDD;1;
L01ED01;Crizotinib;5;DDD;1;
L01ED02;Ceritinib;5;DDD;1;
L01ED03;Alectinib;5;DDD;1;
L01ED04;Brigatinib;5;DDD;1;
L01ED05;Lorlatinib;5;DDD;1;
L01EE;Mitogen-activated protein kinase (mek) inhibitors;5;DDD;1;
L01EE01;Trametinib;5;DDD;1;
L01EE02;Cobimetinib;5;DDD;1;
L01EE03;Binimetinib;5;DDD;1;
L01EF;Cyclin-dependent kinase (cdk) inhibitors;5;DDD;1;
L01EF01;Palbociclib;5;DDD;1;
L01EF02;Ribociclib;5;DDD;1;
L01EF03;Abemaciclib;5;DDD;1;
L01EG;Mammalian target of rapamycin (mtor) kinase inhibitors;5;DDD;1;
L01EG01;Temsirolimus;5;DDD;1;
L01EG02;Everolimus;5;DDD;1;
L01EH;Human epidermal growth factor receptor 2 (her2) tyrosine kinase inhibitors;5;DDD;1;
L01EH01;Lapatinib;5;DDD;1;
L01EH03;Tucatinib;5;DDD;1;
L01EJ;Janus associated kinase (jak) inhibitors;5;DDD;1;
L01EJ01;Ruxolitinib;5;DDD;1;
L01EK;Vascular endothelial growth factor receptor (vegfr)-tyrosine kinase inhibitors;5;DDD;1;
L01EK01;Axitinib;5;DDD;1;
L01EK03;Tivozanib;5;DDD;1;
L01EL;Bruton's tyrosine kinase (btk) inhibitors;5;DDD;1;
L01EL01;Ibrutinib;5;DDD;1;
L01EL02;Acalabrutinib;5;DDD;1;
L01EM;Phosphatidylinositol-3-kinase (pi3k) inhibitors;5;DDD;1;
L01EM01;Idelalisib;5;DDD;1;
L01EM03;Alpelisib;5;DDD;1;
L01EN;Fibroblast growth factor receptor (fgfr) tyrosine kinase inhibitors;5;DDD;1;
L01EN02;Pemigatinib;5;DDD;1;
L01EX;Other protein kinase inhibitors;5;DDD;1;
L01EX01;Sunitinib;5;DDD;1;
L01EX02;Sorafenib;5;DDD;1;
L01EX03;Pazopanib;5;DDD;1;
L01EX04;Vandetanib;5;DDD;1;
L01EX05;Regorafenib;5;DDD;1;
L01EX07;Cabozantinib;5;DDD;1;
L01EX08;Lenvatinib;5;DDD;1;
L01EX09;Nintedanib;5;DDD;1;
L01EX10;Midostaurin;5;DDD;1;
L01EX14;Entrectinib;5;DDD;1;
L01EX18;Avapritinib;5;DDD;1;
L01EX22;Selpercatinib;5;DDD;1;
L01F;Monoclonal antibodies and antibody drug conjugates;5;No common unit for volume;1;
L01FA;Cd20 (clusters of differentiation 20) inhibitors;5;No common unit for volume;1;
L01FA01;Rituximab;5;g (active substance);1;
L01FA02;Ofatumumab;5;g (active substance);1;
L01FA03;Obinutuzumab;5;g (active substance);1;
L01FB;Cd22 (clusters of differentiation 22) inhibitors;5;No common unit for volume;1;
L01FB01;Inotuzumab ozogamicin;5;g (active substance);1;
L01FC;Cd38 (clusters of differentiation 38) inhibitors;5;No common unit for volume;1;
L01FC01;Daratumumab;5;g (active substance);1;
L01FD;Her2 (human epidermal growth factor receptor 2) inhibitors;5;No common unit for volume;1;
L01FD01;Trastuzumab;5;g (active substance);1;
L01FD02;Pertuzumab;5;g (active substance);1;
L01FD03;Trastuzumab emtansine;5;g (active substance);1;
L01FD04;Trastuzumab deruxtecan;5;g (active substance);1;
L01FE;Egfr (epidermal growth factor receptor) inhibitors;5;No common unit for volume;1;
L01FE01;Cetuximab;5;g (active substance);1;
L01FE02;Panitumumab;5;g (active substance);1;
L01FF;Pd-1/pdl-1 (programmed cell death protein 1/death ligand 1) inhibitors;5;No common unit for volume;1;
L01FF01;Nivolumab;5;g (active substance);1;
L01FF02;Pembrolizumab;5;g (active substance);1;
L01FF03;Durvalumab;5;No common unit for volume;1;
L01FF04;Avelumab;5;g (active substance);1;
L01FF05;Atezolizumab;5;g (active substance);1;
L01FF06;Cemiplimab;5;g (active substance);1;
L01FG;Vegf/vegfr (vascular endothelial growth factor) inhibitors;5;No common unit for volume;1;
L01FG01;Bevacizumab;5;g (active substance);1;
L01FG02;Ramucirumab;5;g (active substance);1;
L01FX;Other monoclonal antibodies and antibody drug conjugates;5;No common unit for volume;1;
L01FX02;Gemtuzumab ozogamicin;5;g (active substance);1;
L01FX03;Catumaxomab;5;mg (active substance);1;
L01FX04;Ipilimumab;5;g (active substance);1;
L01FX05;Brentuximab vedotin;5;g (active substance);1;
L01FX06;Dinutuximab beta;5;g (active substance);1;
L01FX07;Blinatumomab;5;mg (active substance);1;
L01FX08;Elotuzumab;5;g (active substance);1;
L01FX09;Mogamulizumab;5;g (active substance);1;
L01FX10;Olaratumab;5;g (active substance);1;
L01FX14;Polatuzumab vedotin;5;g (active substance);1;
L01X;Other antineoplastic agents;5;No common unit for volume;1;
L01XA;Platinum compounds;5;No common unit for volume;1;
L01XA01;Cisplatin;5;g (active substance);1;
L01XA02;Carboplatin;5;g (active substance);1;
L01XA03;Oxaliplatin;5;g (active substance);1;
L01XD;Sensitizers used in photodynamic/radiation therapy;5;No common unit for volume;1;
L01XD03;Methyl aminolevulinate;5;g (active substance);1;
L01XD04;Aminolevulinic acid;5;g (active substance);1;
L01XD05;Temoporfin;5;g (active substance);1;
L01XF;Retinoids for cancer treatment;5;No common unit for volume;1;
L01XF03;Bexarotene;5;g (active substance);1;
L01XG;Proteasome inhibitors;5;No common unit for volume;1;
L01XG01;Bortezomib;5;mg (active substance);1;
L01XG02;Carfilzomib;5;g (active substance);1;
L01XG03;Ixazomib;5;mg (active substance);1;
L01XH;Histone deacetylase (hdac) inhibitors;5;No common unit for volume;1;
L01XH03;Panobinostat;5;g (active substance);1;
L01XJ;Hedgehog pathway inhibitors;5;No common unit for volume;1;
L01XJ01;Vismodegib;5;g (active substance);1;
L01XK;Poly (adp-ribose) polymerase (parp) inhibitors;5;No common unit for volume;1;
L01XK01;Olaparib;5;g (active substance);1;
L01XK02;Niraparib;5;g (active substance);1;
L01XX;Other antineoplastic agents;5;No common unit for volume;1;
L01XX01;Amsacrine;5;g (active substance);1;
L01XX02;Asparaginase;5;Thousand units;1;
L01XX03;Altretamine;5;g (active substance);1;
L01XX05;Hydroxycarbamide;5;g (active substance);1;
L01XX08;Pentostatin;5;g (active substance);1;
L01XX11;Estramustine;5;g (active substance);1;
L01XX23;Mitotane;5;g (active substance);1;
L01XX24;Pegaspargase;5;Thousand units;1;
L01XX27;Arsenic trioxide;5;g (active substance);1;
L01XX33;Celecoxib;5;g (active substance);1;
L01XX35;Anagrelide;5;g (active substance);1;
L01XX41;Eribulin;5;mg (active substance);1;
L01XX44;Aflibercept;5;g (active substance);1;
L01XX52;Venetoclax;5;g (active substance);1;
L01XX71;Tisagenlecleucel;5;Items;1;
L01XY;Combinations of antineoplastic agents;5;No common unit for volume;1;
L01XY01;Cytarabine and daunorubicin;5;;1;
L01XY02;Pertuzumab and trastuzumab;5;g (active substance);1;
L02;Endocrine therapy;;DDD;1;
L02A;Hormones and related agents;;DDD;1;
L02AA;Estrogens;;DDD;1;
L02AA01;Diethylstilbestrol;;DDD;1;
L02AA02;Polyestradiol phosphate;;DDD;1;
L02AA04;Fosfestrol;;DDD;1;
L02AB;Progestogens;;DDD;1;
L02AB01;Megestrol;;DDD;1;
L02AB02;Medroxyprogesterone;;DDD;1;
L02AE;Gonadotrophin releasing hormone analogues;;DDD;1;
L02AE01;Buserelin;;DDD;1;
L02AE02;Leuprorelin;;DDD;1;
L02AE03;Goserelin;;DDD;1;
L02AE04;Triptorelin;;DDD;1;
L02AE05;Histrelin;;DDD;1;
L02B;Hormone antagonists and related agents;;DDD;1;
L02BA;Anti-estrogens;;DDD;1;
L02BA01;Tamoxifen;;DDD;1;
L02BA03;Fulvestrant;;DDD;1;
L02BB;Anti-androgens;;DDD;1;
L02BB01;Flutamide;;DDD;1;
L02BB02;Nilutamide;;DDD;1;
L02BB03;Bicalutamide;;DDD;1;
L02BB04;Enzalutamide;;DDD;1;
L02BB05;Apalutamide;;DDD;1;
L02BB06;Darolutamide;;DDD;1;
L02BG;Aromatase inhibitors;;DDD;1;
L02BG02;Formestane;;DDD;1;
L02BG03;Anastrozole;;DDD;1;
L02BG04;Letrozole;;DDD;1;
L02BG06;Exemestane;;DDD;1;
L02BX;Other hormone antagonists and related agents;;DDD;1;
L02BX02;Degarelix;;DDD;1;
L02BX03;Abiraterone;;DDD;1;
L03;Immunostimulants;3;DDD;1;
L03A;Immunostimulants;3;DDD;1;
L03AA;Colony stimulating factors;;DDD;1;
L03AA02;Filgrastim;;DDD;1;
L03AA03;Molgramostim;;DDD;1;
L03AA10;Lenograstim;;DDD;1;
L03AA13;Pegfilgrastim;;DDD;1;
L03AA14;Lipegfilgrastim;;DDD;1;
L03AB;Interferons;3;DDD;1;
L03AB01;Interferon alfa natural;;DDD;1;
L03AB03;Interferon gamma;;DDD;1;
L03AB04;Interferon alfa-2a;;DDD;1;
L03AB05;Interferon alfa-2b;;DDD;1;
L03AB07;Interferon beta-1a;;DDD;1;
L03AB08;Interferon beta-1b;;DDD;1;
L03AB10;Peginterferon alfa-2b;;DDD;1;
L03AB11;Peginterferon alfa-2a;;DDD;1;
L03AB13;Peginterferon beta-1a;;DDD;1;
L03AB15;Ropeginterferon alfa-2b;3;DDD;1;
L03AC;Interleukins;;DDD;1;
L03AC01;Aldesleukin;;DDD;1;
L03AX;Other immunostimulants;3;DDD;1;
L03AX**;;3;DDD;1;
L03AX03;Bcg vaccine;;DDD;1;
L03AX13;Glatiramer acetate;;DDD;1;
L03AX16;Plerixafor;;DDD;1;
L04;Immunosuppressants;;No common unit for volume;1;
L04A;Immunosuppressants;;No common unit for volume;1;
L04AA;Selective immunosuppressants;;No common unit for volume;1;
L04AA04;Antithymocyte immunoglobulin;;DDD;1;
L04AA06;Mycophenolic acid;;DDD;1;
L04AA10;Sirolimus;;DDD;1;
L04AA13;Leflunomide;;DDD;1;
L04AA18;Everolimus;;DDD;1;
L04AA21;Efalizumab;;DDD;1;
L04AA23;Natalizumab;;DDD;1;
L04AA24;Abatacept;;DDD;1;
L04AA25;Eculizumab;;DDD;1;
L04AA26;Belimumab;;DDD;1;
L04AA27;Fingolimod;;DDD;1;
L04AA28;Belatacept;;DDD;1;
L04AA29;Tofacitinib;;DDD;1;
L04AA31;Teriflunomide;;DDD;1;
L04AA32;Apremilast;;DDD;1;
L04AA33;Vedolizumab;;DDD;1;
L04AA34;Alemtuzumab;;No common unit for volume;1;
L04AA36;Ocrelizumab;;DDD;1;
L04AA37;Baricitinib;;DDD;1;
L04AA38;Ozanimod;;DDD;1;
L04AA40;Cladribine;;DDD;1;
L04AA42;Siponimod;3;DDD;1;
L04AA43;Ravulizumab;;DDD;1;
L04AA44;Upadacitinib;;DDD;1;
L04AB;Tumor necrosis factor alpha (tnf-alpha) inhibitors;;DDD;1;
L04AB01;Etanercept;;DDD;1;
L04AB02;Infliximab;;DDD;1;
L04AB04;Adalimumab;;DDD;1;
L04AB05;Certolizumab pegol;;DDD;1;
L04AB06;Golimumab;;DDD;1;
L04AC;Interleukin inhibitors;;DDD;1;
L04AC01;Daclizumab;;DDD;1;
L04AC02;Basiliximab;;DDD;1;
L04AC03;Anakinra;;DDD;1;
L04AC05;Ustekinumab;;DDD;1;
L04AC07;Tocilizumab;;DDD;1;
L04AC08;Canakinumab;;DDD;1;
L04AC10;Secukinumab;;DDD;1;
L04AC11;Siltuximab;;DDD;1;
L04AC12;Brodalumab;;DDD;1;
L04AC13;Ixekizumab;;DDD;1;
L04AC14;Sarilumab;;DDD;1;
L04AC16;Guselkumab;;DDD;1;
L04AC17;Tildrakizumab;;DDD;1;
L04AC18;Risankizumab;;DDD;1;
L04AD;Calcineurin inhibitors;;DDD;1;
L04AD01;Ciclosporin;;DDD;1;
L04AD02;Tacrolimus;;DDD;1;
L04AX;Other immunosuppressants;;DDD;1;
L04AX01;Azathioprine;;DDD;1;
L04AX02;Thalidomide;;DDD;1;
L04AX03;Methotrexate;;DDD;1;
L04AX04;Lenalidomide;;DDD;1;
L04AX05;Pirfenidone;;DDD;1;
L04AX06;Pomalidomide;;DDD;1;
L04AX07;Dimethyl fumarate;;DDD;1;
M;Musculo-skeletal system;;No common unit for volume;1;
M01;Antiinflammatory and antirheumatic products;3;DDD;1;
M01A;Antiinflammatory/antirheumatic prod.,non-steroids;3;DDD;1;
M01AA;Butylpyrazolidines;;DDD;1;
M01AA01;Phenylbutazone;;DDD;1;
M01AB;Acetic acid derivatives and related substances;;DDD;1;
M01AB01;Indometacin;;DDD;1;
M01AB02;Sulindac;;DDD;1;
M01AB03;Tolmetin;;DDD;1;
M01AB05;Diclofenac;;DDD;1;
M01AB08;Etodolac;;DDD;1;
M01AB15;Ketorolac;;DDD;1;
M01AB16;Aceclofenac;;DDD;1;
M01AB55;Diclofenac, combinations;;DDD;1;
M01AC;Oxicams;;DDD;1;
M01AC01;Piroxicam;;DDD;1;
M01AC02;Tenoxicam;;DDD;1;
M01AC05;Lornoxicam;;DDD;1;
M01AC06;Meloxicam;;DDD;1;
M01AE;Propionic acid derivatives;3;DDD;1;
M01AE01;Ibuprofen;;DDD;1;
M01AE02;Naproxen;;DDD;1;
M01AE03;Ketoprofen;;DDD;1;
M01AE04;Fenoprofen;;DDD;1;
M01AE05;Fenbufen;;DDD;1;
M01AE09;Flurbiprofen;;DDD;1;
M01AE11;Tiaprofenic acid;;DDD;1;
M01AE14;Dexibuprofen;;DDD;1;
M01AE17;Dexketoprofen;;DDD;1;
M01AE51;Ibuprofen, combinations;3;DDD;1;
M01AE52;Naproxen and esomeprazole;;DDD;1;
M01AG;Fenamates;;DDD;1;
M01AG02;Tolfenamic acid;;DDD;1;
M01AH;Coxibs;;DDD;1;
M01AH01;Celecoxib;;DDD;1;
M01AH02;Rofecoxib;;DDD;1;
M01AH04;Parecoxib;;DDD;1;
M01AH05;Etoricoxib;;DDD;1;
M01AH06;Lumiracoxib;;DDD;1;
M01AX;Other antiinfl./antirheumatic agents, non-steroids;;DDD;1;
M01AX01;Nabumetone;;DDD;1;
M01AX05;Glucosamine;;DDD;1;
M01C;Specific antirheumatic agents;;DDD;1;
M01CB;Gold preparations;;DDD;1;
M01CB01;Sodium aurothiomalate;;DDD;1;
M01CB03;Auranofin;;DDD;1;
M01CC;Penicillamine and similar agents;;DDD;1;
M01CC01;Penicillamine;;DDD;1;
M02;Topical products for joint and muscular pain;;ml or g (preparation);1;
M02A;Topical products for joint and muscular pain;;ml or g (preparation);1;
M02AA;Antiinfl. prep., non-steroids for topical use;;ml or g (preparation);1;
M02AA05;Benzydamine;;ml or g (preparation);1;
M02AA07;Piroxicam;;ml or g (preparation);1;
M02AA08;Felbinac;;ml or g (preparation);1;
M02AA10;Ketoprofen;;ml or g (preparation);1;
M02AA13;Ibuprofen;;ml or g (preparation);1;
M02AA15;Diclofenac;;ml or g (preparation);1;
M03;Muscle relaxants;;No common unit for volume;1;
M03A;Muscle relaxants, peripherally acting agents;;No common unit for volume;1;
M03AB;Choline derivatives;;No common unit for volume;1;
M03AB01;Suxamethonium;;g (active substance);1;
M03AC;Other quaternary ammonium compounds;;No common unit for volume;1;
M03AC01;Pancuronium;;g (active substance);1;
M03AC02;Gallamine;;g (active substance);1;
M03AC03;Vecuronium;;g (active substance);1;
M03AC04;Atracurium;;g (active substance);1;
M03AC09;Rocuronium bromide;;g (active substance);1;
M03AC10;Mivacurium chloride;;g (active substance);1;
M03AC11;Cisatracurium;;g (active substance);1;
M03AX;Other muscle relaxants,peripherally acting;;No common unit for volume;1;
M03AX01;Botulinum toxin;;Thousand units;1;
M03B;Muscle relaxants, centrally acting agents;;DDD;1;
M03BA;Carbamic acid esters;;DDD;1;
M03BA02;Carisoprodol;;DDD;1;
M03BB;Oxazol-, thiazine-, triazine derivatives;;DDD;1;
M03BB02;Chlormezanone;;DDD;1;
M03BB03;Chlorzoxazone;;DDD;1;
M03BC;Ethers, chemically close to antihistamines;;DDD;1;
M03BC01;Orphenadrine (citrate);;DDD;1;
M03BX;Other centrally acting agents;;DDD;1;
M03BX01;Baclofen;;DDD;1;
M03BX02;Tizanidine;;DDD;1;
M03C;Muscle relaxants, directly acting agents;;DDD;1;
M03CA;Dantrolene and derivatives;;DDD;1;
M03CA01;Dantrolene;;DDD;1;
M04;Antigout preparations;;DDD;1;
M04A;Antigout preparations;;DDD;1;
M04AA;Preparations inhibiting uric acid production;;DDD;1;
M04AA01;Allopurinol;;DDD;1;
M04AA03;Febuxostat;;DDD;1;
M04AB;Preparations increasing uric acid excretion;;DDD;1;
M04AB01;Probenecid;;DDD;1;
M04AB05;Lesinurad;;DDD;1;
M04AC;Preparations w. no effect on uric acid metabolism;;DDD;1;
M04AC01;Colchicine;;DDD;1;
M05;Drugs for treatment of bone diseases;3;DDD;1;
M05B;Drugs affecting bone structure and mineralization;3;DDD;1;
M05BA;Bisphosphonates;;DDD;1;
M05BA01;Etidronic acid;;DDD;1;
M05BA02;Clodronic acid;;DDD;1;
M05BA03;Pamidronic acid;;DDD;1;
M05BA04;Alendronic acid;;DDD;1;
M05BA06;Ibandronic acid;;DDD;1;
M05BA07;Risedronic acid;;DDD;1;
M05BA08;Zoledronic acid;;DDD;1;
M05BB;Bisphosphonates, combinations;;DDD;1;
M05BB01;Etidronic acid and calcium, sequential;;DDD;1;
M05BB03;Alendronic acid and colecalciferol;;DDD;1;
M05BC;Bone morphogenetic proteins;3;DDD;1;
M05BC01;Dibotermin alfa;3;DDD;1;
M05BC02;Eptotermin alfa;3;DDD;1;
M05BX;Other drugs affecting mineralization;3;DDD;1;
M05BX03;Strontium ranelate;;DDD;1;
M05BX04;Denosumab;;DDD;1;
M05BX05;Burosumab;3;DDD;1;
M05BX06;Romosozumab;3;DDD;1;
M09;Other drugs for disorders of the musculo-skeletal system;3;DDD;1;
M09A;Other drugs for disorders of musculo-skeletal syst;3;DDD;1;
M09AB;Enzymes;;DDD;1;
M09AB02;Collagenase clostridium histolyticum;;DDD;1;
M09AX;Other drugs for disorders of musculo-skeletal syst;3;DDD;1;
M09AX01;Hyaluronic acid;;DDD;1;
M09AX02;Chondrocytes, autologous;3;DDD;1;
M09AX03;Ataluren;;DDD;1;
M09AX07;Nusinersen;;DDD;1;
M09AX09;Onasemnogene abeparvovec;3;DDD;1;
M09AX10;Risdiplam;3;DDD;1;
N;Nervous system;;No common unit for volume;1;
N01;Anesthetics;;No common unit for volume;1;
N01A;Anesthetics, general;;No common unit for volume;1;
N01AB;Halogenated hydrocarbons;;ml or g (preparation);1;
N01AB01;Halothane;;ml or g (preparation);1;
N01AB04;Enflurane;;ml or g (preparation);1;
N01AB06;Isoflurane;;ml or g (preparation);1;
N01AB07;Desflurane;;ml or g (preparation);1;
N01AB08;Sevoflurane;;ml or g (preparation);1;
N01AF;Barbiturates, plain;;No common unit for volume;1;
N01AF01;Methohexital;;g (active substance);1;
N01AF03;Thiopental;;g (active substance);1;
N01AH;Opioid anesthetics;;No common unit for volume;1;
N01AH01;Fentanyl;;mg (active substance);1;
N01AH02;Alfentanil;;mg (active substance);1;
N01AH03;Sufentanil;;mg (active substance);1;
N01AH06;Remifentanil;;mg (active substance);1;
N01AX;Other general anesthetics;;No common unit for volume;1;
N01AX03;Ketamine;;g (active substance);1;
N01AX07;Etomidate;;g (active substance);1;
N01AX10;Propofol;;g (active substance);1;
N01AX13;Nitrous oxide;;L;1;
N01AX14;Esketamine;;g (active substance);1;
N01B;Anesthetics, local;;No common unit for volume;1;
N01BA;Esters of amino benzoic acid;;ml or g (preparation);1;
N01BA03;Tetracaine;;ml or g (preparation);1;
N01BB;Amides;1;ml or g (preparation);1;
N01BB01;Bupivacaine;;ml or g (preparation);1;
N01BB02;Lidocaine;1;ml or g (preparation);1;
N01BB03;Mepivacaine;;ml or g (preparation);1;
N01BB04;Prilocaine;;ml or g (preparation);1;
N01BB09;Ropivacaine;;ml or g (preparation);1;
N01BB20;Combinations;;ml or g (preparation);1;
N01BB51;Bupivacaine, combinations;1;ml or g (preparation);1;
N01BB52;Lidocaine, combinations;;ml or g (preparation);1;
N01BB53;Mepivacaine, combinations;;ml or g (preparation);1;
N01BB54;Prilocaine, combinations;;ml or g (preparation);1;
N01BB58;Articaine, combinations;;ml or g (preparation);1;
N01BC;Esters of benzoic acid;;ml or g (preparation);1;
N01BC01;Cocaine;;ml or g (preparation);1;
N01BX;Other local anesthetics;4;Items;1;
N01BX01;Ethyl chloride;;ml or g (preparation);1;
N01BX04;Capsaicin;;Items;1;
N02;Analgesics;;No common unit for volume;1;
N02A;Opioids;1,2,3;DDD;1;
N02A***;;;No common unit for volume;1;
N02AA;Natural opium alkaloids;1,3;DDD;1;
N02AA01;Morphine;1;DDD;1;
N02AA03;Hydromorphone;;DDD;1;
N02AA04;Nicomorphine;;DDD;1;
N02AA05;Oxycodone;;DDD;1;
N02AA51;Morphine, combinations;3;DDD;1;
N02AA55;Oxycodone and naloxone;;DDD;1;
N02AB;Phenylpiperidine derivatives;3;DDD;1;
N02AB01;Ketobemidone;;DDD;1;
N02AB02;Pethidine;;DDD;1;
N02AB03;Fentanyl;;DDD;1;
N02AB72;Pethidine comb with psycholeptics;3;DDD;1;
N02AC;Diphenylpropylamine derivatives;;DDD;1;
N02AC04;Dextropropoxyphene;;DDD;1;
N02AD;Benzomorphan derivatives;;DDD;1;
N02AD01;Pentazocine;;DDD;1;
N02AE;Oripavine derivatives;;DDD;1;
N02AE01;Buprenorphine;;DDD;1;
N02AF;Morphinan derivatives;;DDD;1;
N02AF02;Nalbufine;;DDD;1;
N02AG;Opioids in comb with antispasmodics;2,3;DDD;1;
N02AG01;Morphine and antispasmodics;2,3;DDD;1;
N02AG02;Ketobemidone and antispasmodics;2,3;DDD;1;
N02AJ;Opioids in combination with non-opioid analgesics;2,3;DDD;1;
N02AJ06;Codeine and paracetamol;2;DDD;1;
N02AJ07;Codeine and acetylsalicylic acid;3;DDD;1;
N02AX;Other opioids;;DDD;1;
N02AX02;Tramadol;;DDD;1;
N02AX06;Tapentadol;;DDD;1;
N02B;Other analgesics and antipyretics;;No common unit for volume;1;
N02BA;Salicylic acid derivatives;2,3;DDD;1;
N02BA01;Acetylsalicylic acid;;DDD;1;
N02BA11;Diflunisal;;DDD;1;
N02BA51;Acetylsalicylic acid, comb excl psycholeptics;2;DDD;1;
N02BA75;Salicylamide, combinations with psycholeptics;3;DDD;1;
N02BB;Pyrazolones;;DDD;1;
N02BB51;Phenazone, comb. excl psycholeptics;;DDD;1;
N02BE;Anilides;2;DDD;1;
N02BE01;Paracetamol;;DDD;1;
N02BE05;Propacetamol;;DDD;1;
N02BE51;Paracetamol, combinations excl psycholeptics;2;DDD;1;
N02BG;Other analgesics and antipyretics;;No common unit for volume;1;
N02BG09;Methoxyflurane;3;DDD;1;
N02BG10;Cannabinoids;;No common unit for volume;1;
N02C;Antimigraine preparations;1,3;DDD;1;
N02CA;Ergot alkaloids;1,3;DDD;1;
N02CA01;Dihydroergotamine;;DDD;1;
N02CA02;Ergotamine;;DDD;1;
N02CA04;Methysergide;;DDD;1;
N02CA52;Ergotamine, combinations;;DDD;1;
N02CA72;Ergotamine, combinations with psycholeptics;;No common unit for volume;1;
N02CC;Selective 5ht(1)-receptor agonists;;DDD;1;
N02CC01;Sumatriptan;;DDD;1;
N02CC02;Naratriptan;;DDD;1;
N02CC03;Zolmitriptan;;DDD;1;
N02CC04;Rizatriptan;;DDD;1;
N02CC05;Almotriptan;;DDD;1;
N02CC06;Eletriptan;;DDD;1;
N02CC07;Frovatriptan;;DDD;1;
N02CD;Calcitonin gene-related peptide (cgrp) antagonists;;DDD;1;
N02CD01;Erenumab;;DDD;1;
N02CD02;Galcanezumab;;DDD;1;
N02CD03;Fremanezumab;;DDD;1;
N02CX;Other antimigraine preparations;;DDD;1;
N02CX01;Pizotifen;;DDD;1;
N02CX02;Clonidine;;DDD;1;
N03;Antiepileptics;1;DDD;1;
N03A;Antiepileptics;1;DDD;1;
N03AA;Barbiturates and derivatives;1;DDD;1;
N03AA**;;;No common unit for volume;1;
N03AA02;Phenobarbital;;DDD;1;
N03AA03;Primidone;;DDD;1;
N03AB;Hydantoin derivatives;;DDD;1;
N03AB02;Phenytoin;;DDD;1;
N03AB05;Fosphenytoin;;DDD;1;
N03AD;Succinimide derivatives;;DDD;1;
N03AD01;Ethosuximide;;DDD;1;
N03AE;Benzodiazepine derivatives;;DDD;1;
N03AE01;Clonazepam;;DDD;1;
N03AF;Carboxamide derivatives;;DDD;1;
N03AF01;Carbamazepine;;DDD;1;
N03AF02;Oxcarbazepine;;DDD;1;
N03AF03;Rufinamide;;DDD;1;
N03AF04;Eslicarbazepine;;DDD;1;
N03AG;Fatty acid derivatives;;DDD;1;
N03AG01;Valproic acid;;DDD;1;
N03AG04;Vigabatrin;;DDD;1;
N03AG06;Tiagabine;;DDD;1;
N03AX;Other antiepileptics;;DDD;1;
N03AX09;Lamotrigine;;DDD;1;
N03AX11;Topiramate;;DDD;1;
N03AX12;Gabapentin;;DDD;1;
N03AX14;Levetiracetam;;DDD;1;
N03AX15;Zonisamide;;DDD;1;
N03AX16;Pregabalin;;DDD;1;
N03AX17;Stiripentol;;DDD;1;
N03AX18;Lacosamide;;DDD;1;
N03AX21;Retigabine;;DDD;1;
N03AX22;Perampanel;;DDD;1;
N03AX23;Brivaracetam;;DDD;1;
N03AX24;Cannabidiol;;DDD;1;
N03AX25;Cenobamate;;DDD;1;
N04;Anti-parkinson drugs;;DDD;1;
N04A;Anticholinergic agents;;DDD;1;
N04AA;Tertiary amines with carbon chain;;DDD;1;
N04AA01;Trihexyphenidyl;;DDD;1;
N04AA02;Biperiden;;DDD;1;
N04AA04;Procyclidine;;DDD;1;
N04AB;Ethers chemically close to antihistamines;;DDD;1;
N04AB02;Orphenadrine (chloride);;DDD;1;
N04AC;Ethers of tropine or tropine derivatives;;DDD;1;
N04AC01;Benzatropine;;DDD;1;
N04B;Dopaminergic agents;;DDD;1;
N04BA;Dopa and dopa derivatives;;DDD;1;
N04BA02;Levodopa and decarboxylase inhibitor;;DDD;1;
N04BA03;Levodopa, decarboxylase inhibitor and comt inhibitor;;DDD;1;
N04BB;Adamantane derivatives;;DDD;1;
N04BB01;Amantadine;;DDD;1;
N04BC;Dopamine agonists;;DDD;1;
N04BC01;Bromocriptine;;DDD;1;
N04BC02;Pergolide;;DDD;1;
N04BC04;Ropinirole;;DDD;1;
N04BC05;Pramipexole;;DDD;1;
N04BC06;Cabergoline;;DDD;1;
N04BC07;Apomorphine;;DDD;1;
N04BC09;Rotigotine;;DDD;1;
N04BD;Monoamine oxidase type b inhibitors;;DDD;1;
N04BD01;Selegiline;;DDD;1;
N04BD02;Rasagiline;;DDD;1;
N04BD03;Safinamide;;DDD;1;
N04BX;Other dopaminergic agents;;DDD;1;
N04BX01;Tolcapone;;DDD;1;
N04BX02;Gedocarnil;;DDD;1;
N04BX04;Opicapone;;DDD;1;
N05;Psycholeptics;1,3;DDD;1;
N05A;Antipsychotics;;DDD;1;
N05AA;Phenothiazine with aliphatic side chain;;DDD;1;
N05AA01;Chlorpromazine;;DDD;1;
N05AA02;Levomepromazine;;DDD;1;
N05AA03;Promazine;;DDD;1;
N05AA04;Acepromazine;;DDD;1;
N05AB;Phenothiazine with piperazine structure;;DDD;1;
N05AB01;Dixyrazine;;DDD;1;
N05AB02;Fluphenazine;;DDD;1;
N05AB03;Perphenazine;;DDD;1;
N05AB04;Prochlorperazine;;DDD;1;
N05AC;Phenothiazine with piperidine structure;;DDD;1;
N05AC01;Periciazine;;DDD;1;
N05AC02;Thioridazine;;DDD;1;
N05AC04;Pipotiazine;;DDD;1;
N05AD;Butyrophenone derivatives;;DDD;1;
N05AD01;Haloperidol;;DDD;1;
N05AD03;Melperone;;DDD;1;
N05AD05;Pipamperone;;DDD;1;
N05AD06;Bromperidol;;DDD;1;
N05AD08;Droperidol;;DDD;1;
N05AE;Indole derivatives;;DDD;1;
N05AE03;Sertindole;;DDD;1;
N05AE04;Ziprasidone;;DDD;1;
N05AE05;Lurasidone;;DDD;1;
N05AF;Thioxanthene derivatives;;DDD;1;
N05AF01;Flupentixol;;DDD;1;
N05AF03;Chlorprothixene;;DDD;1;
N05AF05;Zuclopenthixol;;DDD;1;
N05AG;Diphenylbutylpiperidine derivatives;;DDD;1;
N05AG02;Pimozide;;DDD;1;
N05AG03;Penfluridol;;DDD;1;
N05AH;Diazepines, oxazepines, thiazepines and oxepines;;DDD;1;
N05AH01;Loxapine;;DDD;1;
N05AH02;Clozapine;;DDD;1;
N05AH03;Olanzapine;;DDD;1;
N05AH04;Quetiapine;;DDD;1;
N05AH05;Asenapine;;DDD;1;
N05AL;Benzamides;;DDD;1;
N05AL01;Sulpiride;;DDD;1;
N05AL05;Amisulpride;;DDD;1;
N05AN;Lithium;;DDD;1;
N05AN01;Lithium;;DDD;1;
N05AX;Other antipsychotics;;DDD;1;
N05AX08;Risperidone;;DDD;1;
N05AX12;Aripiprazole;;DDD;1;
N05AX13;Paliperidone;;DDD;1;
N05AX15;Cariprazine;;DDD;1;
N05AX16;Brexpiprazole;;DDD;1;
N05B;Anxiolytics;;DDD;1;
N05BA;Benzodiazepine derivatives;;DDD;1;
N05BA01;Diazepam;;DDD;1;
N05BA02;Chlordiazepoxide;;DDD;1;
N05BA04;Oxazepam;;DDD;1;
N05BA05;Clorazepate potassium;;DDD;1;
N05BA06;Lorazepam;;DDD;1;
N05BA08;Bromazepam;;DDD;1;
N05BA09;Clobazam;;DDD;1;
N05BA12;Alprazolam;;DDD;1;
N05BB;Diphenylmethane derivatives;;DDD;1;
N05BB01;Hydroxyzine;;DDD;1;
N05BE;Azaspirodecanedione derivatives;;DDD;1;
N05BE01;Buspirone;;DDD;1;
N05C;Hypnotics and sedatives;1,3;DDD;1;
N05CA;Barbiturates, plain;;DDD;1;
N05CA01;Pentobarbital;;DDD;1;
N05CA04;Barbital;;DDD;1;
N05CC;Aldehydes and derivatives;;DDD;1;
N05CC01;Chloral hydrate;;DDD;1;
N05CD;Benzodiazepine derivatives;3;DDD;1;
N05CD01;Flurazepam;;DDD;1;
N05CD02;Nitrazepam;;DDD;1;
N05CD03;Flunitrazepam;;DDD;1;
N05CD04;Estazolam;;DDD;1;
N05CD05;Triazolam;;DDD;1;
N05CD06;Lormetazepam;;DDD;1;
N05CD07;Temazepam;;DDD;1;
N05CD08;Midazolam;;DDD;1;
N05CD09;Brotizolam;;DDD;1;
N05CD14;Remimazolam;3;DDD;1;
N05CF;Benzodiazepine related drugs;;DDD;1;
N05CF01;Zopiclone;;DDD;1;
N05CF02;Zolpidem;;DDD;1;
N05CF03;Zaleplon;;DDD;1;
N05CH;Melatonin receptor agonists;1;DDD;1;
N05CH01;Melatonin;1;DDD;1;
N05CM;Other hypnotics and sedatives;;DDD;1;
N05CM02;Clomethiazole;;DDD;1;
N05CM18;Dexmedetomidine;;DDD;1;
N06;Psychoanaleptics;1,3;DDD;1;
N06A;Antidepressants;;DDD;1;
N06AA;Non selective monoamine reuptake inhibitors;;DDD;1;
N06AA02;Imipramine;;DDD;1;
N06AA03;Imipramine oxide;;DDD;1;
N06AA04;Clomipramine;;DDD;1;
N06AA05;Opipramol;;DDD;1;
N06AA06;Trimipramine;;DDD;1;
N06AA07;Lofepramine;;DDD;1;
N06AA09;Amitriptyline;;DDD;1;
N06AA10;Nortriptyline;;DDD;1;
N06AA11;Protriptyline;;DDD;1;
N06AA12;Doxepin;;DDD;1;
N06AA16;Dosulepin;;DDD;1;
N06AA17;Amoxapine;;DDD;1;
N06AA21;Maprotiline;;DDD;1;
N06AB;Selective serotonin reuptake inhibitors;;DDD;1;
N06AB03;Fluoxetine;;DDD;1;
N06AB04;Citalopram;;DDD;1;
N06AB05;Paroxetine;;DDD;1;
N06AB06;Sertraline;;DDD;1;
N06AB08;Fluvoxamine;;DDD;1;
N06AB10;Escitalopram;;DDD;1;
N06AF;Monoamine oxidase inhibitors, non-selective;;DDD;1;
N06AF01;Isocarboxazid;;DDD;1;
N06AG;Monoamine oxidase type a inhibitors;;DDD;1;
N06AG02;Moclobemide;;DDD;1;
N06AX;Other antidepressants;;DDD;1;
N06AX03;Mianserin;;DDD;1;
N06AX06;Nefazodone;;DDD;1;
N06AX11;Mirtazapine;;DDD;1;
N06AX12;Bupropion;;DDD;1;
N06AX16;Venlafaxine;;DDD;1;
N06AX18;Reboxetine;;DDD;1;
N06AX21;Duloxetine;;DDD;1;
N06AX22;Agomelatine;;DDD;1;
N06AX26;Vortioxetine;;DDD;1;
N06AX27;Esketamine;;DDD;1;
N06B;Psychostimulants, agents used for adhd and nootropics;1,3;DDD;1;
N06BA;Centrally acting sympathomimetics;1,3;DDD;1;
N06BA01;Amfetamine;1;DDD;1;
N06BA02;Dexamfetamine;;DDD;1;
N06BA04;Methylphenidate;;DDD;1;
N06BA07;Modafinil;;DDD;1;
N06BA09;Atomoxetine;;DDD;1;
N06BA12;Lisdexamfetamine;;DDD;1;
N06BA14;Solriamfetol;3;DDD;1;
N06BC;Xanthine derivatives;;DDD;1;
N06BC01;Caffeine;;DDD;1;
N06BX;Other psychostimulants and nootropics;3;DDD;1;
N06BX13;Idebenone;3;DDD;1;
N06D;Anti-dementia drugs;;DDD;1;
N06DA;Anticholinesterases;;DDD;1;
N06DA02;Donepezil;;DDD;1;
N06DA03;Rivastigmine;;DDD;1;
N06DA04;Galantamine;;DDD;1;
N06DX;Other anti-dementia drugs;;DDD;1;
N06DX01;Memantine;;DDD;1;
N07;Other nervous system drugs;2,3;DDD;1;
N07A;Parasympathomimetics;2,3;DDD;1;
N07AA;Anticholinesterases;2,3;DDD;1;
N07AA01;Neostigmine;;DDD;1;
N07AA02;Pyridostigmine;;DDD;1;
N07AA51;Neostigmine, combinations;2,3;DDD;1;
N07AB;Choline esters;;DDD;1;
N07AB01;Carbachol;;DDD;1;
N07B;Drugs used in addictive disorders;3;DDD;1;
N07BA;Drugs used in nicotine dependence;;DDD;1;
N07BA01;Nicotine;;DDD;1;
N07BA03;Varenicline;;DDD;1;
N07BB;Drugs used in alcohol dependence;3;DDD;1;
N07BB01;Disulfiram;;DDD;1;
N07BB02;Calcium carbimide;3;DDD;1;
N07BB03;Acamprosate;;DDD;1;
N07BB04;Naltrexone;;DDD;1;
N07BB05;Nalmefene;;DDD;1;
N07BC;Drugs used in opioid dependence;3;DDD;1;
N07BC01;Buprenorphine;;DDD;1;
N07BC02;Methadone;;DDD;1;
N07BC03;Levacetylmethadol;3;DDD;1;
N07BC06;Diamorphine;3;DDD;1;
N07BC51;Buprenorphine, comb.;;DDD;1;
N07C;Antivertigo preparations;;DDD;1;
N07CA;Antivertigo preparations;;DDD;1;
N07CA01;Betahistine;;DDD;1;
N07CA02;Cinnarizine;;DDD;1;
N07CA03;Flunarizine;;DDD;1;
N07CA52;Cinnarizine, combinations;;DDD;1;
N07X;Other nervous system drugs;3;DDD;1;
N07XX;Other nervous system drugs;3;DDD;1;
N07XX01;Tirilazad;;DDD;1;
N07XX02;Riluzole;;DDD;1;
N07XX04;Sodium oxybate;;DDD;1;
N07XX05;Amifampridine;;DDD;1;
N07XX06;Tetrabenazine;;DDD;1;
N07XX07;Fampridine;;DDD;1;
N07XX08;Tafamidis;;DDD;1;
N07XX11;Pitolisant;;DDD;1;
N07XX12;Patisiran;3;DDD;1;
P;Antiparasitic products, insecticides and repellants;;No common unit for volume;1;
P01;Antiprotozoals;2;DDD;1;
P01A;Agents against amoebiasis and other proto.diseases;;DDD;1;
P01AB;Nitroimidazole derivatives;;DDD;1;
P01AB01;Metronidazole;;DDD;1;
P01AB02;Tinidazole;;DDD;1;
P01AX;Other agents against amoebiasis;;DDD;1;
P01AX06;Atovaquone;;DDD;1;
P01AX07;Trimetrexate;;DDD;1;
P01B;Antimalarials;2;DDD;1;
P01BA;Aminoquinolines;;DDD;1;
P01BA01;Chloroquine;;DDD;1;
P01BA02;Hydroxychloroquine;;DDD;1;
P01BB;Biguanides;2;DDD;1;
P01BB01;Proguanil;;DDD;1;
P01BB51;Proguanil and atovaquone;2;DDD;1;
P01BC;Methanolquinolines;;DDD;1;
P01BC01;Quinine;;DDD;1;
P01BC02;Mefloquine;;DDD;1;
P01BD;Diaminopyrimidines;;DDD;1;
P01BD51;Pyrimethamine, combinations;;DDD;1;
P01C;Agents against leishmaniasis and trypanosomiasis;;DDD;1;
P01CX;Other agents against leishmaniasis&trypanosomiasis;;DDD;1;
P01CX01;Pentamidine isethionat;;DDD;1;
P02;Anthelmintics;;DDD;1;
P02C;Antinematodal agents;;DDD;1;
P02CA;Benzimidazole derivatives;;DDD;1;
P02CA01;Mebendazole;;DDD;1;
P02CF;Avermectines;;DDD;1;
P02CF01;Ivermectin;;DDD;1;
P02CX;Other antinematodals;;DDD;1;
P02CX01;Pyrvinium;;DDD;1;
P02D;Anticestodals;;DDD;1;
P02DA;Salicylic acid derivatives;;DDD;1;
P02DA01;Niclosamide;;DDD;1;
P03;Ectoparasiticides, incl scabicides, insecticides and repellants;;ml or g (preparation);1;
P03A;Ectoparasiticides, incl scabicides;;ml or g (preparation);1;
P03AA;Sulphur containing products;;ml or g (preparation);1;
P03AA**;;;ml or g (preparation);1;
P03AB;Chlorine containing products;;ml or g (preparation);1;
P03AB02;Lindane;;ml or g (preparation);1;
P03AC;Pyrethrines, incl synthetic compounds;;ml or g (preparation);1;
P03AC03;Phenothrin;;ml or g (preparation);1;
P03AC04;Permethrin;;ml or g (preparation);1;
P03AC51;Pyrethrum, combinations;;ml or g (preparation);1;
P03AC52;Bioallethrin, combinations;;ml or g (preparation);1;
P03AX;Other ectoparasiticides, incl scabicides;;ml or g (preparation);1;
P03AX03;Malathion;;ml or g (preparation);1;
R;Respiratory system;;No common unit for volume;1;
R01;Nasal preparations;2,3;DDD;1;
R01A;Decongestants and other nasal preparations for topical use;2,3;DDD;1;
R01AA;Sympathomimetics, plain;;DDD;1;
R01AA04;Phenylephrine;;DDD;1;
R01AA05;Oxymetazoline;;DDD;1;
R01AA07;Xylometazoline;;DDD;1;
R01AB;Sympathomimetics,combinations excl corticosteroids;3;DDD;1;
R01AB06;Xylometazoline;3;DDD;1;
R01AC;Antiallergic agents, excl corticosteroids;3;DDD;1;
R01AC01;Cromoglicic acid;;DDD;1;
R01AC02;Levocabastine;;DDD;1;
R01AC03;Azelastine;;DDD;1;
R01AC51;Cromoglicic acid, combinations;3;DDD;1;
R01AD;Corticosteroids;2;DDD;1;
R01AD01;Beclomethasone;;DDD;1;
R01AD04;Flunisolide;;DDD;1;
R01AD05;Budesonide;;DDD;1;
R01AD08;Fluticasone;;DDD;1;
R01AD09;Mometasone;;DDD;1;
R01AD11;Triamcinolone;;DDD;1;
R01AD12;Fluticasone furoate;;DDD;1;
R01AD58;Fluticasone, combinations;2;DDD;1;
R01AX;Other nasal preparations;;DDD;1;
R01AX03;Ipratropium bromide;;DDD;1;
R01B;Nasal decongestants for systemic use;;DDD;1;
R01BA;Sympathomimetics;;DDD;1;
R01BA52;Pseudoephedrine, combinations;;DDD;1;
R02;Throat preparations;3;DDD;1;
R02A;Throat preparations;3;DDD;1;
R02AA;Antiseptics;3;DDD;1;
R02AA03;Dichlorobenzyl alcohol;3;DDD;1;
R02AA05;Chlorhexidine;;DDD;1;
R02AA20;Various;3;DDD;1;
R02AD;Anesthetics, local;3;DDD;1;
R02AD**;;3;DDD;1;
R02AD02;Lidocaine;3;DDD;1;
R02AX;Other throat preparations;;DDD;1;
R02AX01;Flurbiprofen;;DDD;1;
R02AX03;Benzydamine;;DDD;1;
R03;Drugs for obstructive airway diseases;2,3;DDD;1;
R03A;Adrenergics, inhalants;2,3;DDD;1;
R03AA;Alpha- and beta-adrenoceptor agonists;;DDD;1;
R03AA01;Epinephrine;;DDD;1;
R03AC;Selective beta-2-adrenoceptor agonists;;DDD;1;
R03AC02;Salbutamol;;DDD;1;
R03AC03;Terbutaline;;DDD;1;
R03AC04;Fenoterol;;DDD;1;
R03AC05;Rimiterol;;DDD;1;
R03AC12;Salmeterol;;DDD;1;
R03AC13;Formoterol;;DDD;1;
R03AC18;Indacaterol;;DDD;1;
R03AC19;Olodaterol;;DDD;1;
R03AK;Adrenergics comb. w. corticosteroids/other drugs, ex. anticholinergics;2;DDD;1;
R03AK06;Salmeterol and fluticasone;2;DDD;1;
R03AK07;Formoterol and budesonide;2;DDD;1;
R03AK08;Formoterol and beclometasone;2;DDD;1;
R03AK10;Vilanterol and fluticasone furoate;2;DDD;1;
R03AK11;Formoterol and fluticasone;2;DDD;1;
R03AK14;Indacaterol and mometasone;2;DDD;1;
R03AL;Adrenergics in combinations with anticholinergics incl. triple combinations with cort;2,3;DDD;1;
R03AL01;Fenoterol and ipratropium bromide;2,3;DDD;1;
R03AL02;Salbutamol and ipratropium bromide;2;DDD;1;
R03AL03;Vilanterol and umeclidinium bromide;2;DDD;1;
R03AL04;Indacaterol and glycopyrronium bromide;2;DDD;1;
R03AL05;Formoterol and aclidinium bromide;2;DDD;1;
R03AL06;Olodaterol and tiotropiumbromide;2;DDD;1;
R03AL07;Formoterol and glycopyrronium bromide;2;DDD;1;
R03AL08;Vilanterol, umeclidinium bromide and fluticasone furoate;2;DDD;1;
R03AL09;Formoterol, glycopyrronium bromide and beclometasone;2,3;DDD;1;
R03AL11;Formoterol, glycopyrronium bromide and budesonide;2;DDD;1;
R03AL12;Indacaterol, glycopyrroinium bromide and mometasone;2;DDD;1;
R03B;Other drugs for obstructive airway diseases, inhalants;3;DDD;1;
R03BA;Glucocorticoids;;DDD;1;
R03BA01;Beclomethasone;;DDD;1;
R03BA02;Budesonide;;DDD;1;
R03BA03;Flunisolide;;DDD;1;
R03BA05;Fluticasone;;DDD;1;
R03BA07;Mometasone;;DDD;1;
R03BA08;Ciclesonide;;DDD;1;
R03BB;Anticholinergics;3;DDD;1;
R03BB01;Ipratropium bromide;;DDD;1;
R03BB02;Oxitropium bromide;3;DDD;1;
R03BB04;Tiotropium bromide;;DDD;1;
R03BB05;Aclidinium bromide;;DDD;1;
R03BB06;Glycopyrronium bromide;;DDD;1;
R03BB07;Umeclidinium bromide;;DDD;1;
R03BC;Antiallergic agents, excl corticosteroids;;DDD;1;
R03BC01;Cromoglicic acid;;DDD;1;
R03BC03;Nedocromil;;DDD;1;
R03C;Adrenergics for systemic use;;DDD;1;
R03CA;Alpha- and beta-adrenoceptor agonists;;DDD;1;
R03CA02;Ephedrine;;DDD;1;
R03CB;Non-selective beta-adrenoceptor agonists;;DDD;1;
R03CB03;Orciprenaline;;DDD;1;
R03CC;Selective beta-2-adrenoceptor agonists;;DDD;1;
R03CC02;Salbutamol;;DDD;1;
R03CC03;Terbutaline;;DDD;1;
R03CC12;Bambuterol;;DDD;1;
R03D;Other systemic drugs for obstructive airway diseases;;DDD;1;
R03DA;Xanthines;;DDD;1;
R03DA02;Choline theophyllinate;;DDD;1;
R03DA03;Proxyphylline;;DDD;1;
R03DA04;Theophylline;;DDD;1;
R03DA05;Aminophylline;;DDD;1;
R03DC;Leukotriene receptor antagonists;;DDD;1;
R03DC01;Zafirlukast;;DDD;1;
R03DC03;Montelukast;;DDD;1;
R03DX;Other systemic drugs for obstructive airway diseases;;DDD;1;
R03DX05;Omalizumab;;DDD;1;
R03DX07;Roflumilast;;DDD;1;
R03DX08;Reslizumab;;DDD;1;
R03DX09;Mepolizumab;;DDD;1;
R03DX10;Benralizumab;;DDD;1;
R05;Cough and cold preparations;1,3;DDD;1;
R05C;Expectorants,excl combinations with antitussives;3;DDD;1;
R05CA;Expectorants;3;DDD;1;
R05CA10;Combinations;3;DDD;1;
R05CB;Mucolytics;;DDD;1;
R05CB01;Acetylcysteine;;DDD;1;
R05CB02;Bromhexine;;DDD;1;
R05CB06;Ambroxol;;DDD;1;
R05CB13;Dornase alfa (desoxiribonuclease);;DDD;1;
R05CB15;Erdosteine;;DDD;1;
R05CB16;Mannitol;;DDD;1;
R05D;Cough suppressants, excl. combinations with expectorants;3;DDD;1;
R05DA;Opium alkaloids and derivatives;;DDD;1;
R05DA01;Ethylmorphine;;DDD;1;
R05DA04;Codeine;;DDD;1;
R05DA07;Noscapine;;DDD;1;
R05DA09;Dextromethorphan;;DDD;1;
R05DB;Other cough suppressants;3;DDD;1;
R05DB05;Pentoxyverine;;DDD;1;
R05DB20;Combinations;3;DDD;1;
R05F;Antitussives and expectorants, combinations;1,3;DDD;1;
R05FA;Opium derivatives and expectorants;1,3;DDD;1;
R05FA02;Opium derivatives and expectorants;1,3;DDD;1;
R06;Antihistamines for systemic use;;DDD;1;
R06A;Antihistamines for systemic use;;DDD;1;
R06AA;Aminoalkyl ethers;;DDD;1;
R06AA02;Diphenhydramine;;DDD;1;
R06AA04;Clemastine;;DDD;1;
R06AA11;Dimenhydrinate;;DDD;1;
R06AB;Substituted alkylamines;;DDD;1;
R06AB02;Dexchlorpheniramine;;DDD;1;
R06AC;Substituted ethylene diamines;;DDD;1;
R06AC01;Mepyramine;;DDD;1;
R06AD;Phenothiazine derivatives;;DDD;1;
R06AD01;Alimemazine;;DDD;1;
R06AD02;Promethazine;;DDD;1;
R06AD03;Thiethylperazine;;DDD;1;
R06AD04;Methdilazine;;DDD;1;
R06AE;Piperazine derivatives;;DDD;1;
R06AE03;Cyclizine;;DDD;1;
R06AE04;Chlorcyclizine;;DDD;1;
R06AE05;Meclozine;;DDD;1;
R06AE07;Cetirizine;;DDD;1;
R06AE09;Levocetirizine;;DDD;1;
R06AX;Other antihistamines for systemic use;;DDD;1;
R06AX02;Cyproheptadine;;DDD;1;
R06AX09;Azatadine;;DDD;1;
R06AX11;Astemizole;;DDD;1;
R06AX12;Terfenadine;;DDD;1;
R06AX13;Loratadine;;DDD;1;
R06AX18;Acrivastine;;DDD;1;
R06AX22;Ebastine;;DDD;1;
R06AX25;Mizolastine;;DDD;1;
R06AX26;Fexofenadine;;DDD;1;
R06AX27;Desloratadine;;DDD;1;
R06AX28;Rupatadine;;DDD;1;
R06AX29;Bilastine;;DDD;1;
R07;Other respiratory system products;;No common unit for volume;1;
R07A;Other respiratory system products;;No common unit for volume;1;
R07AA;Lung surfactants;;DDD;1;
R07AA01;Colfosceril palmitate;;DDD;1;
R07AA02;Natural phosholipids;;DDD;1;
R07AB;Respiratory stimulants;;DDD;1;
R07AB01;Doxapram;;DDD;1;
R07AB07;Almitrine;;DDD;1;
R07AX;Other respiratory system products;;No common unit for volume;1;
R07AX01;Nitric oxide;;L;1;
R07AX02;Ivacaftor;;DDD;1;
R07AX30;Ivacaftor and lumacaftor;2,3;DDD;1;
R07AX31;Ivacaftor and tezacaftor;3;DDD;1;
R07AX32;Ivacaftor, tezacaftor and elexacaftor;2;DDD;1;
S;Sensory organs;;No common unit for volume;1;
S01;Ophthalmologicals;;No common unit for volume;1;
S01A;Antiinfectives;;Packages;1;
S01AA;Antibiotics;;Packages;1;
S01AA01;Chloramphenicol;;Packages;1;
S01AA02;Chlortetracycline;;Packages;1;
S01AA11;Gentamicin;;Packages;1;
S01AA12;Tobramycin;;Packages;1;
S01AA13;Fusidic acid;;Packages;1;
S01AA26;Azithromycin;;Packages;1;
S01AA27;Cefuroxime;;Packages;1;
S01AA30;Combinations of different antibiotics;;Packages;1;
S01AB;Sulfonamides;;Packages;1;
S01AB01;Sulfamethizole;;Packages;1;
S01AB03;Sulfadicramide;;Packages;1;
S01AD;Antivirals;;Packages;1;
S01AD03;Aciclovir;;Packages;1;
S01AD08;Fomivirsen;;Packages;1;
S01AE;Fluoroquinolones;;Packages;1;
S01AE01;Ofloxacin;;Packages;1;
S01AE02;Norfloxacin;;Packages;1;
S01AE03;Ciprofloxacin;;Packages;1;
S01AE04;Lomefloxacin;;Packages;1;
S01AE05;Levofloxacin;;Packages;1;
S01AE07;Moxifloxacin;;Packages;1;
S01AX;Other antiinfectives;;Packages;1;
S01AX02;Silver compounds;;Packages;1;
S01AX03;Zinc compounds;;Packages;1;
S01AX06;Resorcinol;;Packages;1;
S01AX07;Sodium borate;;Packages;1;
S01B;Antiinflammatory agents;;Packages;1;
S01BA;Corticosteroids, plain;;Packages;1;
S01BA01;Dexamethasone;;Packages;1;
S01BA02;Hydrocortisone;;Packages;1;
S01BA04;Prednisolone;;Packages;1;
S01BA05;Triamcinolone;;Packages;1;
S01BA07;Fluorometholone;;Packages;1;
S01BA13;Rimexolone;;Packages;1;
S01BA15;Fluocinolone acetonide;;Packages;1;
S01BC;Antiinflammatory agents, non-steroids;;Packages;1;
S01BC01;Indometacin;;Packages;1;
S01BC03;Diclofenac;;Packages;1;
S01BC04;Flurbiprofen;;Packages;1;
S01BC05;Ketorolac;;Packages;1;
S01BC10;Nepafenac;;Packages;1;
S01BC11;Bromfenac;;Packages;1;
S01C;Antiinflammatory agents and antiinfectives in comb;;Packages;1;
S01CA;Corticosteroids and antiinfectives in combination;;Packages;1;
S01CA01;Dexamethasone and antiinfectives;;Packages;1;
S01E;Antiglaucoma preparations and miotics;3;DDD;1;
S01EA;Sympathomimetics in glaucoma therapy;3;DDD;1;
S01EA02;Dipivefrine;;DDD;1;
S01EA03;Apraclonidine;;DDD;1;
S01EA05;Brimonidine;;DDD;1;
S01EA51;Epinephrine, combinations;3;DDD;1;
S01EB;Parasympathomimetics;3;DDD;1;
S01EB01;Pilocarpine;;DDD;1;
S01EB02;Carbachol;;DDD;1;
S01EB51;Pilocarpine, combinations;3;DDD;1;
S01EC;Carbonic anhydrase inhibitors;3;DDD;1;
S01EC01;Acetazolamide;;DDD;1;
S01EC02;Diclofenamide;;DDD;1;
S01EC03;Dorzolamide;;DDD;1;
S01EC04;Brinzolamide;;DDD;1;
S01EC54;Brinzolamide, combinations;3;DDD;1;
S01ED;Beta blocking agents;3;DDD;1;
S01ED01;Timolol;;DDD;1;
S01ED02;Betaxolol;;DDD;1;
S01ED03;Levobunolol;;DDD;1;
S01ED05;Carteolol;;DDD;1;
S01ED51;Timolol, combinations;3;DDD;1;
S01EE;Prostaglandin analogues;;DDD;1;
S01EE01;Latanoprost;;DDD;1;
S01EE03;Bimatoprost;;DDD;1;
S01EE04;Travoprost;;DDD;1;
S01EE05;Tafluprost;;DDD;1;
S01F;Mydriatics and cycloplegics;;No common unit for volume;1;
S01FA;Anticholinergics;;No common unit for volume;1;
S01FA01;Atropine;;No common unit for volume;1;
S01FA02;Scopolamine;;Packages;1;
S01FA04;Cyclopentolate;;Packages;1;
S01FA05;Homatropine;;Packages;1;
S01FA06;Tropicamide;;Packages;1;
S01FA56;Tropicamide, combinations;;Packages;1;
S01FB;Sympathomimetics excl. antiglaucoma preparations;4;Packages;1;
S01FB01;Phenylephrine;4;Packages;1;
S01G;Decongestants and antiallergics;3;DDD;1;
S01GA;Sympathomimetics used as decongestants;3;DDD;1;
S01GA02;Tetryzoline;3;DDD;1;
S01GA51;Naphazoline, combinations;3;DDD;1;
S01GA55;Phenylephrine, combinations;3;DDD;1;
S01GX;Other antiallergics;3;DDD;1;
S01GX01;Cromoglicic acid;3;DDD;1;
S01GX02;Levocabastine;3;DDD;1;
S01GX04;Nedocromil;3;DDD;1;
S01GX05;Lodoxamide;3;DDD;1;
S01GX06;Emedastine;3;DDD;1;
S01GX07;Azelastine;3;DDD;1;
S01GX08;Ketotifen;3;DDD;1;
S01GX09;Olopatadine;3;DDD;1;
S01H;Local anesthetics;;No common unit for volume;1;
S01HA;Local anesthetics;;No common unit for volume;1;
S01HA01;Cocaine;;Packages;1;
S01HA02;Oxybuprocaine;;No common unit for volume;1;
S01HA03;Tetracaine;;No common unit for volume;1;
S01HA06;Cinchocaine;;No common unit for volume;1;
S01J;Diagnostic agents;;Items;1;
S01JA;Colouring agents;;Items;1;
S01JA01;Fluorescein;;Items;1;
S01JA51;Fluorescein, combinations;;Items;1;
S01K;Surgical aids;;Packages;1;
S01KA;Viscoelastic substances;;Packages;1;
S01KA01;Hyaluronic acid;;Packages;1;
S01L;Ocular vascular disorder agents;3;DDD;1;
S01LA;Antineovascularisation agents;3;DDD;1;
S01LA01;Verteporfin;3;DDD;1;
S01LA03;Pegaptanib;3;DDD;1;
S01LA04;Ranibizumab;3;DDD;1;
S01LA05;Aflibercept;3;DDD;1;
S01LA06;Brolucizumab;3;DDD;1;
S01X;Other ophthalmologicals;1,4;ml or g (preparation);1;
S01XA;Other ophthalmologicals;1,4;ml or g (preparation);1;
S01XA**;;1;ml or g (preparation);1;
S01XA03;Sodium chloride, hypertonic;;ml or g (preparation);1;
S01XA05;Sodium edetate;;ml or g (preparation);1;
S01XA18;Ciclosporin;;ml or g (preparation);1;
S01XA19;Limbal stems cells, autologous;;Packages;1;
S01XA20;Artificial tears and other indifferent prep.;4;ml or g (preparation);1;
S01XA21;Mercaptamine;;ml or g (preparation);1;
S01XA22;Ocriplasmin;;Packages;1;
S01XA27;Voretigene neparvovec;;Packages;1;
S02;Otologicals;;Packages;1;
S02A;Antiinfectives;;Packages;1;
S02AA;Antiinfectives;;Packages;1;
S02AA01;Chloramphenicol;;Packages;1;
S02AA15;Ciprofloxacin;;Packages;1;
S02AA30;Antiinfectives, combinations;;Packages;1;
S02B;Corticosteroids;;Packages;1;
S02BA;Corticosteroids;;Packages;1;
S02BA08;Fluocinolone acetonide;;Packages;1;
S02C;Corticosteroids and antiinfectives in combination;;Packages;1;
S02CA;Corticosteroids and antiinfectives in combination;;Packages;1;
S02CA02;Flumetasone and antiinfectives;;Packages;1;
S02CA03;Hydrocortisone and antiinfectives;;Packages;1;
S02CA05;Fluocinolone acetonide and antiinfectives;;Packages;1;
S02CA06;Dexamethasone and antiinfectives;;Packages;1;
S03;Ophthalmological and otological preparations;;Packages;1;
S03A;Antiinfectives;;Packages;1;
S03AA;Antiinfectives;;Packages;1;
S03AA30;Antiinfectives, combinations;;Packages;1;
S03B;Corticosteroids;;Packages;1;
S03BA;Corticosteroids;;Packages;1;
S03BA01;Dexamethasone;;Packages;1;
S03C;Corticosteroids and antiinfectives in combination;;Packages;1;
S03CA;Corticosteroids and antiinfectives in combination;;Packages;1;
S03CA01;Dexamethasone and antiinfectives;;Packages;1;
S03CA04;Hydrocortisone and antiinfectives;;Packages;1;
V;Various;;No common unit for volume;1;
V01;Allergens;;No common unit for volume;1;
V01A;Allergens;;No common unit for volume;1;
V01AA;Allergen extracts;;No common unit for volume;1;
V01AA02;Grass pollen;;No common unit for volume;1;
V01AA03;House dust mites;;No common unit for volume;1;
V01AA05;Tree pollen;;No common unit for volume;1;
V01AA07;Insects;;Items;1;
V01AA10;Flowers;;Items;1;
V01AA11;Animals;;Items;1;
V03;All other therapeutic products;;No common unit for volume;1;
V03A;All other therapeutic products;;No common unit for volume;1;
V03AB;Antidotes;1;Items;1;
V03AB01;Ipecacuanha;;Items;1;
V03AB06;Thiosulphate;;Items;1;
V03AB08;Sodium nitrite;;Items;1;
V03AB09;Dimercaprol;;Items;1;
V03AB13;Obidoxime;;Items;1;
V03AB14;Protamine;;Items;1;
V03AB15;Naloxone;;Items;1;
V03AB17;Methylthionine;;Items;1;
V03AB18;Potassium permanganate;;Items;1;
V03AB19;Physostigmine;;Items;1;
V03AB21;Potassium iodide;;Items;1;
V03AB22;Amyl nitrite;;Items;1;
V03AB23;Acetylcysteine;;No common unit for volume;1;
V03AB25;Flumazenil;;Items;1;
V03AB33;Hydroxocobalamin;;Items;1;
V03AB35;Sugammadex;;Items;1;
V03AB37;Idarucizumab;;Items;1;
V03AC;Iron chelating agents;;Items;1;
V03AC01;Desferrioxamine;;Items;1;
V03AC02;Deferiprone;;Items;1;
V03AC03;Deferasirox;;Items;1;
V03AE;Drugs for treatment of hyperkalemia and hyperphosphatemia;1,2;DDD;1;
V03AE01;Polystyrene sulphonate;;DDD;1;
V03AE02;Sevelamer;;DDD;1;
V03AE03;Lanthanum carbonate;;DDD;1;
V03AE04;Calcium acetate and magnesium carbonate;2;DDD;1;
V03AE05;Sucroferric oxyhydroxide;;DDD;1;
V03AE07;Calcium acetate;1,4;DDD;1;
V03AE09;Patiromer calcium;;DDD;1;
V03AE10;Sodium zirconium cyclosilicate;;DDD;1;
V03AF;Detoxifying agents for cytostatic treatment;;No common unit for volume;1;
V03AF01;Mesna;;g (active substance);1;
V03AF02;Dexrazoxan;;DDD;1;
V03AF03;Calcium folinate;;DDD;1;
V03AF04;Calcium levofolinate;;DDD;1;
V03AF05;Amifostine;;DDD;1;
V03AF07;Rasburicase;;DDD;1;
V03AF08;Palifermin;;DDD;1;
V03AG;Drugs for treatment of hypercalcemia;3;DDD;1;
V03AG01;Sodium cellulose phosphate;3;DDD;1;
V03AN;Medical gases;1;L;1;
V03AN01;Oxygen;1;L;1;
V03AX;Other therapeutic products;3;DDD;1;
V03AX**;;3;DDD;1;
V03AX03;Cobicistat;;DDD;1;
V04;Diagnostic agents;;Items;1;
V04C;Other diagnostic agents;;Items;1;
V04CA;Tests for diabetes;;Items;1;
V04CA02;Glucose;;Items;1;
V04CC;Tests for bile duct potency;;Items;1;
V04CC02;Magnesium sulphate;;Items;1;
V04CD;Tests for pituitary function;;Items;1;
V04CD01;Metyrapone;;Items;1;
V04CD05;Somatorelin;;Items;1;
V04CE;Tests for liver functional capacity;;Items;1;
V04CE01;Galactose;;Items;1;
V04CF;Tuberculosis diagnostics;;Items;1;
V04CF01;Tuberculin;;Items;1;
V04CG;Tests for gastric secretion;;Items;1;
V04CG03;Histamine phosphate;;Items;1;
V04CH;Tests for renal function and ureteral injuries;;Items;1;
V04CH02;Indigo carmine;;Items;1;
V04CJ;Tests for thyreoidea function;;Items;1;
V04CJ02;Protirelin;;Items;1;
V04CL;Tests for allergic diseases;;Items;1;
V04CL**;;;Items;1;
V04CX;Other diagnostic agents;;Items;1;
V04CX**;;;Items;1;
V04CX04;Mannitol;;Items;1;
V04CX05;13c-urea;;Items;1;
V04CX06;Hexaminolevulinate;;Items;1;
V07;All other non-therapeutic products;;ml;1;
V07A;All other non-therapeutic products;;ml;1;
V07AB;Solvents and diluting agents,incl irrigat solut;;ml;1;
V07AB**;;;ml;1;
V08;Contrast media;;No common unit for volume;1;
V08A;X-ray contrast media, iodinated;;g (iodine);1;
V08AA;Watersoluble, nephrotropic, high osmolar x-ray contrast media;;g (iodine);1;
V08AA01;Diatrizoic acid;;g (iodine);1;
V08AA02;Metrizoic acid;;g (iodine);1;
V08AA05;Ioxitalamic acid;;g (iodine);1;
V08AB;Watersoluble, nephrotropic, low osmolar x-ray contrast media;;g (iodine);1;
V08AB02;Iohexol;;g (iodine);1;
V08AB03;Ioxaglic acid;;g (iodine);1;
V08AB04;Iopamidol;;g (iodine);1;
V08AB05;Iopromide;;g (iodine);1;
V08AB06;Iotrolan;;g (iodine);1;
V08AB07;Ioversol;;g (iodine);1;
V08AB09;Iodixanol;;g (iodine);1;
V08AB10;Iomeprol;;g (iodine);1;
V08AB11;Iobitridol;;g (iodine);1;
V08AD;Non-watersoluble x-ray contrast media;;g (iodine);1;
V08AD01;Ethyl esters of iodised fatty acids;;g (iodine);1;
V08B;X-ray contrast media, non-iodinated;;No common unit for volume;1;
V08BA;Barium sulphate containing x-ray contrast media;;No common unit for volume;1;
V08BA01;Barium sulphate with suspending agents;;g (active substance);1;
V08BA02;Barium sulphate without suspending agents;;g (active substance);1;
V08C;Magnetic resonance imaging contrast media;3,4;DDD;1;
V08CA;Paramagnetic contrast media;3;DDD;1;
V08CA01;Gadopentetic acid;3;DDD;1;
V08CA02;Gadoteric acid;3;DDD;1;
V08CA03;Gadodiamide;3;DDD;1;
V08CA04;Gadoteridol;3;DDD;1;
V08CA05;Mangafodipir;3;DDD;1;
V08CA06;Gadoversetamide;3;DDD;1;
V08CA08;Gadobenic acid;3;DDD;1;
V08CA09;Gadobutrol;3;DDD;1;
V08CA10;Gadoxetic acid;3;DDD;1;
V08CA11;Gadofosveset;3;DDD;1;
V08CB;Superparamagnetic contrast media;;No common unit for volume;1;
V08CB01;Ferumoxsil;;g (active substance);1;
V08CB02;Iron ferrite with carrier particles;;g (active substance);1;
V08CB03;Ferristene;;g (active substance);1;
V08D;Ultrasound contrast media;;No common unit for volume;1;
V08DA;Ultrasound contrast media;;No common unit for volume;1;
V08DA01;Perflutren, human albumin microspheres;;g (active substance);1;
V08DA02;Microparticles of galactose;;g (active substance);1;
V08DA05;Sulfur hexafluoride, phospholipid microspheres;;g (active substance);1;
V09;Diagnostic radiopharmaceuticals;;No common unit for volume;1;
V09A;Central nervous system;;No common unit for volume;1;
V09A***;;;No common unit for volume;1;
V09B;Skeleton;;No common unit for volume;1;
V09B***;;;No common unit for volume;1;
V09C;Renal system;;No common unit for volume;1;
V09C***;;;No common unit for volume;1;
V09D;Hepatic and reticulo endothelial system;;No common unit for volume;1;
V09D***;;;No common unit for volume;1;
V09E;Respiratory system;;No common unit for volume;1;
V09E***;;;No common unit for volume;1;
V09F;Thyroid;;No common unit for volume;1;
V09F***;;;No common unit for volume;1;
V09G;Cardiovascular system;;No common unit for volume;1;
V09G***;;;No common unit for volume;1;
V09H;Inflammation and infection detection;;No common unit for volume;1;
V09H***;;;No common unit for volume;1;
V09I;Tumour detection;;No common unit for volume;1;
V09I***;;;No common unit for volume;1;
V09X;Other diagnostic radiopharmaceuticals;;No common unit for volume;1;
V09X***;;;No common unit for volume;1;
V10;Therapeutic radiopharmaceuticals;;No common unit for volume;1;
V10A;Antiinflammatory agents;;No common unit for volume;1;
V10A***;;;No common unit for volume;1;
V10B;Pain palliation (bone seeking agents);;No common unit for volume;1;
V10B***;;;No common unit for volume;1;
V10X;Other therapeutic radiopharmaceuticals;;No common unit for volume;1;
V10X***;;;No common unit for volume;1;
V10XX;Various therapeutic radiopharmaceuticals;;No common unit for volume;1;
V10XX02;Ibritumomab tiuxetan (90-y);;No common unit for volume;1;
X;All medicines;;No common unit for volume;1;
